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1Introduction
Of the many disabilities associated with old age, dementia (to lose one's ' mind, in Latin) is
perhaps the most appalling. Approximately 1.2 million people in the United States [156] and
100,000 people in the Netherlands [306] suffer from severe dementia. Estimates for mild
dementia are twice as high. These numbers are on the increase in view of the anticipated
'old-age-boom'. In the last decade, dementia has been increasingly recognized as a major
public health problem, not least because the psychological and physical burden on caregivers
is enormous. Moreover, dementia has an immense effect on society in terms of consumption of
medical facilities [161]: the costs of dementia in terms of nursing homes and other forms of
care in the United States are calculated at about $ 40 billion per year [225] •
The accurate diagnosis of dementia has long been a problem, but in the last decade
considerable progress has been made. Consensus procedures have yielded operational criteria
for the clinical diagnosis of dementia and the main dementing illnesses [7, 45, 207, 266].
Essentially, the diagnosis of dementia involves two steps: first, the diagnosis of the behavioural
syndrome of dementia, and second, the differentiation of diseases that produce dementia.
According to current definitions, dementia is a condition of functional dependency [7]. The
syndrome of dementia should be differentiated from normal ageing and psychiatric disorders
such as depression, delirium and focal neuropsychological deficits. Although dementia can be
caused by more than 70 disorders [115], Alzheimer's disease (AD) and vascular dementia (VD)
account for about 80% of all demented patients [156]. The main problem is the diagnosis of
AD, which is still largely arrived at by excluding other dementing disorders, with dementia and
a progressive course being the only two inclusion criteria. It is evident that an insidious and
progressive disease such as AD does not manifest itself from the very beginning as the
complete syndrome of dementia. Early in the course of AD, the patient may exhibit mild
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memory impairments and changes in other mental domains that are not sufficiently severe to
merit the diagnosis of dementia. Recognizing these prodromes of AD is one of the most
complex problems in psychogeriatry to date.
The early and differential diagnosis of dementia is the main topic of this thesis. Before
discussing the clinical studies that have been performed on this subject, we will discuss shortly
the rationale of an early diagnosis of dementia. Most of the studies described in this thesis
were carried out in the Memory Clinic of the University Hospital of Maastricht, the
Netherlands. The organization of this clinic will also be described briefly. This chapter will also
provide a description of the major questions that this thesis attempted to answer.
Rationale of the need for an early diagnosis of dementia
At present, an accurate diagnosis of early dementia has become a major objective of scientific
research and clinical practice [56,116,124,152,162,219]. There are many reasons for this.
From a scientific point of view, the diagnosis of early AD helps to clarify epidemiological
aspects such as the natural history of the disease, which is of major importance for planning
and developing health-care facilities. The lack of clear diagnostic criteria for early AD is
reflected by the estimates of its prevalence. In contrast to severe dementia, in which the
prevalence is remarkably consistent in various studies (about 5 % of the population of 65 years
and older), the prevalence of mild dementia ranges from 2.6 [19] to 21.9 % and even up to
52.7 % in one Japanese study [124]. This extreme variation is probably mainly due to
differences in the criteria and the methods used to identify cases of mild dementia [123,124].
Second, studying the phenomenology of the very first manifestations of AD provides
information about the specific brain regions involved, and this helps to clarify the underlying
cause. For instance, early onset Alzheimer's disease presents relatively often with language
disorders, suggesting that the left hemisphere may be more vulnerable to the early-onset
variant, compared with the late-onset type. Observations such as this have led to the notion of
heterogeneity of Alzheimer's disease [27, 200]. Third, it is of vital importance that drugs that
enhance cognition in demented patients are tested in the early phases of the disease, before
changes in the brain have become structural [151,336],
From a clinical point of view, an early diagnosis of AD is also of importance. First, a
significant minority of patients with the diagnosis of dementia suffer from treatable conditions
[104,116,197,290], and treatment of these diseases is expected to be more successful in the
early stages [47,180]. Additionally, the focus of geriatric medicine has shifted during the last
decade from the cure of disease to the reduction of'excessive disability' [13]. This approach
supports the idea of an early elective methodological examination in search of treatable
concurrent conditions, such as drug intoxication, paranoia or sensory impairment, even when
the patient is known to be suffering from irreversible dementia. Second, remedial
psychotogical treatments designed to compensate for the cognitive deterioration of
irreversible dementia are likely to be more effective in mild than in severe dementia [101,
129, 210, 341]. Third, a diagnosis of mild dementia is important with regard to the future. It
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enables the health caregivers to plan measures to avoid crises and relieve some of the distress
of the patients' relatives. The caregivers are thus able to anticipate future measures such as
placement of their relative in a nursing home, and they can commence a process of acceptance
and realistic coping, thus preventing possible misunderstandings and counterproductive
interactions [110,230,339]. Fourth, an early diagnosis carries implications for the physician's
management of the patient and his or her relatives. Knowledge of the existence of a dementia
syndrome has, for example, an influence on the choice of drugs prescribed, notably those with
anticholinergic properties [56,124]. In addition, early recognition of dementia has an impact
on the interpretation of information from the patient's history and should lead to a heightened
awareness on the part of the physician. Fifth, it is of great importance to have diagnostic
methods that accurately sort out those patients with mild dementia from those with more
benign forgetfulness. This in the light of the public's growing awareness of dementia as a
major health problem and the corresponding anxiety that is caused by the media [147, 241,
318].
Active detection of people with cognitive deterioration has also raised some scepticism
about the ethical aspects of the consequences for the individual patient, who is left with a
dramatic diagnosis for which no cure exists [56]. However, although this criticism may apply to
community studies, where people are faced with this diagnosis without having asked for this, it
does not apply to daily clinical practice, where an increasing number of elderly people
complain about their memory and seek help for their cognitive problems [51,191] • Memory
impairment may compromise the individual's ability to function in intellectually demanding
activities and employment situations. Subjects with memory complaints may experience great
distress and are not comforted by assurances that the impairment is normal, that they are "just
getting older", or that they are "not becoming demented" [59].
Problems in the early diagnosis of dementia
Many efforts have been made to find objective biological markers for an early diagnosis of
Alzheimer's disease; however, none of these markers has as yet proven to be successful in
individual cases. Clinical neurological findings for mildly demented patients did not differ from
those of normal subjects [107,213]. A considerable overlap between normal subjects and
mildly demented patients exists in the findings obtained by Computed Tomography (CT) [69,
144], Single Photon Emission Computed Tomography (SPECT) [331] and Magnetic Resonance
Imaging (MRI) [280], Studies with Positron Emission Tomography (PET) have shown more
encouraging results [122,249], but PET is not practical because of its enormous costs and its
limited availability. Progress has been made in the development of biochemical markers by
using cerebro-spinal fluid from patients with AD, but this still in an experimental phase [109,
112,287]. Thus, at present biological markers may be of value in differentiating Alzheimer's
disease from other dementing illnesses [144], but not in accurately predicting dementia in
subjects who are not yet demented. Neuropathological data from patients in the early stages
of AD are extremely rare and not representative [60,126, 216]. Given the lack of reliable and
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valid aetiologically based objective tests, the diagnosis of early Alzheimer's disease is still
based on detailed clinical description, differentiation from normality and other behavioural
diagnoses such as depression, neuropsychological examination and follow-up studies [227
264].
Of these aspects, the differentiation between normal states and dementia has been
especially problematic. In the past 30 years, several attempts have been made to define the
clinical and neuropsychological features of the borderline state between normality and frank
dementia. Already in 1958 Krai introduced the terms benign and malignant senescent
forgetfulness to describe the memory complaints of the elderly he studied [170]. Since then,
investigators have tried to describe these states in more detail, eg, very mild or mild cognitive
decline [255], questionable dementia [139], minimal dementia [272], age-associated memory
impairments [59], age-consistent memory impairment and late-life forgetfulness [23]. The
fourth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)
encompasses a new category as well, namely 'age-associated cognitive decline' [37,248,292].
However, the nosological status of many of these proposals is still unclear, especially with
regard to what extent they are related to dementia [68]. Despite enormous scientific effort,
there are still many uncertainties about the diagnosis of the very first stages of Alzheimer's
disease, i.e., before it is manifest as frank dementia. These difficulties in diagnosis are largely
inherent to the multidimensional nature of the condition.
It is a common experience of those who are active in the field of dementia that patients
only come to the notice of health professionals once they are already clearly demented. This
may be because up till now there were only a very few facilities that were adequately
equipped for the diagnosis and treatment of the less disturbed patient. As a consequence,
traditional psychogeriatric departments 'screen' patients who have already been dementing
for some time for potentially treatable causes. In recent years, special memory clinics have
been set up in several places for the evaluation and management of elderly patients with
milder cognitive deficits [4, 14, 38, 241, 319, 328]. In contrast to traditional psychogeriatric
departments, the criterion for referral to memory clinics is usually a mild or moderate
cognitive problem, and not severe dementia. The threshold for referral is therefore lower,
resulting in earlier and better opportunities for preventive interventions. The diagnostic
approach in a memory clinic differs on important aspects from that of the more traditional
psychogeriatric departments. For example, the first question is not what causes the dementia,
but rather whether dementia is present or not. The specific goals of the memory clinics make'
specific demands upon the organization and on the diagnostic procedures used. Existing
memory clinics differ among themselves in the diagnostic approach and their specific goals
[150]. The aims, methods and organization of the Maastricht Memory Clinic (MMC) of the
University Hospital of Maastricht, in which most of the studies of this thesis were carried out, is
described here.
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Outline of the Maastricht Memory Clinic
The MMC opened in May 1986. It was a joint effort of the Department of Neuropsychology
and Psychobiology, University of Limburg, and the Departments of Psychiatry and Neurology of
the University Hospital of Maastricht, the Netherlands [319, 322], The explicit aims of the
MMC are to provide a new service for the diagnosis and treatment of patients with relatively
mild memory problems, whether demented or not, and to perform clinical research with
particular reference to the very early stages of Alzheimer's disease. The following sections
describe the main aspects with regard to the premises, organization and diagnostic procedures
of the MMC. More details of the procedures used are provided in chapters 5,6, and 7.
Premises
Before the MMC was opened, some principles were formulated that formed the basis of the
working methods to be used. These can be summarized as follows. First, the diagnostic
procedures should be based upon clear and well-accepted diagnostic research criteria so that
the clinic can be used for research goals as well. Second, a variety of cognitive and non-
cognitive behavioural aspects should be assessed, because it is not know which features are
particularly distinctive for the diagnosis of early dementia. Third, the diagnostic approach
should be multidisciplinary, with equal input from psychiatry, neurology and neuropsychology.
It was felt that each specialty complements the other with its own specific paradigms,
specialistic expertise and investigational methods. Fourth, in order to enable group
comparisons, the diagnostic procedure must be standardized as much as possible, by using
reliable quantitative measures of the different aspects involved. Fifth, the instruments used
must be sensitive enough to assess subtle impairments and changes with time, and must have
also a difficulty range appropriate for non-demented elderly and for early Alzheimer's disease
in order to avoid floor and ceiling effects. Ideally, both non-demented and demented subjects
should be evaluated with the same instruments, in order to allow for follow-up studies. Sixth,
the tests should be documented in terms of reliability and validity, and norms should be
available as well as equivalent forms for repeated administration. Finally, and most importantly,
the clinic should not only be a centre for diagnosis, but must also offer specific treatment and
care, in order to meet the expectations of the patients. Such a department should work
closely with other disciplines involved in the care of the demented patient.
(Mme o/ tóe dfognosft'c procedure
In the MMC, the criteria of the DSM-III (and from 1987, the DSM-II1-R) are used for the
diagnosis of dementia and other psychiatric syndromes. The criteria of the National Institute of
Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and
Related Disorders Association (NINCDS-ADRDA) are used for the diagnoses of possible and
probable Alzheimer's disease [207). Hachinski's Ischaemic Score is used for the diagnosis of
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vascular dementia. Other neurological and somatic conditions are diagnosed according to usual
clinical guidelines. All patients are examined by, or under the direct supervision of, the author
of this thesis, who is specialized in both psychiatry and neurology, and experienced in the area
of overlap between the two disciplines. In addition, many patients are examined by a
neurologist who has a special interest in neurodegenerative brain diseases The
neuropsychiatric part of the assessment lasts about 1.5 to 2 hours, and information is recorded
in a specially designed standardized patient file. The following scales are routinely
administered, in order to document several important behavioural aspects: the Global
Deterioration Scale, to obtain a measure of the extent of global deterioration [255]; the
Blessed dementia scale, as an overall measure of social functioning [24); Folstein's' Mini
Mental State Examination [97] in order to standardize the clinical impression of cognitive
functioning; and Hamilton's depression rating scale, as a symptom checklist for affective
symptomatology and in order to obtain an overall measure of depression [120]. A CT scan and
ancillary laboratory tests, according to general consensus [281], are performed when there are
objective cognitive deficits.
The neuropsychological part of the assessment lasts another 2 to 2.5 hours and has been
described in length elsewhere [146]. Briefly, this part involves standard psychometric tasks,
combined with a neurobehavioural examination according to Luria- Christensen [42,195] and'
information processing tasks [297], to assess the relevant cognitive functions in the areas of
memory, attention, language, praxis, perceptual functions, speed of information processing
and other aspects. The battery of neuropsychological tests has been designed in order to
contribute to the classification of memory disorders (e.g, dementia or age-associated memory
impairments), but also to provide insight into the psychological mechanisms that lead to a
certain performance level. Special emphasis is also placed on the use of qualitative tests, so
that profiles can be made of the weak and strong aspects of cognitive functioning, thereby
making it possible to offer better opportunities for specific advice and guidance as compared
when quantitative tasks are used.
After the tests have been completed, the results are discussed at a weekly interdisciplinary
meeting. After discussion in this forum, a definite syndromal and aetiological (differential)
diagnosis is made, and treatment proposals are formulated. Finally, a letter is sent to the
referring physician in which all the diagnostic elements, a final diagnosis and the treatment
proposal are described. Once the assessment phase is completed, the diagnostic data are
entered into a database.
The MMC cooperates with other regional departments involved in the care of patients with
dementia, eg, geriatricians and the psychogeriatric department of the Regional Institute of
Ambulatory Mental Health Care (RIAGG). The MMC also participates in the psychogeriatric
platform, a weekly meeting at which requests for nursing home admissions are discussed. In
addition to psychiatric and neurological treatments, patients of the MMC are offered the
chance to participate in ongoing clinical trials with experimental cognition-enhancing drugs
and putative anti-Alzheimer agents. Moreover, a psychological treatment programme has been
developed with the aim of improving coping and compensation strategies with regard to the
cognitive deficits [50, 260].
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^Experience m tóe Memory C/J'/MC
Based on our experience in the MMC, we agree with others [4, 14, 38, 52, 241, 328] that
memory clinics offer an excellent opportunity for combining specific patient care and clinical
research into memory impairments and early Alzheimer's disease. At present (May 1993),
more than 600 patients have been examined in the MMC. The mean age of the first 430
patients was 61.7 years, ranging from 16 to 88 years. Thirty-five per cent fulfilled the
DSM-III-R criteria of dementia, and cognitive impairments could be objectified in another
4956. Sixteen per cent of the patients appeared to have normal cognitive functions on
extensive neuropsychological testing. These figures differ from those from traditional geriatric
departments and clearly reflect the idea that the MMC is a memory clinic, not a dementia
clinic [150].
Some particular problems and limitations of this type of department should be mentioned
as well. The diagnostic work-up is time consuming and requires experience, because it
encompasses several elements for which clinical judgement is needed. The balance between
costs and benefit from the point of view of patient care has still to be examined, although
memory clinics definitely contribute immaterially by removing uncertainties and by offering
help to patients and their caregivers in dealing with their cognitive deficits. As matters
regarding memory having become fashionable, one takes the risk that an expensive service is
available for the 'worried well' who merely want to train their unimpaired memory. This is
avoided by ensuring that all patients are referred by their physicians before they are assessed
in the MMC. However, an intense fear of dementia, whether justified or not, may be a good
reason for further evaluation of the subject in the MMC. Finally, the multidisciplinary type of
assessment makes special demands on the organization, as the assessments of each specialty
have to be combined into an integrated final diagnosis and treatment plan. This means that
extra motivation and enthusiasm on the part of those involved are essential to the success of
the organization.
Aims and outline of this thesis
This thesis addresses clinical aspects of an early diagnosis of dementia, with particular
reference being paid to the differentiation between early dementia and normal age-associated
cognitive impairments and depression. The results of nine different clinical studies are
presented in the next chapters. The main subjects of these studies deal with the differences
between the specialties involved in the diagnosis of dementia, the clinical characteristics of
patients who seek help for cognitive complaints, and the use of clinical features in the
differential diagnosis of dementing disorders. The relevant literature is reviewed first
(chapter 2), in order to depict the current state of the subject.
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The main questions of this thesis are:
a r e tf?e ^Je rewce j tetoeen tóe <%notf/c oa/come o/ tóe WIHOMS
öf /n tóe assessment o / ^ t f ?
As will be shown in the comprehensive review of the literature (chapter 2), the diagnosis of
early Alzheimer's disease is dependent to an important extent on clinical judgement. As a
consequence, theoretically important differences may be expected between the various
disciplines involved, but there are hardly any data on this subject. A related question is
whether a multidisciplinary approach, as is generally recommended, leads to substantial
differences in the diagnostic outcome of patients with memory impairments compared to the
outcomes achieved with a monodisciplinary type of assessment, as is usually the case in daily
clinical practice. Therefore, two studies were carried out. The first study, described in chapter
3, was an experimental study of the interdisciplinary agreement on the diagnosis of dementia
among the participants of a consensus meeting on dementia, which was held in Utrecht, the
Netherlands, in November 1988. Representatives of several different specialties were asked to
diagnose ten fictitious patients with some kind of memory problem. In chapter 4, a study is
presented in which the monodisciplinary approach of referring physicians was compared with
the multidisciplinary diagnostic approach of the MMC. In order to investigate the validity of
the diagnoses of dementia that were made by the MMC, a follow-up study involving patients
diagnosed as demented was carried out into the course of social and cognitive functioning.
The results of this study are presented in chapter 5.
a r e tóe c/m/oi / d w r a c f ó m / i a o/non-rfemewfóflfpatotó iwfro seed; Mp /or
On the basis of the literature, it can be concluded that it is important to examine non-
demented patients with cognitive complaints and various psychiatric disorders in more detail,
as they may provide important clues about the very first manifestations of Alzheimer's disease.'
Therefore, three studies were carried out with patients from the MMC who had cognitive
impairments milder than those meriting the diagnosis of dementia, in order to answer the
following questions:
2.7 W t a />g»d>jtf/nc d/sorrfers, aparf / rom Memento, can èe accow/wmo/ &y cqgroftw?
com/>/am& or cqgmft'w Éfeonfers ?
2.2 Can «e«rop<ryd?o/ogjca/ afys/uncrtotts fee o6/ec///iW /n ww-rferoeHterf/wftente i«f/>
retowe/y w/W comp/amft «6ow? moo/, memory «ra/concentration ?
2.3 M w rfo cogmtoe comp/amte ara/ /owered moo/ retoe to eöd> otóer. Aw/fe» <fo tee
«e«ro/ ) j rycWog/c«/^c te dfeye/opyMrfbe?
The study described in chapter 6 provides an inventory of the various psychiatric disorders that
may be related to cognitive complaints. Chapter 7 describes a study in which 25 patients with
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a dysthymic disorder were compared to 25 normal subjects of the same age, sex and
educational level, in order to investigate whether cognitive deficits could be objectified. A
2-year follow-up study of non-demented patients from the memory clinic is presented in
chapter 8. This study was carried out in order to obtain insight into the development of the
cognitive impairments, and their relationship with depressive symptomatology,
3 Are teiwwbwra/ dwractertóto o/iise in estaW/sèmg tóe aeftb/ogy o/rfemewftfl ?
Alzheimer's disease remains a diagnosis that is largely made by excluding other disorders.
Thus, the reliability of this diagnosis is directly related to the accuracy with which other
disorders can be diagnosed or ruled out. The most frequent disorder that should be
differentiated from Alzheimer's disease is vascular dementia. For a long time, this diagnosis
was made on the basis of clinical features, with ischaemic scores generally being used as the
most important diagnostic tools. The introduction of new diagnostic criteria for vascular
dementia puts more emphasis on the results of data collection from brain-imaging techniques
such as CT or MRI scan. This led us to pose the following questions:
3. ƒ Wfert are tóe rfjjerewcej betoeen current criteria / o r f ascu/ar rf
is tóe zm/wc/ on tóe *%nasis q/jMztómer's disease.'
3.2 Can tóe rfj^erenftflft'o» èetoeen dfabeiwier's rfweose awo" t/ascu/ar Memento 6e
re/j'tfWy on tóe te's o/ Wawbura/ dwracteraft'cs ?
In Chapter 9, several current diagnostic criteria for the diagnosis of vascular dementia are
compared with each other in patients from the MMC in whom disorders other than cerebral
ischaemia and primary degenerative brain disease have been excluded. In chapter 10, the
results of a study of some behavioural characteristics that are often presumed to differentiate
between Alzheimer's disease and vascular dementia, such as depression and retained insight,
are presented.
3 J ft tóe degree o/awareness o/èewjg ccgwiffae/y impaired' re/ated* to tóe depression z«
Depression is an important disorder that can precede, mimic, coexist with or result from
dementia. The prevalence of depression, or at least depressive symptoms, is reported to be
generally higher in patients with dementia than in those without. The pathogenesis of these
depressive symptoms is not well understood and can be explained both biologically and
psychologically. In chapter 11 the relationship between awareness and depression in
demented patients is investigated, in order to determine whether patients who know that
they are deteriorating are more at risk of developing depression than those who lack such
knowledge.
The main findings and the possible implications of the above-mentioned studies are discussed
in chapter 12.

2The assessment of mild dementia:
diagnostic concepts and methodological
considerations*
Introduction
The clinical and scientific importance of an early diagnosis of dementia was described in the
previous chapter of this thesis. In this chapter, we address some relevant issues with regard to
current concepts and definitions of dementia, with particular reference to Alzheimer's disease,
which is the most frequent cause of dementia. Various diagnostic criteria of the states between
normality and frank dementia are discussed. In particular, we pay attention to the validity of
these criteria in terms of prognostic significance. The purpose of this review is to identify
problem areas that influence the progress of research into the diagnosis of mild dementia.
Another purpose of this review is to distil from the literature the clinical phenomenology of
the prodromes of dementia, and to identify specific features that may predict progressive
mental decline in the very early stages of AD.
*Pans of this chapter have been published in:
Verhey FRJJolles, J. Over de spraakverwarring rond het begrip dementie en d e ziekte van Alzheimer. Tijdschrift v
Gerontologie en Geriatrie 1988; 19:89-96.
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Definitions
Historical reviews of the concept of dementia have been presented elsewhere [21,74,186].
Daily practice shows that the way terms are used varies considerably. Therefore, it is essential
to consider the various definitions of dementia and of the two most frequent dementing
disorders, Alzheimer's disease and vascular dementia.
The term dementia was probably used for the first time in the 17th century [21]. Dementia is
now generally regarded as a clinical syndrome and not as a disease, but important differences
exist in the interpretation of this notion. To quote Wells: "the word has successfully defied
attempts to limit its meaning and to fix its definition" [333]. This leads to semantic confusion,
which has a negative influence on health care and on the progress of scientific research.
Various meanings of the word dementia are summarized in Table 1.
The term dementia is used by some researchers to denote a clinical condition, defined only
by observable behaviour, irrespective of its aetiology. For instance, the report on the
NINCDS/ADRDA criteria for clinical Alzheimer's disease states: "Dementia is a diagnosis based
on behaviour and cannot be determined by computerized tomography, electro-
encephalography, or other laboratory instruments, although specific causes of dementia may
be identified by these means" [207]. The consequence of this definition is that dementia can
be caused by both organic and functional disorders. Others limit the definition of dementia to
organic aetiologies. For instance, the DSM-III-R states: "Either there is evidence (...) of
specific organic factor(s) judged to be aetiologically related to the disturbance, or, in the
absence of such evidence, an aetiologic factor can be presumed if the disturbance cannot be
accounted for by any non-organic mental disorder, e.g., major depression accounting for
cognitive impairment" [7]. Still others have extended the definition of dementia by the
characteristics of irreversibility or a progressive course [272]. In common clinical practice and
for lay people, this use of the term is perhaps the most frequent, although it is not supported
by any official source. Finally, the term is also used as an equivalent for primary degenerative
diseases, and is probably meant to imply Alzheimer's disease [294]: a progressive mental
decline caused by a particular irreversible brain disorder.
One is not always fully aware of the fact that the term dementia is a construct only defined
by consensus agreement. Confusion arises when different meanings are used without further
explanation. Thus, a diagnosis of dementia means to one clinician that a thorough examination
should be carried out, whereas the other might perceive patients with the same diagnosis as
untreatable. In order to avoid this counterproductive confusion, it is important that all
elements of the diagnosis -aetiology, prognosis and clinical phenomenology- are named
separately [315].
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Table 1: Different meanings of the word dementia
21
Definition of dementia
1 Clinical syndrome without any
reference to aetiology
2 Clinical syndrome with
progressive course and
irreversibility, without any
reference to aetiology
3 Clinical syndrome with organic
aetiology
4 Clinical syndrome with organic
aetiology and progressive course
5 Clinical syndrome with organic
aetiology.progressive course and
irreversibility
6 Clinical syndrome with organic
aetiology.progressive course,
irreversibility and specific
neuropathological features
Author, year
NINCDS/ADRDA 1984
Small 1982,1983
Verhey, 1988
Schulte, 1989
Kuiper, 1973
Foster, 1990
Wells, 1977
DSM-III, 1980,1987
Cummings, 1983
Frederiks, 1985
Marsden, 1985
van CreveL 1986
NIH, 1987
Godderis, 1985
Roth, 1986
Stam, 1985
Reference
[207]
[288 ,289]
[315]
[40 ,281]
[174]
[100]
[333]
[6 ,7] [63]
[103] [198] [58] [54]
[111] [272]
[294]
The most widely used definition of dementia to date is that of the DSM-III-R [7] (see Table 2).
In short, the DSM definition involves a combination of memory impairment with at least one
of the domains of abstract thinking, judgement, aphasia, apraxia or agnosia, constructional
difficulty, or personality changes. The impairment must be severe enough to interfere with
social functioning. It is important to note here that the DSM-III-(R) definition implies the
acceptance of some degree of heterogeneity: not all cognitive domains are necessarily
affected.
There are some problems with the DSM-III-R definition. First, the inclusion of an organic
aetiology raises logical problems. Because /wnctforaa/ dementia (often referred to as pseudo-
dementia) may present with clinical picture simular to that of orgtfwic dementia [78, 288,
289], the distinction between the two is made on the basis of the presumption that there is an
organic cause underlying dementia. However, to make assumptions in order to fulfil diagnostic
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criteria is logically untenable [196, 315]. Second, the DSM criteria lead to a diagnostic
dilemma, because they require the exclusion of functional disorders such as depression, but
the criteria for depression require the exclusion of organic disorders.
Table 2: DSM-M-R criteria for dementia [7|
1 Demonstrable evidence of impairment in short- and long-term memory. Impairment in short-term memory
(inability to learn new information) may be indicated by an inability to remember three objects after five
minutes. Long-term memory impairment (inability to remember information that was known in the past) may
be indicated by an inability to remember past personal information (e.g., what happened yesterday, birthday,
occupation) or facts of common knowledge (e.g., past Presidents, well-known dates).
2 At least one of the following:
1 impairment of abstract thinking, as indicated by an inability to find similarities and differences between
related words, difficulty in defining words and concepts, and similar tasks
2 impaired judgement, as indicated by an inability to make reasonable plans to deal with interpersonal,
family and job-related problems and issues
3 other disturbances of higher cortical function, such as aphasia (disorder of language), apraxia (inability to
carry out motor activities despite intact comprehension and motor function), agnosia (failure to recognize
or identify objects despite intact sensory function), and "constructional difficulty" (e.g., inability to copy
three-dimensional figures, to assemble blocks, or to arrange sticks in specific designs)
4 personality change, i.e. alteration or accentuation of premorbid traits
3 The disturbances 1 and 2 significantly interfere with wak or usual social activities or relationships wiÉ others.
4 Not occurring exclusively during the course of delirium
5 Either (1) or (2):
(1) there is evidence from the history, physical examination, or laboratory tests of a specific organic factor or
factors) judged to be aetiologically related to the disturbance
(2) in the absence of such evidence, an aetiologic organic fector can be presumed if the disturbance cannot be
accounted for by any non organic mental disorder, e.g., Major Depression accounting for cognitive
impairment
OSVf i/W? cnteria/orseyeróJy o/Wemercria:
Mild : Although work or social activities are significantly impaired, the capacity for independent living remains,
with adequate personal hygiene and relatively intact judgement.
Moderate: Hazardous independent living; some degree of supervision is necessary
severe: Activities of daily living are so impaired that continual supervision is required, e.g., unable to maintain
personal hygiene; largely incoherent or mute.
Third, the evidence of memory impairment is demonstrated by difficulties in remembering
recent or past information. However, the inability of a patient to name this information does
not automatically mean that the information is lost. Therefore, the criteria may be more
difficult to apply in patients with subcortical dementia, in whom recall is impaired but
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recognition is relatively intact [3,71,137]. The distinction of several subgroups of dementia
will be discussed in detail in another section of this chapter. Fourth, the criteria do not define
the minimal duration of the symptoms, nor do they require a normal premorbid level,
although most clinicians will agree that these aspects should be included in the definition.
Fifth, the DSM-IH criteria have been critized for treating the underlying dimensional concept
of dementia as too categorical [152].
Despite these limitations of the DSM-III(-R) criteria, virtually all current research studies
make use of them. It should be bom in mind that the DSM-III-(R) is essentially a research-
orientated instrument. It was not designed to give diagnostic refinement. The main goal is to
reduce the number of false-positive diagnoses, in order to obtain homogeneous samples and to
keep any distortion or dilution of statistical data at the lowest possible level [154]. Therefore,
the threshold for inclusion has been set rather high. In contrast, clinical practice must insist on
a minimum of false-negative diagnoses. The differences in these two starting points should be
noted, especially when applying the criteria for mild dementia. The use of these criteria has
had a major impact on clinical research, and diagnostic accuracy has improved significantly
since the introduction of these criteria. In this thesis we make use of the DSM-III-R criteria of
dementia, except for the last criterion concerning the presumed organic aetiology. The
organicity criterion was also abandoned at the Dutch consensus meeting on the diagnosis of
dementia, in Utrecht, November 1988 [40].
öe/i'ntöott o/awfy Memento
The issue of early dementia is dealt with in the literature in at least two different ways. First,
the term refers to the detection of cases of mild or moderate dementia in order to prevent
crises and to be able to take the necessary action electively, rather than ad hoc in a crisis
situation (e.g., [276]). In this context, it is more correct to speak of the detection of mild,
instead of early, dementia, since the latter unjustly suggests a progressive course as part of the
definition of dementia.
Second, the issue of early dementia applies to the detection of the prodromes of
dementing disorders, i.e., before the disease has developed into dementia (e.g., [1]).
According to current definitions, a diagnosis of Alzheimer's disease implies the clinical
syndrome of dementia [7,207]. A semantic problem should be noted here, as this definition
implies that Alzheimer's disease in its predementing stages is a contradiction in terms, which
is illogical. It is better to define this second approach as the detection of early Alzheimer's
disease rather than as the detection of early dementia.
De/mtóon o/ Aïztóner Wisease
In 1907, Alois Alzheimer [5] described a patient with progressive dementia, caused by a
disease that Kraepelin three years later named 'Alzheimer's disease' [127, 169]. Alzheimer's
disease is characterized pathologically by cerebral deposits of abnormal fibres in senile plaques
and neurofibrillar tangles. The term Alzheimer's disease has been used in different contexts: to
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denote an onset of dementia before the age of 65 years (as opposed to 'senile dementia', after
this age) [159]; for patients who show the clinical triad of aphasia, apraxia, and agnosia (as
opposed to 'dementia simplex', without this triad) [55): and as a neuropathological diagnosis
(as opposed to presenile or senile dementia of the Alzheimer Type, in the absence of
pathological verification) [16,187]. The term 'disease' unjustly suggests a distinct nosological
entity, because there is not one single cause of Alzheimer's disease. Case-control studies have
shown various risk factors to be associated with Alzheimer's disease, of which age and a family
history of dementia are the most prominent [75],
At present, two sets of criteria for AD are widely used: the DSM-III-R criteria for Primary
Degenerative Dementia of the Alzheimer Type (PDD) [7] and the criteria from the National
Institute of Neurological and Communicative Disorders and the Alzheimer's Disease and
Related Disorders Association (NINCDS-ADRDA)[207]. The DSM-III-(R) criteria for PPD
require the presence of dementia, an insidious onset with a generally progressive
deteriorating course, and the exclusion of all other specific causes of dementia by history,
physical examination, and laboratory tests. The criteria may thus also include other relatively
rare disorders, such as Pick's disease, Lewy body disease, and the dementias with non-specific
brain changes (referred to as the '5% problem' [158]).
The NINCDS-ADRDA criteria are compatible with those of the DSM-III-R, but are more
elaborate and better operationalized. For this reason, they are preferred in most studies. The
criteria differentiate between possible, probable, and definite AD. A diagnosis of definite AD
can only be made when the criteria for probable AD are fulfilled, and when there is
histopathological evidence obtained from biopsy or autopsy. Probable AD is defined by the
presence of dementia, an onset between 40 and 90 years of age, and the absence of systemic
disorders that in and of themselves could account for progressive deficits in memory and
cognition. A diagnosis of possible AD is made when there are variations in onset, presentation,
clinical course or in the presence of a second possibly dementing disorder, which is clinically'
not considered to be tóe cause of dementia. Allowance is made for plateaus in the course of
progression or in the presence of associated psychiatric, somatic, or neurological symptoms.
The interobserver reliability of the NINCDS-ADRDA criteria is satisfactory, with kappa
values of about 0.65 [175, 194]. Studies of the validity of the clinical diagnosis of AD from
before the NINCDS-ADRDA criteria generally reported a poor accuracy of the clinical diagnosis
of AD, with sensitivity and specificity rates of 28% and 43%, respectively [214, 311]. In
contrast, various studies of the validity of the diagnosis of AD when the NINCDS-ADRDA
criteria were used reported sensitivity rates between 64 and 95% and specificity rates ranging
from 81 to 100% [26,143, 215,310]. The present evidence is that the clinical diagnosis of AD
corresponds with the pathological diagnosis in about 80% of the cases. It can therefore be
concluded that the modern criteria have elevated the accuracy of the clinical diagnosis of AD
to a highly satisfactory level. However, some remarks can be made here on these studies First
there is considerable variation in the 'gold standard' of the criteria (i.e., neuropathological'
verification) among different pathologists [76,142,162,237]. Moreover, not all patients who
have the typical pathological hallmarks of Alzheimer's disease are perse demented [60] The
alternative way of validating the criteria of AD in the absence of pathological data is by
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documentation of a continuous progressive course [270], but this method cannot differentiate
between AD and other progressive neurodegenerative disorders. Second, data on pathological
validation come almost exclusively from carefully selected samples of patient groups. Most
studies have examined relatively young patients from university centres without significant
comorbidity. Thus, the results of these data cannot be superimposed on the typical geriatric
population without due consideration. Third, most of these validation studies pertain to
material obtained from patients in the terminal stages of dementia, a condition that is much
easier to diagnose. Therefore, the impact of the results from these validation studies may be
more limited in groups of patients who are in earlier stages of their disease.
Another problem is that AD is largely a diagnosis formed by exclusion of other diagnoses.
The only two inclusion criteria are the presence of dementia and a gradual progressive course
[7,207]. Thus, the accuracy of the diagnosis of AD is directly related to the accuracy with
which other diseases are excluded. Consequently, uncertainties in the diagnosis of other
aetiologies, such as vascular dementia (vide infra), carry immediate consequences for the
diagnosis of AD.
Vascular dementia (VD) is a syndrome of cognitive impairment resulting from vascular diseases,
especially ischaemic brain changes. Hardening of the arteries has long been regarded as the
single cause of dementia and the issue of defining VD has received appropriate attention only
recently. VD is the second most common cause of dementia, accounting for about 20% of all
dementias whereas combinations of VD and AD occur in another 10-15% [84, 158, 313]-
Recent studies with 85-year-old patients have suggested an even higher prevalence of VD
[286], Previously, it was thought that the most important determinant of cognitive
deterioration was the total volume of infarcted brain [84, 313]. However, the total size of the
infarcts is often small, and the cognitive deterioration appears to be also closely related to the
side, site, and number of infarcts [79,85]. Although the condition is often named "multi-infarct
dementia", repeated infarctions in the brain are but one of the mechanisms leading to VD.
Therefore, the term multi-infarct dementia should be avoided. The other cerebrovascular
mechanisms include: dementia after one single stroke, small vessel disease, hypoperfusion of
the brain, intracerebral haematoma, subarachnoid haemorrhage, inflammatory arteriopathies
of the brain vessels, and other non-hereditary and hereditary vascular diseases [85].
The most widely used clinical criteria for vascular dementia, those of the DSM-III and
DSM-III-R, are based on clinical description [6,7]. The features are not defined in detail and
leave much room for interpretation (e.g., 'patchy' distributions of deficits); brain-imaging data
are not incorporated. Ischaemic scales have long been used for the diagnosis of VD [117,192,
269]. More recent criteria have also paid attention to the temporal relationship between
dementia and strokes, the number of strokes, and brain-imaging data [46,266].
Current criteria for the clinical diagnosis of VD share the same definition of dementia as
those of other aetiologies. This raises the question whether there are phenomenological
differences between the various dementing disorders. For instance, depression, retained
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insight, and preserved personality have all been reported to occur more frequently in VD than
in AD [87, 118, 199]. However, there is still little empirical evidence that the two types of
dementia can be accurately differentiated on clinical grounds. The cognitive syndrome in
advanced VD may be different from that of AD, but virtually no data exist on the clinical
features of VD in the early stages [12].
Phenomenology of the prodromes of dementia
The onset of AD is often dated in retrospect and with imprecision. The reports from relatives
can provide insight into the very first prodromes, but are largely anecdotal. A fine and
instructive description was published in 1950 by a colleague of a medical scientist [9]:
"Over the period that we worked together, I gradually became aware that the fine edge of his intellect was
becoming dulled. He was less clear in discussion and less quick to make the jump from a new piece of evidence
to its possible significance. He spent more time over his work and achieved less; and he found it increasingly
difficult to get his results ready for publication. He tended also to become portentous and solemn about his
subject, as though one small comer of knowledge nearly filled his world, and the wider horizons were narrowing
in. The change was so slow as to be barely perceptible, and the signs vanished when I tried to pin them down:
they were like those faint stars which are seen more easily when they are not in the direct line of vision....To me it
was as though a light had gone out, but no-one else seemed to notice anything amiss...By this time he was
worried about his general health and attended a doctor from time to time with rather vague symptoms. For
several years he had been said to have low blood pressure, but nothing was found wrong apart from this, and he
was reassured."
Descriptions such as this are convincing and recognizable for clinicians. A similar clinical
picture can be distilled from longitudinal studies and from retrospective studies making use of
relatives' accounts. Typically, predemented subjects demonstrate feelings of anxiety,
worrying, depression and psychological vulnerability. These feelings are less pervasive than in
patients with major depression [ 1, 238, 274]. Their inner feelings may be more dependent on
their environment: they calm down when reassured, but a small amount of stress is likely to
put them out of balance [1, 238]. They get exhausted easily. Passivity, lack of interest, and
coarseness may be common features. They appear less spontaneous and extrovert, and more
withdrawn. Some mental features of this syndrome reflect a disruption of compensating
abilities, such as the rapid exhaustion and the difficulty to adjust to events that are not part of
a daily routine, whereas others are more likely to be secondary phenomena, such as
withdrawal, anxiety, and the tendency to worry [29,41,238,240,275]. Predemented patients
themselves may or may not complain about these changes, but their relatives are likely to do
so [25, 43, 204, 226, 234, 242]. Neurological examination probably does not reveal any
abnormalities nor do ancillary investigations such as laboratory or neuroimaging data [103,
107], although there may be an increase in 'soft' neurological signs early in the course of the
illness [326], Predemented subjects may perform within normal ranges on traditional
psychometric tests of memory, but they are likely to need more time and show the tendency
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to get tired and to slow down when testing takes too long [124,140, 299,300]. If memory is
impaired, then it is usually related to tasks measuring delayed recall [1, 238, 276,300].
The picture of predementia as is presented here should be regarded as tentative. It is not
known if all patients with AD present with a picture similar to the one described here.
Moreover, we do not know its predictive value in terms of specificity. To date, no clear
diagnostic categories adequately classify the above clinical picture. The state may be too
subtle to be described by reliable research criteria. A DSM-HI-R diagnosis of dysthymia may be
appropriate when the period of duration is longer than two years [7]. Patients who have
symptoms of shorter duration will not receive any diagnosis according to DSM-III-R. The
clinical picture of the prodromal stages shows similarities with concepts that used to be
popular in the past, such as neurasthenia [141] or 'Vorseitige Versagenszustande' (premature
states of failure) [20). A qualitative approach, i.e., a detailed psychopathological description, is
probably the most adequate. The importance of a qualitative assessment is underlined by the
relative lack of specificity of the traditional psychometric tests [299].
The classification of mild cognitive syndromes
In this section, several diagnostic concepts and criteria used for the classification of mild
cognitive syndromes are reviewed. At present, there is no consensus as to which concept is the
most valuable. The main reason for this is the lack of longitudinal data which could provide
data on their prognostic value. Nevertheless, the concepts provide a good starting point,
acknowledging that more research still needs to be carried out. Only the descriptions of mild
cognitive syndromes, including mild dementia, are discussed here, because the more severe
stages are beyond the scope of this review. The criteria of the syndromes that are discussed
here are shown in the appendix of this thesis.
BemgK senescenf/i»j>e(/«/wess (BSF)
The concepts of 'Benign Senescent Forgetfulness' (BSF) and 'Malignant Senescent
Forgetfulness' (MSF) were introduced more than 30 years ago. They are probably the earliest
attempts to distinguish clinically between normal age-related memory changes in the elderly
and those forms of memory change with a worse prognosis [170,171,173]. The term has
often been used in the medical literature and has become a generally accepted notion among
clinicians. BSF presents as "...patchy and variable, with difficulties remembering details of
experiences (names and places), but with relative ease in recalling the experiences itself.
Usually, the forgotten details are recalled later". The condition is not progressive and does not
increase the risk of the subject developing dementia. In contrast, MSF is characterized by an
inability of the subject to recall events in the recent past, disorientation with regard to
personal data, and retrogressive loss of remote memories. Subjects with MSF remain unaware
of their deficit and frequently produce confabulations.
28 CHAPTER 2
The description of BSF is based on observations of retirement-home residents with a mean
age of nearly 80 years. From a nosological point of view, it is unclear whether BSF is different
from normal ageing or should be seen as a distinct entity between normality and pathology
(dementia). Krai never made any distinction between a normal group and his benign patients.
He considered MSF as the 'axis syndrome of psychosis with senile brain disease' [171]. Thus,
MSF was meant to describe pathology, but it is unclear whether the concept should be
regarded as a synonym of what is now called dementia, as a pan of it, or whether it should be
differentiated from it.
BSF and MSF were never defined appropriately in operational terms. As a consequence,
research data on the reliability of the criteria are sparse. Only few data exist on the prognostic
value of BSF. Krai carried out a 4-year follow-up study with 20 patients with BSF and 34 with
MSF; only one patient with BSF declined cognitively, whereas all patients with the malignant
form did [171]. Death rates in BSF and MSF also differed significantly from one another: 38 %
vs. 61.7 % after a 4-year observation period. Recently, a 3-year follow-up study of patients with
supposed BSF was reported by O'Brien et al.[226]: six of the 68 patients with BSF (9%) had
become demented, which was about twice the expected rate. These latter findings cast doubt
on the view that BSF always follows a benign course.
Because of the ill-defined criteria and their uncertain nosological status, the use of the
terms BSF and MSF cannot be recommended for research and clinical purposes, in spite of
their widespread popularity.
^e -assocwte^ memory impatrmen/
The term 'Age-Associated Memory Impairment' (AAMI) was introduced by Crook et al. in 1986
[59]. AAMI denotes a condition in otherwise healthy middle-aged or elderly subjects (fifty
years or older) who complain about memory loss and who score at least one standard deviation
below the mean for younger adults on neuropsychological testing for secondary memory. The
AAMI criteria were provisionally established in order to have a operational definition of
« o m a / cognitive ageing. Furthermore, they serve as a basis for selecting research subjects in
order to study the epidemiology, course, and clinical significance of normal ageing, and to
evaluate the effect of pharmalogical or other forms of intervention [89,203].
The concept of AAMI was criticized recently for being too broad. It was also received with
scepticism because of the possible attraction to the pharmaceutical industry of delineating a
new disorder and thus creating an artificial market for products against ageing [11,68,227].
The usefulness of the concept can be doubted since the authors assume that "most of the
people over 50 years may be affected by AAMI to some degree" [203]. However, the criteria
provide a firm basis for research into memory changes related to normal ageing and, in
contrast to BSF and MSF, AAMI has been defined operationally.
More specific remarks on the AAMI concept were made by Blackford and LaRue [23], Their
points of criticism included: omission of an upper age limit, omission of any means of
quantification of subjective complaints, the criterion that "performance is one SD below the
mean established for young adults on a standardized test for secondary memory", which
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precludes the use of tests developed especially for old populations, and the likelihood of
meeting the above-mentioned criterion when more tests are administered. Besides, the AAMI
criteria provide a minimum for the deviation in memory performance («/ fezs/ one standard
deviation), but no maximum, although dementia should be ruled out. Blackford and LaRue
[23] suggested the use of a battery of four or more tests of secondary memory and added to
AAMI the following new categories: Age Consistent Memory Impairment (ACMI), for
performance within ± 1SD of the mean established for age on 75% or more of the tests
administered, and Late life Forgetfulness (LLF) to denote performance between 1 and 2 SD
below the mean established for age on 50% or more of the tests administered. These
modifications can be regarded as an interesting elaboration. Data on the reliability or validity
of the AAMI criteria have not been published yet.
In summary, the AAMI criteria were meant to denote a normal state related to ageing, but
they do not preclude a progressive decline per se. To date, no longitudinal data have been
reported and therefore the prognostic significance of the AAMI concept remains unsettled.
The use of the term AAMI in clinical practice is limited. Nevertheless, the criteria are well
defined operationally and provide an excellent starting point for further scientific research.
The recent adaptations of Blackford and LaRue (ACMI and LLF) warrant further evaluation.
Neither the DSM-IH, nor its revised version, contains criteria to classify mild cognitive
impairment under the level of dementia [7], The DSM-IV will include a new category termed
'Mild cognitive changes (subthreshold)' as part of the class of 'Cognitive impairment disorders'
[248,292,293]. In contrast to the first version of the DSM-III, the DSM-III-R specifies the
severity of dementia in terms of functional capacity (see table) [7].
The DSM-III-(R) criteria of mild dementia have proved to be reliable [99] • Their validity
has been examined in a 1-year follow-up study with 79 mildly demented, but otherwise
healthy AD patients [138]. All patients who were initially diagnosed as AD received the same
diagnosis at follow-up, indicating a sensitivity of the clinical diagnosis of 100%. In addition, the
clinical diagnosis of AD appeared to be more sensitive than neuropsychological testing or
administering the MMSE. Another follow-up study with 55 AD patients (28 with mild
dementia, 22 with moderate dementia and 5 with severe dementia) from several teaching
hospitals yielded comparable rates [99]. However, the outcome was less favourable in a recent
prospective community study with 87 mildly and moderately demented subjects with a
DSM-III diagnosis of the Alzheimer type or Vascular dementia [224] . Of the 48 patients (33
with AD and 15 with vascular dementia) who could be tested after a period of three years, no
less than 20 patients (11 AD, 33%) did «or show intellectual deterioration and cognitive
decline remained doubtful in another 11 patients (9 with AD, 27%). Thus, it can be concluded
that the prognostic value of the DSM-III criteria for the mildest stages of dementia is high
when applied by experienced clinicians to selected patient groups. In field studies, however,
the criteria appear to be less accurate.
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In 1982, Reisberg and coworkers [255] presented the Global Deterioration Scale (GDS) for
the grading of primary degenerative dementia. The GDS is to date one of the most widely
used clinical instruments to stage the course of AD. The scale describes cognitive and
behavioural changes in seven stages. Stage 1 describes normality (no complaints, no deficits),
stage 4 meets the (DSM-III) criteria for dementia, and stage 7 describes the terminal phase of
dementia in which the patient is bedridden and mute [257] (see also the appendix of this
chapter). Reisberg et al. stressed in their original paper that clinicians should be aware that
the GDS presupposes accurate clinical diagnosis of the syndrome and that symptoms
characteristic of stages 2 and 3 do not necessarily imply the onset of AD [255]. In fact, the
absence of any objective deficits in employment or social situations in stage 2 is contradictory
to the diagnosis of dementia as defined by the DSM criteria. As a consequence, patients with
AD can only be classified as 'GDS 2' in retrospect and, vice versa, patients who receive a GDS
score of 2 are by definition not demented, and thus cannot be diagnosed as AD. It is important
to note this, because there is a danger that the mere use of the GDS implies a diagnosis of AD.
The interrater reliability of the GDS is high (kappa values of 0.82-0.92) [101, 113]. Its
criterion validity was demonstrated by significant correlations with psychometric measures, CT
and PET scan parameters [101,113, 255-257].
Considering the scale in more detail, however, the description of stage 2 appears to be
rather non-specific. For example, the description only refers to "forgetting where one has
placed familiar objects or forgetting the names of known persons" without specifying for
example the impact of the complaints. Furthermore, only a clinical interview is required to
exclude objective evidence of memory deficits. The characteristics of stage 3 are more
specific, but they refer almost exclusively to memory or related cognitive domains. The GDS
has been criticized for being too narrowly defined because it places too much emphasis on
memory functioning [124, 140]. Moreover, behavioural features may array themselves
differently from the way they are positioned in the GDS [77].
The prognostic properties of the various stages have been established reasonably. In a 2-
year-follow-up study, the 30 patients in stages 2 and 3 (16 and 14 patients, respectively)
remained alive, well, and living at home [259]; only the patients in stage 3 of the GDS
declined mildly on cognitive but not on functional assessment parameters. In another study,
with a follow-up period of approximately 3.5 years, only two of 40 patients with GDS stage 2
demonstrated notable cognitive deterioration [254]. Five of the 32 patients (16%) with a GDS
score of 3 had a negative outcome, i.e., three patients worsened, one was hospitalized and
one died; on the other hand, three patients showed improved social functioning. However,
the neuropsychological parameters worsened in 72 % of these patients after a 2-year follow-up
[96]. Of the 22 patients with GDS stage 4, 72 % went on to deteriorate in social functioning
[254]. The patients of this study were healthy (except for dementia), did not suffer from
depression and had Hamilton scores lower than 16, Recently, it has been reported that "50%
of the GDS 3 cases declined and received a diagnosis of AD within several years" [88], but
details of that study were not available at this time.
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In summary, the GDS provides a practical tool for staging dementia, ranging from normal to
very severe dementia. The scale should be used in combination with other diagnostic methods
and presupposes an accurate syndromal and aetiological diagnosis. The global nature of the
scale is both its weakness and its strength. A GDS score of 2 reflects normal ageing in
practically all patients, whereas GDS stage 3 represents borderline cognitive functioning.
From the stage of GDS 4, a progressive course of decline is likely.
C/MJ'OJ/ Memento raftngsca/e.- ^ Kes/jbnaèfe «nrf miW rfemenfta
The Clinical Dementia Rating scale (CDR) was designed by the Washington Research group on
Dementia [139] and rates the severity of dementia as questionable, mild, moderate, or severe
(scores of 0.5,1,2, or 3). The individual performance is rated separately in each of the
following categories: memory, orientation, judgement, and problem-solving, community
affairs, home and hobbies, and personal care. From these ratings, an overall CDR score is
calculated according to a complicated algorithm.
The criteria carry high face validity and are based on a broad sample of cognitive
performances in daily life. Memory performance in daily life is considered to be the central
criterion, the other features as secondary. The interrater reliability and the construct validity
of the CDR have been demonstrated [34]. The scale has been used in several longitudinal
studies, which make the CDR probably the best tested rating scale for staging dementia to
date [16-18,276], One follow-up study with 43 patients rated as CDR 1 (mild dementia)
reported that 41 patients progressed into more severe stages at a follow-up after 66 months
[17,18]. Recently, more follow-up data were reported from 16 subjects with questionable
dementia of the Alzheimer type (CDR 0.5) [276, 300]. The patients were selected by
experienced clinicians using strict inclusion and exclusion criteria. After 84 months of
follow-up, 11 of the 16 patients (69%) had AD verified by autopsy and/or progressed to a more
advanced CDR stage. Subjects with questionable dementia differed from controls and from
patients with mild dementia on several psychometric measures [300]. However,
neuropsychological testing did not allow for a differentiation between those patients who
progressed and those who did not, since objective levels of performance between the groups
appeared to overlap extensively.
In summary, the CDR is a well documented scale for rating dementia in selected samples.
The scale is more difficult to administer than the GDS. From stage CDR 1, an outcome of
deterioration can be reliably predicted, whereas stage CDR 0.5 reflects the borderline state.
CMDffi m/ninw/ (femenfe anrf m/fcf «femenft'a
The Cambridge Mental Disorders of the Elderly Examination (CAMDEX) consists of a
standardized psychiatric interview with the patient and caregiver, and a brief
neuropsychological battery (the CAMCOG) [271, 272]. The CAMDEX was especially designed
for the detection of early dementia and describes four syndromes as guidelines for the staging
of dementia: minimal, mild (early), moderate, and severe dementia. In contrast to the GDS
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and the CDR, the CAMDEX can be used to obtain a syndromal and an aetiological diagnosis.
The criteria should be used in a "flexible manner", leaving "some room for clinical judgement"
[271]. The face validity of the criteria is high. The interrater reliability of the CAMDEX is good
[272],
Until now, no studies using the CAMDEX with selected groups of patients have been
published. O'Connor et al. applied the CAMDEX in two longitudinal community studies in
Cambridge on the same cohort, with a follow-up period of 12 and 24 months [232,233], The
subjects had been examined in a two-stage design, by which only those with a score of less
than 26 on the Mini-Mental State Examination [97] were assessed further with the CAMDEX. It
should be noted that the Cambridge cohort involved a more "geriatric" sample, i.e., the
patients were older and less selected for absence of somatic or psychiatric disorders than the
above-mentioned studies with the GDS and the CDR. This was reflected in a high overall
mortality rate: from 44 subjects diagnosed as minimally demented, 11 patients died and only
29 were able to be reviewed after the first year of the study; only 6 of them showed
progression of cognitive impairment, while 13 patients were judged to be normal [232].
However, after one more year of follow-up, 12 of the 24 retested subjects had progressed to
dementia [233] • The authors concluded that although the CAMDEX criteria were in general
feasible, the criteria for minimal dementia were more difficult to apply in clinical practice
[229, 232]. Errors in the diagnosis of minimal dementia occurred especially in people of a
below-average intelligence, in the old and frail, and in patients with sensory impairments. The
need for repeated assessments over lengthy periods was stressed in order to document the
natural history of dementia correctly. The Cambridge follow-up study provides an illuminating
example of the practical problems of community surveys and gives much insight into the
differences between an epidemiological approach and approaches using carefully selected and
evaluated clinical populations such as those described above [229].
Comparison of the different criteria for mild cognitive syndromes
When evaluating the prognostic significance of the different proposals for the borderline states
between normal forgetfulness and frank dementia, it is important to note that hardly any of
the criteria of the above-mentioned studies have been used in their own right: in most of the
studies the diagnoses were made on the basis of a thorough investigation by experienced
clinicians (e.g., [276]). In these studies, the criteria were used for the staging of severity, not
for the diagnosis of AD itself. Only the studies with the CAMDEX were carried out without any
other forms of assessment [232, 233] • Comparison of the different concepts and criteria
discussed above reveals a considerable overlap in clinical characteristics. At the outset, there
are few differences between Krai's benign forgetfulness and Reisberg's very mild cognitive
decline (GDS 2). Likewise, stage 3 of the GDS closely resembles the description of very mild
cognitive impairment of the CDR (CDR 0,5) and the CAMDEX criteria for minimal dementia,
whereas GDS 4, CDR 1, and mild dementia of the CAMDEX are all highly compatible with the
criteria for mild dementia defined by the DSM-III-R. However, the concepts differ in details
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[102,219,302], and thus comparison of the results of these studies should be approached with
some caution.
Table 3: Rates of progressive decline of patients rated according to current concepts of cognitive impairment or
early AD.
GDS2
GDS2
BSF
GDS3
CAMDEX
CDR0.5
BSF
CAMDEX
DSM-III
CAMDEX
CAMDEX
CDRO.5
GDS3
GDS4
CDR1
DSM-III
DSM-III
very mid cognitive decline
very mild cognitive decline
benign senescent forgetfulness
mild cognitive decline
minimal dementia
questionable dementia
benign senescent forgetfulness
mild dementia
mild and moderate dementia
minimal dementia
mild dementia
questionable dementia
mild cognitive decline
moderate cognitive decline
mild dementia
mild dementia
mild dementia
Reference
[270}
[254]
[171]
[227}
[254}
[232}
[270]
[241]
[232]
[224]
[233]
[233]
[276]
[96]
[254]
[17]
[99]
[138]
N
7
40
20
68
32
29
27
6
67
33
24
56
16
32
22
53
27
79
follow-
up
(mths)
36
42
48
36
42
12
36
24
12
36
24
24
84
24
42
66
12
12
age
(yrs)
66-92
68,7
80,5
67,2
71,1
80,3
66-92
80,3
74,0
80,3
80,3
71,7
71,3
72,3
71,4
74,4
67,4
C/F
C
C
C
C
C
F
C
c
F
F
F
F
C
C
C
C
C
C
%with
decline
0
5
5
9
16
21
26
33
37
40
50
50
69
72
73
95
96
100
Note: C = Clinical study; F = Field study
The results from the follow-up studies into the prognosis of the different criteria for early AD
are summarized in Table 3. On average, the patients were relatively young and the mean
follow-up periods were short. Furthermore, the studies show considerable variation in the
number of subjects, their mean age, and the duration of the follow-up period. In general, field
studies were less successful in predicting dementia than those carried out in specialized
dementia clinics. The diagnosis of mild dementia, more so than in the advanced stages, deals
with a subtle interplay of disturbed behaviour, cognition, and affectivity, which are all complex
concepts in their own right. Simple demarcations between normal ageing and mild dementia,
as are necessarily used in epidemiological studies, cannot adequately cover "the wealth of
clinical material that needs to be taken into account" [229]. This makes it hard to compare
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the studies with each other. With these conderations in mind, it can be concluded that the
likelihood of further cognitive decline is low (but not zero) for subjects with mere memory
complaints classified as BSF or GDS 2, intermediate for patients with questionable dementia,
GDS 3 or CAMDEX minimal dementia, and high for patients with GDS 4, DSM mild dementia,
CAMDEX mild (early) dementia and CDR1. Stated in another way, subjects who complain only
about poor memory, without objective evidence of impaired memory and who perform well in
daily activities cannot be regarded as being at high risk of becoming demented. In contrast,
those who demonstrate objective cognitive impairments interfering with social functioning
probably will decline. These statements are based on the results of studies with selected
samples. In individuals with mild cognitive changes, it is still impossible to predict the
outcome accurately.
Clinical and methodological issues
7fre con/»««wm fcetoeen worm#/ dgezngatti/ Memento
When looking for the characteristics of mild dementia and, more specifically, of very early AD,
it is important to discuss first what should regarded as normal. Usually, an operational,
statistical definition of normality is used. Observations can be regarded as normal if they fall
within some fixed boundaries, for instance, in the middle 90% of their range [132]. Rowe and
Kahn recently stressed in an important theoretical review on ageing [273] that the variability
of a given parameter, for instance, performance on a memory test, increases with age. The
authors paid attention to the heterogeneity present even in normal, i.e., non-diseased, groups
of elderly people. They argued that a distinction should be made between 'successful' and
'usual' ageing. Succesful ageing refers to changes that are intrinsic to age itself, whereas usual
ageing is the result of ageing plus all non-pathological deficiencies that occurred earlier in life.
These deficiencies are not intrinsically related to the process of ageing per se. However, they
are still closely associated with ageing, because their effects are greater in old age (due to
increased vulnerability or reduced resistance) [132,149]. In addition, the chance of being
affected by these deficiencies increases with ageing.
The relevance of the distinction between successful and usual ageing was recently
illustrated by Houx et al. [132-134], who demonstrated that the variability of various cognitive
measures depends largely upon the sum of potentially health-threatening factors that occurred
earlier in life. Examples of these factors, called Biological life Events (BLE s), are mild brain
injuries, repeated general anaesthesia, or periods of alcohol abuse. In a group of people who
were all "normal" according to regular gerontological criteria, BLE-free subjects showed no
increase in the variance of performance in memory and speed, whereas in those with one or
more BLE s the age-associated decline was much more pronounced.
These observations are important when looking at the differences between dementia and
normality. There is a growing body of evidence that suggests a continuum between normal
and pathological cognitive decline. For instance, a study of randomly selected 70- to 79-year-
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old women yielded a smooth and unimodal distribution of cognitive functions and behavioural
changes [32]. This does not, of course, imply that Alzheimer's disease is merely exaggerated
ageing. Instead, it highlights the fact that differentiation in cross-sectional diagnoses is
difficult. Therefore, in the absence of reliable biological markers, some uncertainties must be
accepted in the cross-sectional diagnosis of very early AD. Another consequence of the
continuum is that different groups need different diagnostic criteria. Currently available norms
have only been differentiated according to various age groups. An alternative approach would
involve a more individualized assessment of early AD. What is normal for one person, may not
be normal for another. For instance, it may be relevant to develop other norms for those
subjects with several BLE s as compared to those subjects without any.
Afon-cqgnz'/we tebawcra/ markers o/ e«r/y f/mewfta
Without exception, the current definitions characterize dementia as a state of cognitive
failure. Indeed, there is good evidence that deficits of memory are among the earliest features
of AD [138,268,334]. However, this does not mean that impaired memory is a prerequisite
for the diagnosis of AD in its prodromal stage. That which has to be proven is accepted as proof
when memory impairment is tautologically considered to be the main characteristic of the
preceding stages of dementia (e.g., [300]). A large amount of evidence from epidemiological
and descriptive studies shows that non-cognitive symptoms are prominent in the disintegration
of psychological organization. These non-cognitive symptoms involve perception, motility,
personality organization, emotional experience, and volition (see [22] for review). Recently,
Berrios has challenged the view that prodromes of dementia should be defined as a form of
'mini-dementia', i.e., only quantitively differing from dementia.
The most frequently studied non-cognitive aspects of early AD are changes in affectivity and
in personality [29,41, 73, 78, 94, 98,240, 274-276]. These are discussed below in more
detail.
Depression can be related to dementia in several ways. First, severe depression may present
with the picture of dementia. This condition has also been called 'pseudodementia' [163],
although there is nothing 'pseudo' about it for those who adhere to the strict syndromal
definition of dementia [131,196,315]. Second, depression and dementia may coexist [253]:
depression can be then seen as an understandable psychological reaction to the growing
awareness of an impending deterioration [323,333] or as a result of biochemical abnormalities
in the brain [342,343]. Third, depression may precede dementia [172, 252]: depression may
thus be a very early symptom or subclinical dementia may become manifest under the stress of
depression or treatment with antidepressive (often anticholinergic) drugs. Fourth, dementia,
notably the subcortical types, can mimic depression [262]. And fifth, it is also possible that
both conditions develop independently of one another.
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The notion of depression being an early manifestation of dementia is still under debate. In
a retrospective study, relatives of patients with AD reported depression and agitation in about
40% as being the first symptom of dementia [181]. In prospective studies, depressive
symptoms in elderly patients were also found to increase the risk of the patient developing
subsequent dementia when present in combination with cognitive deficits [172,252].
However, other studies did not report an increased prevalence of depressive symptomatology
in subjects who subsequently developed dementia [157,238].
The results of these studies have to be evaluated carefully, because the definitions used for
depression and dementia may be different from those adhered to today. For instance, in most
of the studies, a favourable effect of antidepressant drugs was taken as proof of the presence of
depression and of the absence of dementia. It is likely that the 'pseudodemented' patients
were in fact patients with true dementia caused by Alzheimer's disease, but whose depressive
presentation strongly biased the diagnosticians. Support for this notion comes from
neuropsychological studies that found more differences between depression and depressive
pseudodementia than between depressive pseudodementia and dementia [78, 98].
Furthermore, most of the evidence of depression as a possible precursor of AD comes from
studies carried out in departments caring primarily for demented or cognitively impaired
subjects. This may reflect the referring physician's suspicion of organic cognitive impairment
rather than functional psychiatric disorders. Therefore, the results may be biased on the basis
of selection.
In summary, patients with depressive symptoms and cognitive deficits may relatively often
have subclinical AD. Unfortunately these patients have been rejected from participation in
most studies on AD, probably due to a dichotomous view in which depression and dementia
are regarded as mutually exclusive. More refined clinical and neuropsychological descriptions
and prospective neuroimaging and neurochemical studies should be carried out in order to
elucidate the relationship between depressive symptoms and mild dementia.
Person#/tfy dwwges preceding ^emenfta
Personality changes in relation to AD have been studied only recently. In a study carried out in
die Maastricht Memory Clinic on the first symptoms of dementia reported by the caregivers,
personality changes preceded the cognitive manifestations in 10 out of 24 patients with mild
AD (Verhey, 1987, unpublished data). Most of the patients had been judged by their relatives
as having become lazier, slower and more withdrawn. Petry et al. [240] compared the spouse
ratings of the patient's current behaviour with ratings on personality as remembered prior to
the appearance of any symptoms of AD. They found that AD patients became more passive,
more coarse and less spontaneous. The personality changes occurred early in the course of the
disease and could not be attributed to the decline in intellectual function. Similar profiles
(diminished initiative, loss of self confidence, decreased extroversion, growing apathy,
relinquishment of hobbies and increased rigidity) have also been found in other studies [1,29,
41, 238, 274]. Many subjects had subtle personality changes long before dementia became
clinically manifest. These studies revealed a remarkable uniformity in the direction of
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personality changes (slower, less open, more withdrawn). This challenges the frequently
claimed notion that personality changes involve an exaggeration of premorbid personality
traits (eg, [7,187]).
One recent study merits special attention because of its longitudinal design: a nine-year
prospective study, performed in Gotenburg, Sweden [1, 238]. In this study, a sample of
randomly selected 70-year-old subjects were examined by using psychological tests and
personality assessments. After nine years, those subjects who subsequently developed
dementia were compared with those who did not. The findings of the Gotenburg study
confirmed the outcome of the above-mentioned studies, namely that personality changes
occur early in the course of AD. Moreover, it appeared that the time needed to complete
several cognitive tests and the personality dimension pertaining to mental energy predicted
the development of dementia. Mental energy was assessed by questions concerning energy
resources, attitude towards new and difficult tasks, ability to change from one task to another
and a tendency to get stressed and worried. The psychiatric interview revealed significantly
more often a history of loss of interests and self-confidence and difficulties in making decisions
in those subjects who subsequently deteriorated.
Thus, personality changes are likely to be among the earliest features of AD. Although the
assessment of personality in demented patients presents unusual and difficult methodological
problems, personality alterations may be seen as a marker of early AD and warrant further
investigation.
S«è;ec/ive cognitive comptete as an ear/y marker o/Wemen/ta
With respect to the early detection of dementia, it is important to know whether the
judgement of ones own memory (often referred to as metamemory [245, 284]) reflects
objective cognitive functioning and whether memory complaints have diagnostic meaning.
Complaints of memory are quite common in the elderly and in middle-aged subjects.
Difficulties in remembering were reported by no less than 73% of the 40-year-old and by 91%
of the 70-year-old subjects [25]. Cognitive complaints are associated with normal ageing,
organic brain diseases, and a variety of other disturbances such as metabolic disorders, use of
drugs, or affective disorders. Besides this, the growing interest of the media in dementia and
Alzheimer's disease may have increased the awareness of memory deficits as a possible first
sign of mental deterioration [318]. Although the majority of people who complain about this
do not regard a decreased memory as a severe handicap [303], some of them do experience
these complaints as distressing and this warrants their further examination.
A lot of evidence suggests that memory complaints in older adults correlate to a large
extent with depression, but only modestly with their performance on objective memory tests
[25,43, 204, 234, 242, 303]. However, the finding that the association of subjective
complaints to depression is stronger than to dementia should not be interpreted too
dichotomous manner since depression may also be a presenting symptom of Alzheimer's
disease [252]. Thus, metamemory seems to be a poor predictor of dementia. However, a
recent study reported that the relatives' assessments of the patients' memory, measured by
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standardized questionnaires, was a reasonable predictor of dementia, with an overall
classification accuracy rate of 74%; this rate was improved by 11% with the addition of
objective memory tests [204]. These findings underline the diagnostic importance of taking a
history from a relative or other informant who can report on the premorbid behaviour of the
patient. The value of this has not been investigated sufficiently so far in clinical research.
Although metamemory may be a poor predictor of cognitive decline in patients who are
already demented, it would be of interest to investigate whether complaints of one's
decreasing cognitive functions may anticipate manifest dementia.
Dementia is generally recognized as a problem that requires a multidisciplinary approach [179,
290, 308], but in clinical practice the diagnosis is usually made by one discipline. The several
specialties involved in the field of psychogeriatrics often regard their own discipline as
essential. For example, at the CBO consensus meeting on dementia in the Netherlands
(Utrecht) in 1988, each of the representatives from neurology, psychiatry, neuropsychology,
and geriatric medicine stated that patients with dementia should be examined by their own
discipline [40]. A meta-analysis of the literature on the prevalence of dementia recently
showed that specialty of the person making the assessment (e.g., general practitioner,
psychiatrist, neurologist, or geriatrician) is an important methodological variable accounting
for interstudy differences in the prevalence of dementia [153]. In view of the importance of
clinical judgement in the assessment of mild dementia, it is remarkable that so little attention
has been paid to which discipline is the best equipped to make this diagnosis. Will every
patient indeed benefit from a diagnostic work-up by all above-mentioned specialities ? Or is it
possible to determine specific problem areas that require the expertise of specific specialists ?
These questions are still unanswered.
Neuropsychological tests can make the diagnosis of mild dementia considerably more certain
[124, 140]. There are many neuropsychological tests [183], but special demands are made
when they are applied to the diagnosis of mild dementia, e.g., the tests should not be too
difficult or time-consuming, and appropriate norms must be available for subjects of different
ages [140]. Several approaches for the assessment of AD have been proposed, including
traditional psychometry [299], approaches using the information-processing paradigm [30,
155, 297], behavioural neurology [81, 301], and combinations of these three [146]. Subjects
with mild dementia and healthy controls differ on a number of neuropsychological functions,
including aspects of memory [81, 86, 114, 265,299,334,335], word fluency [299], spatial
abilities [140], and other functions [145, 146,212], Memory impairment is a prominent
feature of dementia and is regarded as essential for the diagnosis [7,207]. In particular,
measurements of delayed recall have been reported to have a high sensitivity and specificity in
the diagnosis of early AD [67,265, 335]. Unfortunately, no consensus has been reached so far
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on the choice of neuropsychological tests. The NINCDS-ADRDA criteria for AD have
determined the different cognitive domains to be examined and only suggested some
commonly used tests. More recently, however, efforts have been made by the Consortium to
Establish a Registry for Alzheimer's Disease (CERAD) to standardize the assessment of
cognitive functions [217,218].
Much emphasis is traditionally laid on memory functions in all neuropsychological
approaches, but memory loss is not the sole basis for a diagnosis of dementia. By definition,
demented subjects also have deficits in cognitive domains other than memory [7,138, 207]. In
particular, tests for language (fluency, naming) have found to be valuable in the assessment of
early AD [138,217,334,335]- Abroad neuropsychological approach including tests that assess
language, praxis, attention, visual perception, and problem-solving is recommended for the
diagnosis of AD [207]. Although memory tests alone differentiate reliably between selected
patients with mild AD and healthy subjects [81, 86,114, 239, 299], diagnostic errors can be
expected when the tests are used in unselected populations, e.g., in alcoholics, depressives, or
physically ill subjects [10,49]. The performance of mildly demented subjects on traditional
psychometric tests shows considerable overlap with that of normal subjects, possibly due to a
lack of consideration for individual aspects, such as premorbid intelligence, anxiety, sensory
impairments, or physical disorders. In addition, genuine memory deficits have to be sorted out
from apparent deficits. These apparent deficits can be due to ineffective strategies, impaired
attention, reduced processing capacity, fear of failure or impairment of other cognitive
processes that influence memory [247]. These psychological aspects have to be taken into
account before a reliable judgement on memory functioning can be made.
Therefore, clinical judgement cannot be missed and is probably more sensitive to early AD
than psychometric methods [138,274], Thus, although neuropsychological tests provide an
essential cornerstone to the diagnosis of mild dementia, they should be integrated with other
types of assessment, notably those from psychiatry and neurology. A combination of the two,
clinical assessment and psychometric tests, with techniques based upon different paradigms is
the most accurate approach to date.
ikfórfe cqgnitfve rafeg scate
The use of brief screening tests to obtain an objective measure of the mental status has
increased dramatically over the past decades. The major advantage of all structured screening
tests over unstructured bedside examinations is that they provide standardized methods of
data collection and interpretation and thus improve diagnostic accuracy. A variety of different
screening tests exist, of which the Mini-Mental State Examination (MMSE) is definitely the
most widely used [97]. The MMSE serves as an example of the feasibility of other similar
screening instruments as well [90,91,130,222, 246], but it should be noted that differences
exist between the several scales. However, a detailed discussion of these differences is beyond
the scope of this review.
The MMSE was originally designed to differentiate organic from functional psychiatric
patients. Nowadays, it is largely used with demented subjects as a diagnostic tool in
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epidemiological and clinical studies for assessing the severity of cognitive impairment and to
document cognitive changes over time. The psychometric properties of the MMSE are well
documented. The scale has moderate-to-high levels of reliability. Furthermore, its score
correlates highly with the scores obtained with other screening instruments, indicating good
construct validity; its sensitivity is satisfying in moderate and severe dementia. In addition, the
scale can reliably document cognitive changes in longitudinal research with dementia patients
(see [312] for an overview).
However, there are also serious limitations to bedside screening instruments. For instance,
the MMSE has been criticized because it is highly verbal and it does not pay enough attention
to the measurement of visuospatial praxis. Therefore, it cannot detect focal lesions in the right
hemisphere. However, the most important shortcoming of all bedside rating scales is their lack
of sensitivity to mild cognitive impairments and their failure to discriminate between mild
dementia and normal ageing. For instance, applying the traditional cut-off score of the MMSE
(between 23 and 24) to patients with mild dementia results in a false-negative outcome in
about half of the patients [106,138,165,246]. Similar figures were found for other screening
tests [90, 91, 222, 246]; no dementia screening test is superior in this respect [130]. In
addition, many screening tests are influenced by the patient's race and level of education [90,
Thus, bedside screening tests are inaccurate in the diagnosis of mild dementia in individual
patients. Bedside tests do not increase the level of diagnostic accuracy achieved through
clinical examination alone [312]. However, administering the MMSE, or similar scales, may be
of use to standardize global cognitive assessment, to document a clinical impression of
cognitive dysfunctioning, and to obtain a baseline measurement for longitudinal evaluation in
daily practice.
C/in/co/ teterogewejty o / /Ae afemenfta syndrome
Dementia is currently defined in an identical way as many different diseases. The DSMIII-R
definition allows for considerable variation in the clinical picture [7]. The sine qua non in this
definition is the combination of memory impairments and disruption of social functioning.
Furthermore, patients with dementia may or may not have impaired abstract reasoning,
disordered judgement, aphasia, apraxia, agnosia, or personality changes. This raises the'
question whether there is only one type of dementia. There have been several attempts to
classify dementia in subgroups according to different patterns of cognitive impairments and to
the underlying pathology. The major divisions are between cortical and subcortical, and
between frontal and non-frontal.
The subcortical type of dementia was described for the first time in 1974 by Albert et al. [3]
in patients with supranuclear palsy (SNP). Subsequently, other neurological disorders have
been viewed as being typically subcortical: Huntington's disease, Parkinson's disease, Wilson's
disease, lacunar state, normal pressure hydrocephalus, and AIDS [15,61,72,206], Subcortical
dementia is characterized by forgetfulness, slowing of thought processes, impaired ability to
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manipulate acquired knowledge, alteration of personality, apathy, and depression. In contrast,
amnesia, aphasia, apraxia, and agnosia are regarded as cortical features.
The frontal type of dementia has been described by Neary and coworkers [220, 221]. Its
anatomical substrate is in the prefrontal regions of the cerebrum. The typical clinical picture of
frontal dementia is characterized by personality changes such as impulsivity, apathy or
coarseness, the loss of abstract attitude, perseveration, utilization behaviour and deficits in
selective attention, arousal, and ability to screen out irrelevant stimuli [184, 185, 195, 209,
221). Pure amnesia and instrumental deficits (aphasia, apraxia, or agnosia) are rare, although
anomia may also be part of the frontal picture. Many of these alterations lead to socially
inappropriate behaviours, whereas the cognitive functions may still be relatively intact. A
typical example of a disorder presenting with this frontal symptomatology is Pick's disease,
although a frontal-type dementia has been described in patients who lack these typical
pathological hallmarks of Pick's disease [220,221].
Although the concepts of cortical, subcortical, and frontal dementia have considerably
stimulated interest into classifications on the basis of brain-behaviour relationships, their
validity remains uncertain. There is a considerable overlap in the clinical presentation of the
different types of dementias and their differentiation on the basis of cerebral localization
appears to be difficult [338]. Relatively few data exist on the features of the different types of
m/W dementia. In a recent retrospective study, the presenting symptoms of Alzheimer's
disease and Pick's disease were compared [208]: personality changes, hyperorality, and
disinhibition were reported to be more frequent in Pick's disease, but personality changes
occur also early in the course of Alzheimer's disease [274]. Bradyphrenia and impaired
memory recall are said to be early symptoms of subcortical dementia's [44, 71]. Whether
these clinical characteristics can differentiate between the different diseases in their early
stages is a question that remains to be answered.
Mgrowps o/j4fe!)«mer's rfwease
A question related to the above-mentioned issue is whether Alzheimer's disease represents
one concept or more. There is much evidence to suggest heterogeneity of Alzheimer's
disease. Subtypes can be distinguished with regard to dinical features [45, 200], age at onset
[92,121], rates of deterioration [125,296], brain-imaging parameters [279], histopathology
[27], neurochemical parameters [148], and genetic aspects [160]. Some studies suggested a
subgroup of slow or non-progressive AD [36, 200, 296]. For instance, an early onset has often
been associated with more prevalent and severe language disorders and a faster rate of
progression than an onset after 65 years of age [45,125, 282]. Until now, attempts to describe
the earliest manifestations of AD have not paid much attention to the issue of heterogeneity.
However, this aspect deserves more investigation as it implies that different subgroups may
present with different symptoms. For instance, aphasia may be a more sensitive marker for
early Alzheimer's disease in relatively young patients, whereas impaired visuoconstructton may
be a more sensitive marker in elderly subjects.
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COM//«MOMS aec//ree as « « ear/y manfeer
Alzheimer's disease is a disorder which is characterized by a gradually progressive decline in
cognitive and behavioural functions [207]. The process of change may be more important than
the absolute levels of functioning. For instance, the decrease of a few points on the
Mini-Mental State Examination [97) within a given period maybe more meaningful than the
absolute scores, even when above the traditional cut-off point. The course of decline in AD has
only recently been studied more systematically in demented patients [36 105 325] but
hardly any studies exist on the prognostic value of certain changes in non-demented subjects
Sophisticated measurements that are sensitive enough to detect small changes with time are
needed. Some other questions have still to be answered. How long should the minimal length
of the intervals be? Which cognitive and functional changes are among the earliest symptoms?
Which characteristics are best suited to longitudinal assessment?
It should be noted that most of the research into AD has been carried out in relatively young
and healthy patients, although dementia is more prevalent among the older and more
diseased population. Older populations show higher levels of comorbidity The relevance of
this aspect has been noticed by O'Connor [229], who was confronted in his field studies with
particular diagnostic errors in very old subjects and those with significant comorbidity Old
patients are more difficult to investigate appropriately. Besides, many old patients live in
nursing homes or other protected environments, where criteria for social and functional
decline are harder to meet than in younger subjects who are still working [60]. Moreover
samples with a high age will inevitably suffer more from methodological flaws such as higher
mortality figures and decreased attendance at follow-up. Therefore, data from studies of
relatively young patients cannot directly be applied to the typically geriatric population It
seems likely that the early detection of AD in young and healthy subjects requires a different
approach compared to that in the older samples. These aspects have generally been neglected
so far in research of the earliest stages of AD.
Conclusions
A conclusion of this review of the literature is that there is no unquivocal and reliable method
currently available for the individual diagnosis of AD under the level of clinically manifest
dementia. The first manifestations of this disease are subtle and difficult to distinguish from
other behavioural syndromes. Once the threshold of dementia - as defined, for instance by
the DSM-III criteria - is passed, the prognosis can be predicted quite accurately So 'far
prodromes of Alzheimer's disease have not yet been adequately translated into reliable
diagnostic criteria. This may be due to a number of factors. Perhaps, the instruments used
(e.g., consensus criteria, psychometric tests) are not the proper ones. The traditional 'gold
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standard' of neuropathology is virtually unavailable in this area. Validation must come from
careful documentation of a progressive decline, with adequate assessment tools and
sufficiently long periods of follow-up. Compared to the enormous amount of research into
dementia and AD, the number of longitudinal studies of early AD is small. At present, little can
be expected from epidemiological field studies which of necessity work with reduced sets of
data. A more individualized approach is needed that takes into account possible confounders
from various categories such as earlier biological life events [132, 149], psychological states
such as depression, bereavement or anxiety, premorbid personality, social factors, old age,
comorbidity and sensory impairment. A clinical phenomenological approach combined with
quantitative psychometric tests is probably the most sensitive method for the diagnosis of early
AD but has the disadvantage of subjectivity.
Much research remains to be done. Doctors should be made aware of the importance of the
detection of early AD with regard to the development of possible therapeutic strategies in the
future, and should be encouraged to refer subjects at risk to specialised multidisciplinary
services. A next step will be the collection of clinical data of people suspected of being at risk.
Refinement of the available clinical instruments has a high priority. As it is not yet known
which features are especially characteristic, a broad description is needed based on methods
derived from traditional psychopathology, psychometric tests and qualitative clinical measures.
Psychopathological descriptions must include the (alterations in) affectivity, volition, and
self-experience. A more standardized assessment of personality characteristics is also useful.
The history of the patient's relatives should receive much more attention, as this has proved
to be one of the most sensitive instruments for the detection of early changes to date. It
certainly needs to become more standardized. The categories from the DSM-III-R are
obviously too static to delineate the prodromal stages precisely. More dynamic diagnostic
strategies are needed to improve the accuracy of the diagnosis of very early AD. Tasks derived
from the information processing paradigm may provide more insight into the different
elements of psychological processes [297].
Another step would be to establish the validity of this presumed syndrome of predementia
or, perhaps, various clusters of symptoms. This can be done in longitudinal studies, with
repeated measurements over time. However, we first need to know which symptoms are the
best ones to be followed over time and what the minimal period of follow-up in the earliest
phases should be. Other configurations of symptoms may be detected and found to be of
relevance by means of statistical procedures such as cluster analysis. Construct validation can
be acheived by using SPECT, MRI or other neuroimaging techniques. Syndromes or symptoms
with a potentially predictive value can then be isolated and earmarked as the essential
hallmarks of early Alzheimer's disease. It will only be possible to develop less extensive
diagnostic procedures of sufficient validity once it is known which signs and symptoms are
characteristic of early Alzheimer's disease.

3Diagnosing dementia:
different disciplines, different diagnoses ?
o/ a cowsewws mee/mg ow
Introduction
The lack of clear diagnostic criteria for dementia has for a long time hampered research and
patient care, but in the last decades much progress has been made. In 1980, the DSM-III
criteria for dementia were introduced, with a recent revision in 1987 [6, 7]. In 1984, an
expert workgroup of the National Institute of Neurological and Communicative Disorders and
Stroke, and the Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA)
reached consensus about the criteria for the clinical diagnosis of Alzheimer's disease, which is
the most frequent cause of dementia [207]. Several guidelines for the diagnosis of vascular
dementia have been proposed as well [44, 84, 119, 192, 266, 269), although these are
adhered to less uniformly, as their validity is still debated. Usually, the diagnosis of vascular
dementia is based on the ischaemic score of Hachinski or one of its modifications [117]. These
criteria have been proposed tentatively, to be modified on the basis of new insights. In the last
years, several studies have reported on the validity and reliability of these criteria. The
inter-rater reliability and reproducibility of the NINCDS-ADRDA criteria appear to be
satisfactory [99,175]. Their validity is also acceptable, with a clinico-pathological agreement
rate of about 80% [26,215,261,310].
Although the criteria were originally designed for research purposes, they are now
generally accepted as the basis for the diagnosis of dementia in daily patient care [54, 167,
281]. However, although the merits of the criteria for scientific research are obvious, there are
Translation and adaptation from: FRJ Verhey, LA Plugge , JJE van Everdingen, J Jol les . "Dementie:
verschillende disciplines, verschillende diagnosen?" Tijdschrift voor Geriatrie en Gerontologie 1991;22:187-194.
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hardly any data about how the criteria are adhered to in clinical practice. A few studies have
investigated possible differences between a referrer's diagnosis on one hand and that of a
specialized academic centre on the other [108,128,322]. It appeared that dementia was both
under- and overdiagnosed in quite a number of patients. However, the academic centres used
data that differed both quantitatively and qualitatively from those of the referrer, because the
centres had access to more diagnostic resources, such as neuropsychology and sophisticated
brain-imaging techniques. Therefore, these studies do not allow examination of the extent to
which the differences in diagnoses are related to differences in the use of the criteria.
This paper describes an experimental study into the way clinicians of different disciplines
make their diagnosis. We carried out an inquiry among the participants of the Dutch
Consensus Meeting on Dementia, which took place in Utrecht, the Netherlands, in November
1988, and which was organized by the Dutch Organization for Quality Assurance in Hospitals
(CBO). The participants of this meeting were asked to give their diagnosis (or diagnoses) of
ten written case reports, which contained all data required to reach the diagnosis of dementia
and its aetiology. In contrast to the studies mentioned in the previous paragraph, all
participants received the same set of data..
The first aim of this study was to assess whether there are any systematic differences in the
diagnostic outcome between the various disciplines involved in the diagnosis of dementia-
Second, we investigated the influence of certain patient variables, such as degree of cognitive
decline, upon the level of consensus and the agreement with a gold standard.
Methods
All 458 persons who were registered for the CBO consensus meeting on dementia received a
booklet with five case descriptions (set 1) two weeks before the meeting. An introductory
letter and a form were enclosed, and participants were requested to write down the diagnosis
(or diagnoses) for these case reports. The participants were also asked to answer questions
concerning their age, discipline, years of experience with dementia, and number of hours
spent weekly in the differential diagnosis and classification of patients with dementia.
Participants were not asked explicitly to formulate their diagnoses according to certain
guidelines, in order to avoid any reference to the consensus meeting and thereby possibly
influencing diagnostic usage and terminology. One week after the meeting a second booklet
with five other case descriptions was sent to all who responded to the first part of the inquiry
(set 2). Participation in the inquiry occurred anonymously.
Afatera/
The two sets of five case reports each were selected from the records of real patients from the
Maastricht Memory Clinic, but to guarantee the patient's privacy, any information that might
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identify the patient was changed. The information was incorporated in the following
paragraphs: introduction, medical history, as reported by the caregiver, psychiatric and
neurological history, medical history, medication data, intoxication data, psychosocial data,
daily functioning, physical examination, neurological examination, psychiatric examination,
neuropsychological examination, blood examination and additional examinations (such as CT
scanning, X-ray of the chest and electrocardiogram). The clinical data were presented without
any reference to the interpretation of them, e.g., wording such as 'no abnormalities' or
'impaired performances' was avoided as much as possible. The two sets of case reports were
comparable in the severity and the complexity of the cognitive disorder. Each case description
contained enough data to make a diagnosis according to the DSM-III-R criteria for dementia
and to those of the NINCDS-ADRDA for the diagnosis of Alzheimer's disease. Sufficient data
were provided to determine a score on Hachinski's Ischaemic Scale [119] and on the Global
Deterioration Scale [255], in order to obtain a measure of the probability of a vascular
aetiology and the degree of cognitive decline, respectively.
To establish a reference to enable comparison of the diagnoses, the same ten case descriptions
were presented a few weeks after the consensus meeting to an independent multidisciplinary
committee of three renowned clinicians (a psychiatrist, a neurologist and a neuropsychologist)
experienced in the differential diagnosis and classification of dementia. The three clinicians
were given the opportunity to discuss the data thoroughly and to formulate the final
diagnoses. The committee was asked to state the diagnoses at both the syndromal and the
aetiological level. The committee took about 4 hours to establish the diagnoses. The
diagnoses were used as the golden standard or Reference Diagnoses (RD). The committee
reached a consensus for all patients, except for the aetiology of patients 4 and 6: in these two
patients there were two possible aetiological diagnoses. The Reference Diagnoses are
summarized in Table 1.
In order to perform a meaningful quantitative analysis of the diagnoses, the results of the
inquiry were classified according to the following two-step hierarchical system. First, a
syndromal diagnosis was made, and then the aetiological diagnosis. At the syndromal level, the
possibilities were dementia, cognitive disorder not labelled as dementia, no cognitive
disturbances, no statement on cognitive functioning. At the aetiological level, the following
categories were included: primary degenerative, cerebrovascular cause, neurological cause
other than cerebrovascular, somatic/ internal cause, intoxication/ side-effect of drugs, e.g.,
major tranquilizers, depression induced, related to psychosocial factors, and no statement on
aetiology. Differences in the terminology used were taken into account at scoring; thus,
diagnostic statements such as Alzheimer's disease, senile dementia, SDAT or primary
dementia, were all coded as 'dementia, primary degenerative' and, likewise, statements such
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as vascular dementia, Multi-Infarct Dementia, Binswanger's disease, and atherosclerotic
dementia were all coded as 'dementia, cerebrovascular cause'. Although the diagnosis of
depression is usually adhered to in a syndromal way [7], it was used here in an aetiological
sense, i.e., as a possible cause for cognitive deterioration (cf. depression-induced dementia).
Table 1. "Golden standard" diagnoses made by a multidisdplinary expert committee.
1 1 74-year-old woman
syndrome: moderate dementia, with depression
aetiology: probable Alzheimer's disease
2 80- year-old woman
syndrome: moderate dementia,
aetiology: probable Alzheimer's disease; drug induced parkinsonism
3 80-year-old man,
syndrome: severe dementia,
aetiology: vascular dementia, drug induced parkinsonism
4 66-year-old woman
syndrome: mild dementia,
aetiology: possible Alzheimer's disease or depression induced dementia
5 71-year-old woman
syndrome: slight cognitive deficit
aetiology: CVA; adjustment disorder
2 6 62-year-old man
syndrome: slight cognitive deficit
aetiology: history of HA
7 80-year-old woman
syndrome: severe dementia,
aetiology: probable Alzheimer's disease
8 86-year-old woman
syndrome: mild dementia,
aetiology: vascular dementia with depressive symptoms
9 72-year-old man
syndrome: mild dementia,
aetiology: possible Alzheimer's disease; possible subdinical CVA
10 67-year-old man
syndrome: moderate dementia,
aetiology: vascular dementia
Note: CVA = cerebrovascular accident; 1TA = transient ischaemic attack
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Results
One-hundred and twenty-seven out of the 458 participants of the consensus meet ing
completed the pre-consensus questionnaire. Of these 127 respondents, 90 completed the post-
consensus questionnaire. Five of these 90 respondents were not actively involved in health
care; thus, the data of the remaining 85 participants were analysed. Various characteristics of
these 85 respondents are shown by discipline in Table 2. About 20 % of the participants of a
given discipline responded, and no significant difference was found between the response rate
per discipline and the actual number of participants per discipline who attended the consensus
meeting (Pearson chi-square, n.s.). The disciplines were also comparable with regard to the
number of years of experience of the participants in health care, mean age, and the reported
amount of time spent reading the syllabus by the CBO on the diagnostic dilemma's of
dementia that was edited (ANOVA, n.s.).
Table 2. Number of participants (n, %) in CBO meeting and characteristics of respondents by discipline
#(%) .yews o/ age fours CBO sy//a&KS
respora&g expercewce (meanj dteö
neurologists
psychiatrists
psychologists
nureinghomeGP's
other physicians
others
TOTAL
100
57
66
133
74
28
458
(22)
(12.5)
(14.5)
(29)
(16)
(6)
(100)
24
13
10
26
12
5
90
(26.5)
(14.5)
(11)
(29)
(13.5)
(5.5)
(100)
17.1
11.9
13.9
131
12.1
43.8
40.3
43.7
40.1
39.8
2.2
2.5
3.4
2.9
2.75
First, we investigated whether there was any difference in the level of consensus before and
after the consensus meeting. This was examined separately for the syndromal and for the
aetiological diagnoses. As a measure of the degree of agreement, the proportion of the
number of pairs for which there was agreement relative to the possible pairs of assignments
was used. The way this proportion of agreement was calculated is derived from the kappa-
methods of agreement for k raters and n objects [285], and is described in more detail in our
previous article [243]. In order to examine the differences in pre-meeting and post-meeting
consensus, a two sided test was used to compare the level of proportion of agreement of each
discipline for the five case reports. First, we tested for differences among all participants
together. There were no significant differences in the level of consensus in the ten case
descriptions or any differences with regard to the aetiological diagnoses. When calculated for
each discipline separately, we did not find any significant differences either.
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Having concluded that there was no significant difference in the level of consensus before and
after the consensus meeting, we combined the results of the ten case descriptions for further
analyses. We investigated the level of agreement between the respondent's diagnoses and the
Reference Diagnoses (RD) made by the multidisciplinary committee. For each diagnosis that
corresponded with the RD, the respondent received one point, both with regard to the
syndromal diagnosis and the aetiological diagnosis. Thus, 10 points could be scored for the
syndromal diagnosis and 10 points for the aetiological diagnosis. In patients 4 and 6, in which
the multidisciplinary committee could not reach consensus on the aetiology, both alternatives
were considered "correct". The degree of agreement with the RD for syndrome and for
aetiology is shown in the figures 1 and 2. First, the syndromal diagnoses of all 85 clinicians
were analysed together: the mean score of agreement with the RD was 7.6±1.4 (range 1-10).
There were no significant differences between the disciplines, the different disciplines being
equally accurate in diagnosing dementia.. The mean agreement score with the RD for the
aetiological diagnosis, calculated for the entire group, was considerably lower: 5.3±1.7
correct diagnoses (range 1-8). Statistical analysis revealed the following significant differences
(Waller Duncan K-ratio T test, p<0.05) between the disciplines: the neurologists had more
correct diagnoses (mean score:6.2) than the psychiatrists, the nursing home physicians, and
the other physicians. The psychiatrists made less correct diagnoses than the neurologists and
the psychologists, whilst the other disciplines had an intermediate number of correct
diagnoses. No significant relationship could be found between the agreement with the RD and
the severity of the cognitive syndrome as assessed by the GDS score. However, the number of
diagnoses that were correct appeared to be significantly lower in the five patients in whom
depressive symptomatology was present compared to the other five patients without signs of
depression (T test for paired samples). This difference was found for both the syndromal
diagnosis (4.00 «j. 3.57, p<0.05) and the aetiogical diagnosis (3.32 us. 7.S>7,/><0.0/).
Next, we investigated whether some disciplines used some diagnoses more than the other
disciplines. The following results were significant (Waller-Duncan t test, p<0.05): the
psychiatrists and the nursing home physicians made a syndromal diagnosis without any
aetiological specification the most often, whereas the neurologists made more aetiological
diagnoses. The diagnosis Alzheimer's disease was made more frequently by the neurologists
than by the other disciplines. The diagnosis depression was made more often by the
psychiatrists. Intoxication or drug side-effects was used more often by the nursing home
physicians and the other physicians than by the psychiatrists and the psychologists, whereas the
neurologists had an intermediate position. There were no significant differences for the other
diagnostic categories (i.e., internal somatic, cerebrovascular, neurological and psychosocial).
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Figure 3.1 Mean number of syndrome diagnoses in
agreement with the Reference Diagnosis
Figure 3.2 Mean number of aetiological diagnoses in agreement with the reference
diagnosis. Significant were the following differences: neurologists vs.
psychiatrists, nursing home physicians and other physicians; psychologists vs.
psychiatrists.
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Finally, we investigated whether we could identify certain factors that influenced the level of
consensus. It appeared that there was significantly more consensus for the syndromal
diagnoses than for the aetiologic diagnoses (two-sided sign test, p<0.001). Moreover, there
was a significant relationship between the level of consensus and the degree of cognitive
decline, i.e., the GDS score (Figure 3).
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Figure 3.3 Relation between the level of consensus and the GDS score, for syndrome and
aetiology.
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Figure 3.4 Number of terms used by 85 participants of the CBO consensus meeting on
dementia for the cognitive syndrome in ten factious cases
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In patients with a mild or moderate degree of cognitive decline, there was a greater
diversity of diagnostic opinions than compared with the more severely disturbed patients. This
was the case for both syndromal and aetiological diagnoses (R=0.66 and 0.70, respectively,
p<0.05). Thus, almost every participant diagnosed dementia in patients with severe dementia.
The number of different terms that were used to designate the proper diagnosis by the
GDS score score of each patient are presented in figure 4. As can be seen, the number of
terms increased dramatically in the lower GDS stages.
Discussion
Several findings have emerged from this study. In the first place, we could not establish any
change in the level of consensus one week after the consensus meeting, compared to the
situation before the meeting. This finding can be explained in various ways. It is possible that
the respondents had already reached a high level of consensus on the diagnosis of dementia
before the meeting took place. The syllabus that was sent to all participants may have
contributed to this unanimity. It is also possible that those participants who responded to the
inquiry formed a selected group of people with a more than average interest in and
knowledge of dementia. A third possibility is that the information from the oral presentations
and the discussion at the meeting was too limited and fragmentary. However it seems more
probable that the time between the first (pre-meeting) and the second (post-meeting) inquiry
was too short to achieve any substantial change: physicians who have established their own
way of diagnosing dementia over many years may not change their use of criteria and terms
within two weeks, even though their diagnostic procedure does not correspond to that
proposed at the consensus meeting. A third inquiry after a longer period of time would be
necessary in order to assess the effects of the consensus meeting with more confidence.
Second, the level of consensus correlated directly with the severity of the cognitive
decline. At first sight, this may seem a quite obvious finding, since the diagnosis of mild
dementia is generally regarded as more difficult than that of a more advanced stage. However,
upon further consideration this finding is remarkable, because the problem of mild dementia is
especially formed by the fact that the condition is insufficiently recognised [124}. "Mild
dementia is a latent condition, detectable only by challenge [309]". In our study, all the
necessary elements were presented beforehand. Thus, the failure to recognize symptoms of
dementia was precluded as a possible source of diagnostic error. Thus, a more probable
explanation may be that the diagnostic criteria were applied less vigorously in patients with
mild cognitive decline than in patients with more severe dementia. It is also possible that
clinicians are more reluctant to use the stigmatizing term of dementia for patients with milder
forms of cognitive decline, although it is realized that the regular diagnostic criteria (such as
those of DSM-III-R [7]) are met. Both situations may lead to a semantic confusion between
clinicians, since the functional significance of the term is disregarded [315] •
Third, the number of correct diagnoses, i.e. the agreement with the Reference Diagnosis,
was considerably influenced by the presence of depressive symptomatology. Even the
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Multidisciplinary Committee that served as the 'gold standard' could not reach full consensus
on patients 4 and 6, in whom there was a combination of dementia and depression.
Apparently, standard criteria are more difficult to apply to patients with a combined
symptomatology.
Fourth, the results of this study clearly show that the various disciplines focus upon different
aspects of the dementia syndrome and its multidimensional aspects. For example, neurologists
and psychiatrists, not so long ago still united in the specialty of neuropsychiatry,'now seem to
be each other's antipoles. This may be ascribed to differences in diagnostic traditions between
the disciplines: neurologists are generally trained in diagnosing nosological entities, whilst
psychiatrists are more inclined to use a descriptive and functional diagnostic approach' [188].
Both ways of diagnosing complement each other.
The level of agreement with the RD reached for the syndromal diagnosis was on average
higher than for the aetiological diagnosis. However, it should be noted that there were more
diagnostic possibilities to chose from with regard to the aetiological diagnoses. The relatively
low agreement with the RD of the psychiatrists and, to a lesser extent, the nursing home
physicians, was marked significant. Apparently, these disciplines are used to a mere syndromal
approach.
Some methodological issues of the present study have to be considered. The use of the
diagnostic outcome of the Multidisciplinary Expen Committee (MEC) as the 'gold standard'
can be debated. The diagnoses made by the MEC could not be compared with post-mortem
data. However, the diagnosis of dementia is characterized by the absence of a clear, objective,
and unambiguous diagnostic marker. Dementia is a clinical syndrome that is entirely defined'
by consensus [207]. The same is true for the most frequent causes of dementia, notably
Alzheimer's disease, if neuropathological data are not available. In the absence'of such
external criteria, there is no other standard than the careful application of generally accepted
diagnostic criteria. Thus, the diagnoses can be made most reliably by inviting a number of
experts from relevant fields and asking them to adhere to the consensus criteria, after ample
discussion of each case.
The question could be raised whether the findings of our study, in which written case
reports were used, can be generalized to daily practice with 'real' patients. To avoid this
source of error, the present investigation should have been carried out with living patients or
with videotaped interviews, but such a design would have caused many practical problems.
Reduction of the realistic situation by written case reports may have influenced the results of
this study in a negative way. However, many of the respondents are familiar with written case
reports, although it is not known whether this is the same for every discipline. Assessment of a
patient by reviewing their files ('paper visits') is not unusual in daily clinical practice.
Therefore, we do not expect the manner on which the clinical data were presented would
have had a substantial effect on our results. It can be stated that the amount of clinical data
presented in the case reports of our study is probably much larger, and from more different
disciplines, than is usually the case in daily practice.
The extrapolation of the findings of our study to all members of a particular discipline
should also be given due consideration. Although 85 (67%) out of 127 clinicians responded to
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both the first and the second inquiry, they account for only 18% of the total number of
participants. It can be questioned whether those who attended the consensus meeting and,
more specifically, those who responded to the inquiry, can be regarded as representative for
their profession. As is the case in all inquiries in which the response is voluntary, the
respondents cannot be regarded as a random sample. To quote Rumke: "Regarding the
apparent objectivity of a statistical conclusion, it should be noted that the decision that the
sample can be viewed as random is often subjective itself'. It is clear that the respondents of
our study do not represent the average clinician: they probably had more affinity for
psychogeriatry than randomly selected clinicians. An indication for this is the mean duration of
the respondents' clinical experience, which is more than 10 years (Table 2). Therefore, the
level of consensus and the agreement with the Reference Diagnosis will probably be lower in
less selected samples of diagnosticians.
Conclusion
A systematic and multidisciplinary approach, based on generally accepted and validated
criteria, has frequently been recommended for the diagnosis of dementia [7, 53, 5 i 167,207,
281,322]. The present study illustrates the need of such an approach. The study demonstrates
that different disciplines focus upon different aspects of the multidimensional problem of
dementia. Together, the disciplines form the complete diagnosis. Especially for patients with
mild stages of cognitive decline and with a combination of cognitive and depressive
symptomatology, a more vigorous adherence to diagnostic criteria is required. In these
patients there is much diversity of diagnostic opinions. This aspect should be given more
emphasis in the continued education of every clinician who is involved with dementia.

Diagnosing dementia:
a comparison between a monodisciplinary and a
multidisciplinary approach*
Introduction
In the last decade, a consensus has been reached on the diagnostic criteria for dementia and
Alzheimer's disease (AD) [7,207]. The National Institute of Neurological Diseases and
Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders
Association (NINCDS-ADRDA) workgroup proposes a broad multidisciplinary and systematic
approach for the diagnosis of AD. This includes extensive history taking from the patient and a
knowledgeable collateral source as well as physical, neurological, psychiatric and
neuropsychological examination. The workgroup recommends documentation by validated
scales such as Folstein's Mini-Mental State Examination (MMSE) [97], the Ischernic Score
[119], Hamilton's Depression Rating Scale (HDRS) [120] and the Blessed Dementia Scale
(BDS) [24], Moreover, laboratory assessments and computed tomography of the brain are
required to diagnose secondary causes of dementia. Although originally designed for research
purposes, the NINCDS-ADRDA criteria have been widely accepted as the basis for diagnostic
procedures in clinical practice as well [40,54,66].
The validity and reliability of the DSM-III and NINCDS-ADRDA criteria has been
investigated extensively and appear to be highly satisfactory [26,175, 194, 215, 261, 310]. It
was concluded from these studies that careful use of such a standard classification system, with
standard assessment techniques, is important to minimize the variance between clinicians
[194].
* FRJ Verhey, J JoUes, RWHM Ponds, N Rozendaal, LA Plugge, HCW de Vet, FW Vreeling and PJM van der Lugt.
Journal of Neuropsychiatry and Clinical Neurosciences, 1993; 5; 78-85
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Although these criteria have been widely used since their introduction, the way these
NINCDS-ADRDA and other criteria are applied in routine clinical practice has received little
attention. A muitidisciplinary approach to dementia is generally recommended [179,253,290,
308], but in daily practice the diagnosis is usually made by a member of a single discipline,
who lacks the expertise of other relevant disciplines. Given the multiconditional nature of
dementia, discrepancies can be expected between the diagnostic outcome from a
monodisciplinary and a muitidisciplinary approach, but exact figures on this topic are, to our
knowledge, sparse.
In a previous study [244, 317], we compared the diagnoses often case descriptions, made
by 85 participants in a Dutch consensus meeting on dementia from varying specialties with
those of a muitidisciplinary expert committee, regarded as the "gold" standard. We found that
1) neurologists reached a significantly higher agreement with the committees etiological
diagnoses than the psychiatrists did; 2) all specialties were comparable with regard to the
syndromal diagnosis, i.e. whether dementia was present or not; and 3) depression was
diagnosed more often by psychiatrists than by neurologists. However, this inquiry concerned
written case reports in which all data relevant for the diagnosis dementia and its etiology had
been presented beforehand. The major difficulty in practice is to recognize and to decide
about the presence or absence of clinical symptoms; thus, this study did not provide insight
into the way diagnoses are made in the less structured situation of daily practice.
The aim of the present study was to obtain insight into possible differences in diagnostic
outcome between a systematic muitidisciplinary approach and a monodisciplinary one in
common clinical practice, particularly with respect to the diagnoses of dementia, Alzheimer's
disease, and depression. We therefore compared the diagnoses made by the Maastricht
Memory Clinic (MMC), which uses a standardized muitidisciplinary approach [322], with the
original referrer's diagnosis.
Methods
Four hundred and thirty consecutive patients, referred between May 1986 and July 1991 to
the outpatient MMC of the University Hospital of Maastricht were evaluated. All patients had
been referred because of dementia or memory complaints associated with aging. The patients
were referred by general practitioners (n=151); neurologists (n=175); psychiatrists or the
local psychogeriatric service (n=77); or others, mainly internists or geriatricians (n=27).
Before a case was evaluated by the MMC, the referrer's diagnosis was obtained from a
standardized admission form or from the referrer's letter. Referrers were not made aware of
the present study since the aim of the study was to investigate the diagnostic outcome in
common daily practice; announcing the purposes of the study would have influenced the
diagnostic behavior of the referring clinicians. The MMC assessment was made within 4 weeks
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of the first referred assessment. The comparison of diagnostic outcomes pertains only to the
cognitive, emotional or behavioral syndrome and the related neuropsychiatric diseases.
All patients received an extensive diagnostic assessment, which lasted about 4 to 5 hours. The
diagnostic program is summarized in table 1. The history and physical, neurological, psychiatric
and neuropsychological examinations were always performed again by the MMC for each
patient. Ancillary tests were not routinely repeated if they had been done previously within a
reasonable period of time. The criteria for dementia and other psychiatric conditions were
those of DSM III and DSM-IH-R [6, 7]. The diagnosis of probable or possible Alzheimer's
Disease (AD) was made according to the NINCDS-ADRDA criteria [207]. An Ischemic Score
(IS) [119] of less than 5 was also required. An IS of 5 or more was seen as indicative of a
cerebrovascular etiology, in the absence of other causes. Other neurological and somatic
conditions were diagnosed according to usual clinical guidelines. The neuropsychological
investigation has been described extensively elsewhere [146] and has been devised to assess
all relevant cognitive functions in the domain of memory, attention, language, praxis,
perceptual functions, and speed of information processing. Briefly, a battery of standard
psychometric tasks was combined with a neurobehavioral examination according to Luria-
Christensen [42,195) and information processing tasks [297]. The standard tests were: Rey
auditory verbal learning task, Trail Making Test, Stroop test, symbol- digit modality test, digit
span, fluency, various subtests of the Wechler Adult Intelligence Scale (WAIS), and tests for
complex visual functions. After the examinations had been completed, the results were
discussed at a weekly interdisciplinary meeting. After discussion in this forum, a definite
syndromal and etiological diagnosis was made, and a proposal for treatment was formulated.
Afterwards, a letter was sent to the referrer in which all diagnostic elements, final diagnosis
and proposal for treatment were described.
A two-step procedure was used to classify the diagnoses of the referrer as well as of the MMC.
First, it was decided whether a syndrome of dementia was present or not and whether
cognitive disorders were objectified or not. This was done because the diagnostic criteria of
many neuropsychiatric diseases require the presence of dementia [7, 207]. For example, for
the diagnosis of Alzheimer's disease, the presence of dementia is a prerequisite.
The nat step was to classify the etiology of the syndrome, with the following alternatives:
1) Not specified (NS), 2) Probable or possible Alzheimer's disease (AD), 3) cerebrovascular
cause, e.g., multi-infarct dementia and focal ischemia (CV), 4) Neurological cause other than
cerebrovascular, e.g., Parkinson's disease and head trauma (NE), 5) Somatic/ internal cause,
e.g., metabolic disorders (SO), 6) Intoxication/ side effect of drugs, e.g., major tranquilizers
(IN), 7) Mood disorder, e.g. major depression and dysthymia (DP)8) Psychiatric or
psychological disorder other than 7, e.g. psychosis or personality disorder (PS).
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When there was more than one possible cause, the patient was classified according to the
most probable cause for the cognitive deterioration. For this analysis, depression was seen as a
cause for the cognitive syndrome and not as a syndrome by itself. The diagnoses of the
memory clinic served as a reference for the calculation of the specificity and sensitivity of the
referrer's diagnoses.
Table 1. Standard diagnostic procedure in Maastricht Memory Clinic
History from patient and significant other
Medical history
life events, premorbid functioning
Physical examination
Neurological examination
Psychiatric examination
Blood tests (hematology, glucose, biochemical analyses, TPHA, vitamins, TSH)
ECG, chest X-ray
EEG when epilepsia is suspected
CT-scan when cognitive decline is objectified
Afeuropsycfo/ogy [146]:
Psychometric tasks
Luria-Christensen neuropsychological investigation
Information processing tasks
Mini Mental State Examination (for degree of cognitive dysfunctions)
Hachinski's Ischemic Score (for documentation of cerebrovascular factors)
Hamilton Depression Rating Scale (for degree of depressive symptoms)
Blessed Dementia Scale (for degree of behavioural dysfunctions)
Global Deterioration Scale (for global assessment of cognitive decline)
Results
Of the 430 patients evaluated, 111 patients had been referred because of dementia; its
presumed etiology was specified in 74 cases. The remaining 319 had been referred because of
memory complaints without any reference to the diagnosis of dementia. In this group, the
referrer specified the presumed etiology in 189 cases. Table 2 lists the patient characteristics
and MMC findings by the different referring disciplines. Sixty-five percent of the patients were
between the age of 45 and 75 years. Patients referred by the psychiatrists were younger,
whereas those referred by the general practitioners and 'other referrers' were somewhat
older than the average of 61.7 years.
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Table 2. Distribution of patient characteristics of 4.30 memory clinic patients by specialty
Characteristics from
MMC evaluation
N
mean age (yrs.)
education'
sex(M/V)
jVftHnL/mcW M/MgHwSW, /» (70,
dementia
cognitive disorder
no cognitive disorder
Scores mean
MMSEb
GDSc
BDS-1 d
HRSDt
General
Practitioner
151
64.9
4.1
78/73
58(38%)
55(36%)
38(25%)
23.1
3.1
4.1
10.5
Neurologist
175
60.1
4.0
100/75
55(31%)
103 (59%)
17(10%)
26.1
3.2
2.9
8.7
Patients referred by
Psychiatrist
77
57.9
4.1
49/28
24 (31%)
42 (55%)
11 (M%)
23
3.2
4.3
12.4
Others
27
64.8
4.6
15/12
15 (56%)
9 (33%)
3 (11%)
20.1
4.2
7.0
10.1
Total
430
61.7
4.1
242/188
152 (35%)
209 (49%)
69 (16%)
24.1
3.3
3.8
10.1
P < '
0.001
n.s.
0.005
0.005
0.005
0.005
'KruskaWallistest
Ï education according to Verhage, 1-7 scale: 1 is incomplete primary school, 7 is university [314]
i> Score on the Mini-Mental State Exam of Folstein et ai. [97]
t Score on the Global Deterioration Scale [255]
d Score on the Blessed Dementa Scale, first part (behavior, personality) [24]
«Score on the Hamilton's Depression Rating Scale, 17 items [ 120]
Cognitive and social functioning, as measured by MMSE and BDS, was on average better in the
patients referred by the neurologists and worse in those referred by 'other referrers'. There
were no patients with very severe dementia (i.e., score of 7) on the Global Deterioration
Scale (GDS) [255]. In 69 patients (16%), the complaints about cognitive functions could not be
objectified by neuropsychological tests.
The sensitivity and specificity rates are shown in Table 3 for the referrer's diagnosis of
dementia irrespective of its etiology; for dementia caused by AD; and for cognitive disorders
without dementia, caused by depression or dysthymia. Because in daily practice the term
'dementia' with etiology unspecified is often used for Alzheimer's disease, rates were also
calculated for primary degenerative and unspecified dementia together. In addition, sensitivity
and specificity rates were calculated for depression together with other psychiatric conditions
in order to examine whether refrrer and MMC agreed in the differentiation between organic
or functional etiologic categories.
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Table 3- Sensitivity and specificity of referrer's diagnosis of dementia, Meimer's disease and depression, by
specialty.
Patients referred by
Discipline General Neurologist Psychiatrist Others Total
Practitioner
<n=151) (n=175) (n=77) (n=27) (n=430)
Dementia syndrome
prevalence
sensitivity
specificity
Alzheimer's disease
prevalence
sensitivity
specificity
Alzheimer's disease
0.38
0.60
0.99
0.25
0.18
0.98
0.31
0.73
0.89
0.15
0.33
0.95
(including referrer's diagnoses of "unspecified dementia")
prevalence
sensitivity
specificity
Depression
prevalence
sensitivity
specificity
0.25
0.55
0.96
0.22
0.45
0.97
Depression and other psychiatric conditions
prevalence
sensitivity
specificity
0.33
0.42
0.92
0.15
0.63
0.92
0.16
0.21
1.0
0.25
0.16
0.99
0.31
0.38
0.94
0.22
0.12
0.97
0.22
0.24
0.93
0.36
0.68
0.96
0.44
0.62
0.88
0.56
0.53
0.83
0.22
0.33
0.95
0.22
0.50
0.81
0.07
0.00
1.00
0.15
0.00
1.00
0.35
0.61
0.93
0.20
0.23
0.96
0.20
0.51
0.93
0.21
0.44
0.99
0.31
0.37
0.95
Of the 279 patients not fulfilling the criteria of dementia, only 19 (7%) had been referred as
being demented. In 16 of these 19 patients, the DSM-III(-R) criterion that cognitive
disturbances must lead to a significant interference with daily activities was not fulfilled.
Depressive symptoms coexisted with a neurological disorder, most often cerebral infarction
and Parkinson's disease, in 11 of these 19 patients. On the other hand, in 60 of the 152
demented patients (39 %), a diagnosis of dementia had not been made previously.
Underreporting of dementia occurred especially with mild dementia: the sensitivity rates for
the referrer's diagnosis of dementia were for the GDS stages 3,4,5 and 6; 0.50,0.54,0.64 and
0.79, respectively. The presence of depressive symptoms was another factor that influenced
the diagnosis dementia: sensitivity rates for patients with a HRSD score of <13 were 0.68,
whereas for patients with a HRSD >13 these rates were only 0.36. The sensitivity rates were
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the lowest for the psychiatrists' diagnoses of dementia and the highest for those of the
neurologists; the general practitioners and the other referrers were in between. The same
pattern of sensitivity was seen for the diagnosis primary degenerative dementia, whether
clustered or not with unspecified dementia. The opposite of this pattern, however, could be
seen for the sensitivity rates for depression, with or without the inclusion of other psychiatric
conditions. Fifty of the 89 patients with depression without dementia and 82 of the 130
patients with nondementing psychiatric conditions had not been diagnosed previously as such.
Neurologists tended to underreport these conditions.
Table 4. Agreements and discrepancies in diagnostic classifications between referrer and Memory Clinic
(N=430)
Diagnosis by referrer
Demetifo
Not specified
Primary degenerative
Cerérovascular
Other neurologic cause
Somatic/internal cause
Intoxic/drug side effea
Depression
Other psychiat disorder
AWemenft'fl
Not specified
Primary degenerative
Cerérovascular
Other neurologic cause
Somatic/internal cause
Intox./ drug side effect
Depression
Other psychiat disorder
7bto/diagnosed by AfC
code
NS
AD
CV
NE
SO
IN
DP
PS
code
NS
AD
CV
NE
SO
IN
DP
PS
Diagnosis by Memory Clinic
Demetó
NSAD
• 25
- 20
- 1
- -
• 2
NSAD
- 28
- -
• •
• 7
- 1
• 4
• 88
ia
CV
6
6
18
2
-
CV
4
-
3
1
1
41
NE
2
3
1
4
NE
1
6
•
17
SO
1
SO
1
-
2
IN
-
-
-
-
1
-
IN
-
-
-
-
-
1
-
-
2
DP PS
- -
- -
•
-
-
-
- -
DP PS
- -
- -
•
• -
1 •
- -
1 -
- -
2 -
Afo
NS
•
-
2
-
-
-
-
NS
24
-
-
-
•
-
1
-
27
Dew
AD
-
-
-
-
-
-
-
AD
2
-
-
-
1
-
3
(enli
CV
1
1
6
-
-
-
-
CV
4
-
6
-
-
-
1
-
19
fa
NE
1
1
-
2
-
1
-
NE
10
-
-
63
-
•
-
1
79
SO
-
-
1
-
-
-
SO
-
-
-
8
1
10
IN
1
-
-
-
-
-
-
IN
3
•
•
-
1
5
-
-
10
DP
1
-
•
-
-
-
DP
30
-
2
7
6
1
39
3
89
7bi
PS
1
-
-
-
-
-
-
PS
24
-
-
2
4
1
•
9
41
37
32
28
9
1
4
-
130
11
78
29
aU
45
18
430
Note: Values shown are numbers of patients. Figures printed in bold represent agreements in syndromal and
etiological diagnoses between referrer and Memory Clinic (MQ
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Table 5 . Newly reponed disorders in 430 patients from the Maastricht Memory Clinic:
Patients referred by
CVA
Vitamin deficiency
Alcohol abuse
Drug side effects
Thyroid disorder
Parkinson's disease
Epilepsia
ALS
Depression /dysthymia
Anxiety
Psychosis
Phobia/OCD
Alcohol abuse
CVA
Drug side effects
Cerebral neoplasm
Parkinson's disease
Vitamin deficiency
Cerebral contusion
ALS
NPH
Epilepsia
Sjögren disease
Depression / dysthymia
Adjustment disorder
Personality disorder
Phobia/OCD
Dyslexia
GJ>.
(n=151)
2
2
1
1
.
1
1
1
9
2
-
1
.
4
-
1
.
1
1
.
11
1
2
.
1
&6totó& o / rtÉw/y re/wrta/ conrfi'ft'ons (n)
Somatic
Psychiatric
15
27
/tatfo weaVy reporterf to jfenoow öft^gwarej (96)
Somatic
Psychiatric
14
33
Neurologist
(n=175)
9
.
1
1
3
1
1
7
3
1
-
6
1
2
1
1
1
33
7
3
2
-
29
56
20
72
Psychiatrist
(n=77)
2
2
1
1
2
i
3
.
1
1
1
1
.
5
2
_
-
14
9
48
18
Others
(n=27)
3
1
1
-
1
4
4
50
Total
(n=430)
13
4
3
3
3
2
2
19
7
1
1
6
6
5
2
2
2
1
1
1
1
1
50
8
7
2
1
59
96
19
44
Note: Values shown are numbers of patients. Each patient can have more than one diagnosis.
CVA = cerebrovascular accident; ALS = amyotrophic lateral sclerosis; OCD = obsessive-compulsive disorder; NPH
= normal pressure hydrocephalus. GP = general practitioner
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In Table 4, the agreements and discrepancies of diagnoses are shown in more detail for all
patients. The overall accuracy rate for all referrers was 46%; that is, in only 198 of the 430
patients did the referrer's and MMC's diagnostic classifications agree. When, more liberally, all
unspecified-diagnosis patients not referred as demented were ignored, and when unspecified
dementia was classified as primary degenerative, these diagnoses agreed in 199 of the 300
patients (66%). Calculated for each discipline separately, these more liberal accuracy rates
were as follows: general practitioners, 71%; neurologists, 64%; psychiatrists, 68%; other
referrers, 50%.
In contrast to the above-mentioned classifications, which were limited to the most
important cause, Table 5 enumerates all relevant diagnoses, other than dementia or
Alzheimer's disease, that had not been reported previously by the referrer. In this analysis,
depression and dementia were not perceived as mutually exclusive. If, for example, a
demented patient also fulfilled the DSM-III-R criteria for depression (with the exeption of the
last, nonorganic, criterion), both dementia and depression were rated. The findings were
ranked according to cognitive status (demented or not) and to diagnostic category, i.e.,
'psychiatric' (DSM-IlI-R's axis 1 and 2) or 'somatic' (axis 3).
As can be seen, 19% of the somatic diagnoses and 44% of the psychiatric diagnoses had not
been reported previously. Neurologists and psychiatrists were, again, each other 's
counterparts: the majority of psychiatric diagnoses (56 out of 78,72%) had not been reported
earlier by the neurologists, whereas almost the half of the somatic diagnoses (48%) had not
been mentioned previously by the psychiatrists.
Discussion
The results of this study show that the multidisciplinary and systematic approach based on the
NINCDS-ADRDA and DSM-III-R criteria leads to substantial differences in the diagnostic
outcome compared to the monodisciplinary procedure usually adhered to in everyday practice.
Disagreement between referrer's and the MMC's diagnoses for dementia and Alzheimer's
disease occurred especially in mild dementia, in the presence of depressive symptomatology
and in patients referred by psychiatrists. Somatic conditions with relevance for cognitive
functioning were often unreported in the group referred by psychiatrists. On the other hand,
depression and other psychiatric conditions went frequently unreported, most often in
patients referred by neurologists. It should be noted, however, that the patient groups from
the various referrers differed with respect to age and the scores on the MMSE, HDRS and BDS,
and thus comparisons should be made cautiously. The findings suggest that neurologists and
psychiatrists are complementary to each other, and emphasize the need of a combined
approach to these multidimensional problems.
Before we discuss the possible implications of this study, a few methodological points have
to be addressed. The validity of the MMC diagnoses can be debated. Validation of some of the
etiological categories can be achieved by neuropathologic data, which were not available in
this study, furthermore, the diagnosis of degenerative or vascular dementia can be validated by
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continued cognitive deterioration [124,270]. In another study we followed 110 patients with
dementia, and it appeared that 95% of the patients had deteriorated in cognitive oand/or
social functioning after a mean follow-up period of 41 months, indicating the validity of the
MMC diagnosis (Verhey *?/ a/., 1992, unpublished data: see chapter 8). Some diagnoses, such as
dementia [7, 207], depression or other psychiatric conditions [7], are based exclusively on
clinical data. Ideally, one would like to have a third set of diagnoses of all patients,
independent of those of the MMC or referrer in order to compare the latter two approaches,
but such a design would raise many practical problems.
In the absence of clear data on the validity of the MMC diagnoses, the use of sensitivity and
specificity measures could be discussed. This study should not be seen as a comparison
between 'true' or 'false'. We used sensitivity and specificity rates in order to obtain a
quantitative measure for the differences between the diagnostic outcomes from a
monodisciplinary, not standardized and subjective approach and a multidisciplinary, systematic
and approach, based on clear criteria. However, it is reasonable to assume that the validity of
the latter approach will be greater, and thus, with some precautions, can serve as a 'gold
standard'. This approach, establishing a so-called 'authoritative opinion' (158], has been used
in other studies as well [108,197].
The fact that the refferer's diagnosis was noted by a MMC staff member and thus not
obtained blindly is another possible methodological flaw of this study. However, this source of
error was minimized by establishing the referrer's diagnosis before any part of the MMC
evaluation started.
Finally, the fact that a patient was referred to the MMC might have influenced the accuracy
of some referrer's diagnoses, both in a positive and negative way. It is conceivable that
referrers were not as thorough in their diagnostic procedures as they would have been had no
reference been available. In some cases the referrer's diagnosis may have been only
preliminary. However, the opposite might also be the case, that is that feedback by way of
MMC reports about earlier referred patients might have increased the chance of agreement on
future diagnoses. It is not clear to what extent these factors might have influenced the results
of this study.
Our findings confirm the results of previous investigations [194,243,244]. Comparisons
between the diagnostic outcomes of referrers and a multidisciplinary team have been carried
out previously [ 108,128,179,197, 329]. In two studies [108,128], the reference pattern and
patient characteristics were comparable with those of the present study. Garcia e/a/. (1981)
found that dementia was overdiagnosed in at least 26% of the patients, which is much higher
than the 7% of our study. However, it is important to recognize that in Garcia's study all
patients had been referred for suspected dementia, which automatically leads to
overdiagnosis. In the other study [128], the overall percentage agreement between the
tentative diagnosis at referral and the final diagnosis was 59%, which approximates the
percentages of 46% to 66% found in our study. In Garcia's study three errors were found to be
important for the overdiagnosis of dementia: equating atrophy on CT-scans with clinical
dementia, taking focal neuropsychological deficits for global, and failure to recognize
depression. Of these, only the last was a common source of diagnostic discrepancy in our study.
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Another frequent factor for both over- and underdiagnosing dementia in our study was the
failure to obtain information about daily functioning from a knowledgeable collateral source, a
prerequisite needed to fulfill criterion C of DSM-III-R for dementia. This finding pleads for a
more vigorous application of standardized scales that measure social functioning, such as the
BDS, in routine diagnostic procedures.
Underdiagnosis often occurred in mildly demented patients and in patients with coexisting
psychiatric symptoms or a specific neurological disorder. As has been stated by others [ 194],
these factors may lead to the use of ambiguous terminology and to misinterpretation of the
diagnostic criteria. Underreporting of dementia might be related to a reluctancy to use a
stigmatizing diagnosis or to the fact that in common linguistic use the term 'dementia' is
reserved for Alzheimer's disease. In both situations, however, the avoidance of the term
dementia is inappropriate, since it disregards the functional significance of the diagnosis of
dementia; namely, that the patient is, at least to a certain degree, dependent on his or her
environment for extra support and care.
Conclusion
This study suggests that there is a need for a standardised and multidisciplinary diagnostic
model for the diagnosis of dementia and other age-associated cognitive disorders, using well-
accepted and clear, explicit terms. In the last decade the emphasis on the diagnosis of
dementia has shifted from the search for a single reversible cause to the detection of all
somatic and psychiatric conditions that may influence cognitive functioning [13, 179]. This
study shows that many chances to influence these conditions go unrecognized without a broad
multidisciplinary approach. Although this study does not allow a strict comparison between the
specialties, the results suggest that neurologists and psychiatrists complement each other in
diagnosing dementia and depression. This underlines the advisability of more frequent use of
an integrated neuropsychiatric approach for cognitively disturbed patients.

5The validity of the diagnosis of dementia:
a follow up study of demented patients
from the Maastricht Memory Clinic
Introduction
One of the major steps forwards in research in geriatric psychiatry has been the development
of criteria for the clinical diagnosis of dementia and dementing illnesses. At present, the
criteria of DSM-I11-R for the syndrome of dementia [7], and those of the work-group of the
National Institute of Neurological and Communicative Disorders and Stroke (NINCDS /
ADRDA) for Alzheimer's disease (AD) [207] are widely accepted. The diagnosis of mild or
moderate dementia is notoriously more difficult than in more advanced stages because the
history of symptoms is usually shorter and the clinical picture is not fully developed and shows
more overlap with that of other mental conditions such as depression, focal neuropsychological
deficits or normal age-associated cognitive impairment. In contrast to the situation in more
severe stages, the prevalence of mild dementia varies widely depending on which set of
criteria has been used. For instance, in a study comparing five current sets of criteria for mild
dementia, the frequency varied from 3 to 64 per cent [219].
There are no simple bedside screening instruments with sufficient sensitivity for the
mildest stages of dementia. This diagnosis requires clinical judgement and a certain level of
experience, given the amount of data that has to be considered [229]. For instance, the
DSM-III-R criteria appear to classify dementia successfully, ie, are highly predictable with
regard to a progressive course, when adhered to by experienced clinicians [99); however,
when the same criteria were applied by untrained research assistants, the diagnosis of
dementia had much less prognostic significance [232]. Thus, the clinical diagnosis of relatively
mild dementia still carries some uncertainty and must be validated, even when it is made by
using of generally accepted research criteria. Given the difficulties of obtaining in vivo
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neuropathological data, documentation of a progressive cognitive or behavioural decline offers
an important alternative for validation of the diagnosis AD or VD [270]. Although a progressive
course is not required for the diagnosis of dementia, it is characteristic of most of the
dementing disorders [7,46,207]. As dementia progresses and cognitive or social deterioration
becomes more evident, there is less uncertainty about the diagnosis, whereas the diagnosis
can be questioned when there is no such decline.
The purpose of the present study was to examine the number of patients who showed
progressive decline on follow-up in a sample of patients with AD and vascular dementia (VD)
with mild or moderate dementia, as diagnosed by using current research criteria. These
numbers give an indication of the accuracy of the clinical diagnoses and thus of the validity of
the diagnostic method that was used. Because patients with aetiologies other than AD or VD,
such as alcohol-related dementia or head trauma dementia, have a more unpredictable clinical
course, only the former two aetiological categories were included in this study.
Patients
Consecutive outpatients from the Maastricht Memory Clinic (MMC) were examined. Patients
were included when they 1) fulfilled the DSM-III-R criteria for dementia [7]; 2) fulfilled the
criteria of probable AD [207] or VD, according to DSM-III-R criteria and a score of four.or more
on Rosen's modified Ischemic Score [269], 3) had been investigated at least eighteen months
before the study took place. This period was taken as a arbitrary minimum period of follow-up.
The diagnostic procedure was based on recent research criteria [7,207] and is described in
more detail elsewhere [316]. The procedure included, in short, a semi-structured history,
somatic, neurological, psychiatric investigations and an extensive neuropsychological
examination; the modified Ischemic Index of Rosen et al.[269]; the Global Deterioration
Scale, GDS [255]; the Blessed dementia scale, BDS [24]; Folstein's' Mini Mental State
Examination, MMSE [97]; and Hamilton's depression rating scale, HRSD [120]. The syndromal
and aetiological diagnoses were made by the author of this thesis after discussion of the
clinical findings and the results of the ancillary examinations.
Methods
Available data that could provide insight into the course of the symptoms since the first
assessment in the MMC were collected by a research assistant who did not know the patients.
Sources of information encompassed notes in the patient records, including those from other
regional departments such as the psychogeriatric service from the Institute of Social Psychiatry
(RIAGG), and the minutes of the regional 'psychogeriatric platform'. In this meeting,
representatives of the five local professional institutes that are concerned with psychogeriatric
care discuss weekly arising problems with demented patients in the Maastricht region.
Additionally, requests for admission to a nursing home are always discussed at this meeting,
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and extensive minutes are taken. If information could not be obtained from these sources, the
general practitioner was contacted and asked to rate changes in general functioning, cognitive
functioning and need for extra support on a five point scale (much better, slightly better,
unchanged, slightly worse, much worse).
On the basis of these data, the research assistant judged whether a patient had
deteriorated or not. In the cases that were not covered by the above-mentioned descriptions,
the clinical course was supposed not to be progressive. Cognitive and social deterioration was
defined as follows:
Cbgnrtw (fe(erioraftb«:
decline as assessed by from quantitative data from cognitive tests, such as a 10% reduction or
more of the score on the MMSE (97] or other neuropsychological tests, or
written descriptions, from professionals other than those of the MMC, from which cognitive
deterioration was apparent, such as obviously increased forgetfulness or aphasia, or
evidence of progressive cognitive decline as reported by the general practitioner.
increased need of support in daily activities, apparent from intensive attendance by social
psychiatric mice, district nurse or comparable organizations, other than the MMC, or
placed in a nursing home or on the waiting list for it in case no need for these measures existed at
the date of the first assessment in the MMC, or
written descriptions, from professionals other than those from the MMC, by which decreased
behavioural functioning was apparent, such as wandering or overt aggressive outburst, or
evidence of progressive functional decline, as reported by the general practitioner.
Results
One hundred and fourteen patients, 81 with AD and 33 with VD were included in this study.
The patients' main characteristics are shown in table 1. Fifty-three patients had mild dementia
(as defined by a GDS score of 3 or 4), 46 were moderately demented (GDS 5), and 15 were
severely demented (GDS 6). The average period of follow-up was 41 months (16.7-71.2).
5b«rce o/m/omwft'on
Four patients (4/114,3.6%) could not be traced. Thirty-six patients had been described by
more than one source and in none of these cases were there inconsistencies in the
information. The sources of information were as follows: a) 59 patients had been followed in
the MMC, b) 60 patients had been discussed in the psychogeriatric platform, c) 22 patients had
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been described in patient records from other institutes and d) 18 patients had been seen by
their general practitioner. '
Table 1. Patient characteristics
N
M/F
Age (mean, years.)
range
GDS (mean, range)
MMSE (mean, range)
BDS (mean, range)
Alzheimer's disease
81
34/47
72.0 ±8.9
50-88
4.5(3-6)
17.9(3-26)
6.8
vascular dementia
33
21/12
74.7+7.3
58-88
5.0(4-6)
14.7(6-24)
9.3(3-23)
Information about cognitive decline was available for 104 patients. Of these, 99 patients (95
%) had been described as having deteriorated cognitively, while in 6 patients the cognitive
functions had not clearly changed (5 patients) or had improved (1 patient).
With regard to changes in social functioning, information could be obtained for all 110
patients. Twenty-four were still living in their own home without extra help whereas 3
needed extra professional support. Fifty patients had moved into a psychogeriatric nursing
home, 4 were on the waiting list for a nursing home and 13 patients could no longer live
independently without professional support. Sixteen patients died since the MMC assessment-
in 13 of these patients, cognitive and social functioning had deteriorated in the period before
death Information about the clinical course of the other 3 deceased patients was not
available. All pattents with social deterioration were reported to have also declined
cognitively.
Taken together, 95% (99/104) of the patients traced showed evidence of progressive
deterioration. Taking into account the patients who could not be traced or for whom there
was too little data, this rate of decline varied between 87% (99/114, worst case) and 96%
(110/114, best case).
Although further statistical analysis was not meaningful due to the small numbers there
were no clear differences between patients with AD and VD (rates of decline 88 6 and 90 3%
respectively). Slightly fewer patients with mild dementia declined cognitively compared to
those with moderate dementia and with severe dementia, as measured by the GDS score
(GDS 3 and 4:89%, GDS 5:97%, GDS 6:100%). The characteristics of patients who did or did
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not show mental decline are shown in table 2. On average, the follow-up period for the non-
decliners was 7 months shorter than for the decliners. No substantial differences could be
found in age, educational level and the scores on Hamilton's depression scale. The non-
decliners were slightly less cognitively disturbed, but had somewhat lower scores than the
decliners on the Blessed dementia scale, which reflects social functioning.
Table 2. Comparison between patients who had or had not declined at follow-up
N
M/F
Number AD/VD
Age (mean, years)
Education(l-7)[3l4j
GDS score
MMSE score
BDS score
HRSD score
Follow-up period (months)
Declined
99
48/56
71/28
73.1±8.7
3.6
4.65±0,8
17.1+5.9
7.7±4.2
8.9+4.9
41.4+16.6
Discussion
Not declined
5
4/1
3/2
71±3.4
3.7
4.2+0.4
19.8±4.2
4.8±2.0
7.8±1.7
34.3±18.2
The main purpose of this study was to establish the number of patients who showed a
progressive decline, in order to validate the current diagnostic methods for the clinical
diagnosis of dementia caused by Alzheimer's disease and vascular dementia. The data indicate
that 95% (86-96%) of the patients demonstrated the expected course of progressive
deterioration, ie, only 6% (4-14%) may have been misdiagnosed. Given the large proportion of
mild and moderate dementia in this population, this figure can be regarded as satisfactory and
illustrates the validity of the clinical diagnostic methods used.
Previous studies reported higher rates of misclassification [158]. In one often cited
follow-up study, the percentage of misclassification for dementia after four years was 31 per
cent, which could be ascribed for the greatest part to misdiagnosed depression [267]. It is
likely that the high misclassification rate found in this study was related to the lack of
standardized diagnostic criteria at the time of the study. Later studies on this subject, in which
diagnostic criteria were more explicitly applied, suggested lower frequencies of misdiagnosis
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on follow-up, ie, between 1 [180] and 18 [290] per cent, but the degree of dementia in the
patients of these studies was on the average more severe.
Because of the qualitative and global nature of the follow-up data, the results of this study
should be regarded with caution. It should be noted that the absence of cognitive decline
does not rule out a progressive dementing disorder since plateaus in the clinical course may
occur [207] or the follow-up period may have been too short. Thus, the real rate of
progressive deterioration may be higher than that found in this study. However, evidence of a
continuous progressive course does not necessarily imply a diagnosis of AD or VD, as other
degenerative brain diseases share this characteristic as well.
In summary, we conclude that the diagnosis of dementia by the DSM-III-R criteria [8], of
Alzheimer's disease by the NINCDS-workgroup [207] and the criteria for vascular dementia
[269], as adhered to by the Maastricht Memory Clinic, can be regarded as being accurate.
6Psychiatric disorders in patients attending
an outpatient memory clinic*
Introduction
Deficits of memory and other cognitive functions in the elderly patient may indicate a variety
of internal somatic, neurological or psychiatric disorders. Principally, the assessment of the
memory disturbed patients involves two steps: first a syndromal diagnosis is made, e.g.,
"dementia", "delirium" or "amnestic disorder; second, it is investigated which factors produce
that cognitive syndrome. Besides a comprehensive internal and neurological examination, a
thorough psychiatric investigation is generally recommended [54, 167, 207, 281J. Numerous
organic disorders are known to cause cognitive deficits. In contrast, most studies mention
major depression as the single functional cause [38, 82, 108, 179, 241, 290, 328, 329].
Because it is not known whether, and to what extent, psychiatric disorders other than major
depression are also accompanied by impaired cognition, the present study examined the
psychiatric diagnoses of 430 consecutive outpatients attending a memory clinic.
* Adapted and translated from:Verhey FR), Jolles J, Ponds RVPHM and Vreeling FW. Psychiatrische stoornissen bij
patiënten van een geheugenpolikliniek. Nederlands Tijdschrift voor Geneeskunde 1993:37:1054-1058
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Patients
Four hundred and thirty patients received a complete assessment in the memory clinic of the
University Hospital of Maastricht between May 1986 and May 1991. Patients had been referred
because of deficits or complaints about memory or other cognitive functions. These patients
formed a heterogeneous group with respect to the severity of the cognitive impairment and
the underlying aetiology. Table 1 shows the relevant demographic characteristics, the sources
of referral and the cognitive syndrome (distinguished as dementia, no dementia, cognitive
impairments objectified by neuropsychological tests, or subjective complaints, not
objectifiable by neuropsychological tests).
Table 1. Characteristicsof430patientsreferredbeauseofmemorydeficits,byaetiologicalategory.
number of patients
mate/female
age, mean (range)
referrer/V, (56)
general practitioner
neurologist
psychiatrist
other
cognitive syndrome
dementia
no dementia
objectified!
not objectified^
aetfo/ogic
primary cerebro-
degenerative vascular
91
36/55
72 (50-88;
39 (43)
28 (31)
18 (20)
6(7)
88(97)
3(3)
0(0)
60
40/20
) 72(35-88)
15 (25)
31 (51)
7(12)
7(12)
41 (69)
19 (31)
0(0)
other internal-
neurological somatic
96 24
60/36 18/6
56.6(16-81)57(27-87)
20 (21)
59(61)
12 (13)
5 ( 5 )
17(18)
73 (76)
6 ( 6 )
10(41)
8(33)
3(13)
3(13)
4(17)
17(71)
303)
no
diagnosis*
132
71/61
56 (21-85)
50 (38)
44 (33)
34(26)
2 ( 2 )
77(58)
53(40)
unknown total
27 430
17/10 242/188
61.7 (23-85) 61.7 (16-88)
18(67)
5(19)
3(H)
1(4)
0(0)
20(74)
7(26)
152(35)
175(41)
77(18)
26(6)
152(35)
209(49)
69(16)
* No diagnosis on axis III of DSM-III-R [7]
t Cognitive impairments objectified by neuropsychological tests
t Subjective cognitive complaints, without objectifiable impairments
With regard to the physical disorders or conditions described on axis III of the DSM-III-R
(Diagnostic and Statistical Manual of mental disorders, 3rd edition [6] and, after 1987,3rd
revised edition [7]), the following alternatives were possible: 1) primary degenerative cause,
most often probable Alzheimer's disease, 2) cerebrovascular cause, 3) neurological cause other
than cerebrovascular, 4) somatic/ internal cause, also including intoxication and drug
side-effects, 5) no diagnosis on axis III and 6) cause unknown.When there was more than one
possible cause for the cognitive deterioration, the patient was classified according to the most
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probable cause. The most frequent diagnoses in category 3 ('neurological cause other than
cerebrovascular') were epilepsia (n=23), head trauma or whiplash trauma (n=20), Parkinson's
disease (n=15), Huntington's disease (n=7), and cerebral tumour (n=6). Frequent diagnoses
in category 4 ('somatic-internal') were drug side-effects (n=6) and alcohol abuse (n=4).
Methods
Every patient underwent an extensive neuropsychiatric and neuropsychological examination
according to the standardized diagnostic procedure described in chapter 4. The major
elements of this procedure are shown in table 2.
Tèle 2. Standard diagnostic procedure in Maastricht Memory Clinic
efewenr w'tfjpflrti'cM/flr reference to..,
history of the patient
history of the caregiver
neuropsychiatric history
somatic history
somatic investigation
neurological investigation
psychiatric investigation
neuropsychological investigation
ancillary investigations
rating scales
complaints, first symptoms, course, insight into ones' deficits, subjective
meaning, metamemory.
complaints, first symptoms, course, 'objective' data about social functioning,
personality changes.
family history, early development, education, professional career, psychiatric
and neurological history, head trauma, epilepsia, cerebrovascular accidents,
neurotoxic agents.
standard, alcohol and drugs, nutrition
standard, signs of ageing
standard, release phenomena, behavioural neurology
consciousness, depression, anxiety, obsession, psychosis, personality,
behavioural disorders.
psychometric tests, behavioural neurology [42] and tests derived from the
information-processing paradigm [297]: memory recall, recognition, span,
speed, susceptibility to interfering stimuli, complex information processing,
apraxia, aphasia, agnosia, planning, evaluation, orientation, intelligence, reading,
writing, calculating, personality questionnaires
blood chemistry, X-ray, CT, MM, EEG
Mini Mental State Examination [97] (for degree of cognitive dysfunctions);
Hachinski's Ischemic Score [119) (for documentation of cerebrovascular
factors); Hamilton Depression Rating Scale [120] (for degree of depressive
symptoms); Blessed Dementia Scale {24) (for degree of behavioural
dysfunctions); Global Deterioration Scale [255] (for global assessment of
cognitive decline)
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The neuropsychiatric assessment was carried out by an experienced neuropsychiatrist. The
mean duration of the diagnostic assessment, including neuropsychological testing, was about 4
hours.
Psychiatric conditions, including dementia, were diagnosed according to the criteria of the
DSM-III [6] and, after 1987, DSM-III-R [7]. For this study, only the axes I, II and III were
taken into account (clinical syndromes, personality disorders and physical disorders,
respectively). The diagnosis of 'probable Alzheimer's disease' or 'possible Alzheimer's disease'
was made according to the criteria of the NINCDS-ADRDA work group [207], Vascular
dementia was diagnosed by using the DSM-III-R criteria and the ischaemic score of Hachinski
etal. [119] (score >7).
Results
Table 3 shows a matrix of the psychiatric diagnoses on axes I and II (rows) and the different
axis III categories (columns). An organic mental syndrome was diagnosed in 189 patients and a
functional mental syndrome was diagnosed in 152 patients. The remaining 89 patients did not
have a psychiatric diagnosis according to the criteria of the DSM-III(-R).
One hundred and fifty-two of the 189 patients with organic mental syndromes had
dementia, and in 53 of them (36%) the dementia was complicated by additional
psychopathology. Thirty-four of these patients had a depressive symptomatology. In two of
these patients with dementia combined with depression, the dementia was presumed to be
induced by the depression, which was apparent by a significant improvement of cognitive
functioning after the start of antidepressive therapy. In the remaining 51 patients with
complicated dementia, the psychopathology was not regarded as being the cause of the
syndrome of dementia.
In 37 patients, an organic mental syndrome other than dementia was diagnosed, notably
organic personality syndrome (n=19) and organic mood syndrome (n=l6). Organic personality
syndrome occurred with various disorders, e.g., Pick's disease, head trauma and alcohol abuse,
whereas organic mood syndrome frequently occurred with Parkinson's disease (n=6). One
hundred fifty-two patients received together 159 diagnoses of a functional mental disorder on
axis I or axis II. Most often, this involved a mood disorder, notably depression or dysthymia
(38% and 25%, respectively); dysthymia, previously called neurotic depression or personal
depression, is a condition which tends to be chronic, in which the mood is less severely
disturbed and in which there are fewer somatic symptoms than in major depression [7], A
functional mental disorder other than a mood disorder was diagnosed in 59 patients (38%).
This especially involved adjustment disorders, personality disorders and anxiety disorders. In
101 patients of the 152 with a functional mental disorder.(66%), the cognitive complaints
could be objectified by neuropsychological testing; in the remaining patients, performance in
the neuropsychological tests was normal.
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Téle 3- Relationship between psychiatric diagnoses (on axes I and II of the DSM-IH(-R) [7] andrelevant
physical disorders (axis III) in 430 patients attending a outpatient memory clinic.
aeftb/cgzco/ category o/oxis ƒƒ/
primary cerebro other internal- no unknown toto/
degenerative vascular neurological somatic diagnosis*cmaxes/<ra///
aró/or / / 12 34 15 20 89
dementia,
uncomplicated
with depression
with delusions
with delirium
with anxiety
with behavioural disorder
with obsessions
organic personality syndrome
organic mood syndrome
organic delusional syndrome
delirium
/«ncftOTM/ m#!to/ disorders
depression
dysthymia
adjustment disorder
personality disorder
anxiety disorder
phobia/obsessive
compulsive disorder
dyslexia
mental retardation
somatoform disorder
atypical psychosis
55
20
2
6
3
2
3
2
-
-
•
27
9
1
1
2
1
2
3
•
1
•
1
-
13
3
.
1
10
10
5
2
11
2
1
.
-
-
•
4
-
.
3
1
1
1
5
-
1
•
1
-
1
1
-
-
2
.
-
-
-
-
50
35
9
16
3
4
2
1
1
2
-
1
-
-
-
2
1
-
1
.
•
99
34
3
1
8
5
2
19
16
1
1
61
39
23
18
6
4
2
2
2
2
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p betoken p ^ / a f n c symptoms,
The cognitive symptoms, the psychiatric condition and the underlying disorder may be
interrelated in several ways. The following five case histories illustrate this.
Patient A, a 72-year old man, was referred for differentiation between dementia and
depression. Investigation yielded apparent signs of Parkinson's disease. Moreover, the patient
had progressive dementia with deficits of memory retrieval, abstract thinking, excessive
cognitive slowing and depression, for he could give no reason. Low doses of antidepressant
medication caused confusion in the patient. In contrast, levo-dopa therapy improved the
symptoms of Parkinson's disease and depression, although the cognitive symptoms remained
unchanged.
Comment. The psychiatric symptoms as well as the cognitive symptoms in this patient were
probably both caused by an underlying brain disease [62].
Patient B, a 63 year old man, was also referred to examine whether he suffered from dementia
or depression. After his daughter's death 2 years ago, he demonstrated memory deficits,
apathy, disorientation and he neglected his personal hygiene. He was found to fulfil the
criteria of dementia, and more specifically, with characteristics of the subcortical type. Formal
neuropsychological testing appeared hardly possible due to a lack of motivation. The patient
responded with numerous "don't know" answers on questioning. Antidepressant therapy and
supportive psychotherapy resulted in a significant improvement of both the affective and the
cognitive symptoms.
Cowmen/. In this patient, a primary psychiatric disorder (i.e., depression) resulted in
cognitive impairments, severe to warrant the diagnosis dementia. This condition, previously
termed "pseudodepression, can be explained in psychological terms, e.g., lack of motivation
[48,78], as well as by biochemical mechanisms [78,343]. However, this condition of so called
depression-induced dementia eventually turns out to be the very first manifestations of a
primary brain disease, notably Alzheimer's disease, in more cases than would be expected on
the basis of chance.
Patient C was a 70 year old woman whose brother had been diagnosed as suffering from
Alzheimer's disease 2 years before. From the start she was terrified by that diagnosis- "I have
the same disease in my head as my brother, and that's very bad!". She reported panic attacks
when confronted with her cognitive impairments, and she showed signs of panic on
neuropsychological testing. The diagnostic assessment revealed mild dementia caused by
Alzheimer's disease, with memory deficits and slight aphasia dominating the clinical picture.
Commewf. Besides the primary organic mental syndrome, there were also signs of a
psychological reaction: cognitive symptoms resulted from a brain disease, but her intact insight
into her deficits led to the feeling of fear. Such situations can exist especially in the early
stages of Alzheimer's disease (see also chapter 11, [321]).
PSYCHIATRIC DISORDERS IN A MEMORY CLINIC 81
Patient D, a 56 year old book-keeper, has been fired because of signs of 'surménage'. He had
complaints of depression, poor concentration, irritability and abnormal fatiguebility. The
classification according to the DSM-II1-R criteria was dysthymic disorder. He had a history of
two mild head injuries and two operations with general anaesthesia many years ago. On
neuropsychological testing, no memory impairments could be objectified, but he performed
poorly on tests measuring susceptibility for interfering stimuli and cognitive speed. After 2
years, he reported no signs of depression, but his neuropsychological performance remained
unchanged.
Comment Patients with this type of profile of complaints and neuropsychological
performance are encountered quite frequently in our memory clinic. Although these
complaints may often be interpreted in psychological terms [2], biological factors may also be
relevant with regard to their pathogenesis. Earlier studies showed that a group of patients
with dysthymia had a higher prevalence of previous exposure to potentially brain damaging
influences, such as use of alcohol, brain trauma and anaesthesia, than normal age-matched and
education matched controls [149,320). These so called "biological life events" are correlated
with decreased cognitive functioning with increasing age. It is often unclear whether the
cognitive symptoms result from the psychiatric condition, or vice versa, i.e., whether the
cognitive impairments lead to symptoms of depression. The fact that the signs of depression in
this patient had improved after 2 years, in contrast to the cognitive aspects, suggests a primary
role of the cognitive impairments. This will be discussed in more detail in chapter 8 of this
thesis.
Patient E, a 62 year old woman, worried about her memory, although neuropsychologica!
testing revealed no abnormal performances. Her personality could be described as obsessive.
Moreover, she was very afraid of becoming demented.
Commen/. There were no signs of an organic disorder or of any cognitive deficit in this
patients. Her complaints were probably related to worries about Alzheimer's disease and the
extreme demands that she made on her own memory.
Discussion
Although affective disorders (major depression and dysthymia) formed the greater part of the
functional psychiatric diagnoses of the group that was studied, memory complaints also
occurred together with many other psychiatric conditions. In most other studies, however,
depression is seen as the single functional cause of cognitive impairments. In eight
publications on the causes of memory disorders in patients from comparable memory clinics,
involving 998 patients, psychiatric disorders other than dementia were diagnosed in 133
patients. Major depression was the main disorder, accounting for 112 patients (84%) [38, 82,
108, 179,241,290,328, 329). In our sample, however, primary and secondary affective
disorders together formed not more than 60% of all psychiatric conditions. Notably,
adjustment disorders, anxiety disorders and personality disorders also occurred with the
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cognitive symptoms. As illustrated by the five case histories described above, the relationship
between the psychiatric condition and the cognitive problems can be more complex than just
a linear causal one and has to be elucidated by individual psychiatric assessment.
It could be argued that the MMC is a specialized neuropsychiatric department, and
therefore some selection bias may have influenced the outcome of our study. As was shown in
chapter 4, however, in almost half of the patients (44%) the psychiatric condition was not
recognized until assessment took place in our memory clinic [316]. As a consequence, the
existence of a psychiatric disorder in these patients could have led to selection bias. Thus', the
results of the present study are probably relevant to the more general neurological, psychiatric
or geriatric practice.
There are several possible explanations for the discrepancies between the results of our
itudy and those of most other studies. The MMC partly functions as a tertiary reference centre;
about half of the patients had been referred by their general practitioner. Sources of referral
of other studies show considerable variation: some show quite a few self-referrals [241] others
referrals by general practitioners [38, 82, 108], whereas the majority of patients in other
studies were referred by medical specialists [179]. Moreover, studies differ substantially with
regard to the mean age of the patients (varying from 57.7 years [179] to 75.8 years [290]), as
well as to the proportion of patients with dementia (varying from 51% [241] to 94% [179])'. In
study, the mean age was 61.7 years, and 35% of the patients fulfilled the criteria of dementia.
Each of these aspects influences the prevalence of psychiatric disorders, although it is difficult
to account for the exact extent and the direction of the selection bias in terms of these
factors.
Additionally, the differences between the various studies could be explained by differences
in the way the assessment was carried out. Thus, the psychiatric evaluation in some studies is
explicitly restricted to checking whether symptoms of depression are present or not [38 108]
In other studies, psychiatric evaluation only takes place when other specialists suspect
depression to be present [82), or the diagnostic criteria for psychiatric disorders are not stated
clearly [241, 290]. Therefore, it is plausible that the relatively high number of patients with
depression and the low number of patients with non-affective psychiatric disorders could result
from an incomplete psychiatric examination. This would probably lead to an underestimation
of the prevalence of non-affective psychiatric disorders and, as a consequence, potential
possibilities for treatment will not be used or will be used inappropriately.
Conclusion
Although affective disorders are the most frequent psychiatric disorders that accompany
memory complaints, several other psychiatric conditions are also related to these complaints
Therefore, psychiatric assessment of patients with memory disorders should not be restricted
merely to looking for depressive symptoms.
7Cognitive dysfunctions in middle-aged subjects with
late-onset dysthymia attending a memory clinic*
Introduction
It is well established that many cognitive abilities deteriorate with age [57,145, 247]. Elderly
people aged 65 and above perform tasks involving new information, planning of new activities
and effortful, controlled processing relatively [28, 57]. Above all, there is a general slowing of
behaviour with increasing age [277]. There is relatively less information about the effect of
age on cognitive functioning in middle-aged subjects although complaints about memory,
attention and concentration among middle-aged persons are very common [59,176,247]. It is
relevant in this respect that a significant part of the patients in specialized memory clinics [38,
39,241,316] is formed by middle-aged subjects with complaints about memory, attention and
concentration. These patients often do not fit well into the available classifications, e.g. DSM
III-R. Recent experimental evidence suggests that the cognitive performance of middle-aged
subjects might already be inferior to that of young adults [132-134]. However, information on
the relation between cognitive complaints and objective deficits in middle-aged subjects is
sparse.
There are only few diagnoses that cover middle-aged persons with complaints about
memory related functions, loss of energy and mood disturbances. When accompanied by mild
but persistent affective complaints, a diagnostic classification of late-onset dysthymia is the
most relevant. According to the Diagnostic and Statistical Manual for Mental disorders, revised
3rd edition, (DSM-III-R) [7], a diagnosis of dysthymia is made when there is no major
depression, when two or more of a variety of nonspecific complaints are present and when the
symptoms are chronic, i.e., lasting two years or more. The complaints mentioned in DSM III-R
* JJolles, Fig Vertiey, PJ HOIK and EJ Reyersen van Buuren, submitted for publication
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are: chronic disturbance of mood (depressed and/or irritable), poor appetite, insomnia, low
energy and fatigue, feelings of hopelessness, as well as cognitive complaints, such as poor
concentration and difficulty making decisions. Subtyping of DSM-IH's dysthymia is allowed for
age of onset (before and after the age of 21) and the relationship to preexisting chronic axis I
or III disorders (primary or secondary type). Other relevant diagnostic categories for memory
complaints in eiderly subjects concern Benign Senescent Forgetfulness (BSF)[171J and
Age-Associated Memory Impairment (AAMI)[59]. BSF originally describes memory complaints
in the senium. The concept is ill defined and its nosological status has not been established
yet. A diagnosis of AAMI essentially pertains to normal aging and is only possible when
problems in the cognitive domain are prominent and when no major neurological or
psychiatric diagnosis can be made, documented for example by a score on the Hamilton
Depression Rating Scale [120] of less than 13.
There is little knowledge about the nature of the cognitive dysfunctions that might be
present in middle-aged subjects who complain about memory and who have mild but
persistent mood changes. In the last decade, information processing deficiencies have been
proposed in relation to affective disorders. In this view, every stage and type of infotmtioa
processing has implications in determining aspects of cognitive dysfunctioning in depressive
people [211]. Attentional and motivational dysfunctions, encoding and rehearsal problems, and
alterations in decision making and response patterns can thus be present. Weingartner [330]
linked the cognitive dysfunctions in depression to alterations in motivation, appreciation and
drive, resulting in disturbances of all kinds of effort-demanding cognitive processes as
formulated in terms of the influential theory of Shiffrin and Schneider [283]. The problems
that these depressive patients experience are especially evident in tasks involving sustained
attention, effort, time constraints and increased memory load. Similar deficits are seen in the
various subtypes of major depression [201]. However, it is not known whether milder forms of
depression - including dysthymia - are also characterised by these cognitive deficits. In
addition, little is known about the relative contribution of the factor age. The literature
contains conflicting reports regarding the negative effects of depression and age on cognitive
functioning. For instance, some authors argue that depression and age have no effect [223]
whereas others state that they have an adverse effect [251].
The present study investigates middle-aged dysthymic subjects (aged 40-65) who seek help
for their cognitive complaints in a specialized memory clinic. Such health care facilities have
been set up in recent years primarily for the early diagnosis and treatment of elderly subjects
with dementia, but few facilities exist for the diagnosis and treatment of memory complaints in
non-demented presenile and senile persons [59,316]. The major question was whether these
patients are characterised by objectively assessed decreased performance in neuropsycholo-
gical tests as compared to age-matched controls. The relevance of finding cognitive
dysfunctions in this particular group is that dysthymia is usually seen from a psychopathological
or psychosocial perspective, e.g., as a residual state of major depression, as a personality
disorder or neurotic disorder [2,164,166,332] and not from the perspective of physiological
aging. A clinical experiment was performed in which the performance of 25 dysthymic patients
was compared to that of individually age-matched control subjects in a number of neuropsy-
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chological tests. The selection of the cognitive neuropsychological tests was based upon
earlier work in which impairments were found in particular stages of information processing in
AAMI patients [31,330]. Our main hypothesis was that the patients would show a deficit in
tasks involving effortful, time consuming processing. Tasks requiring mainly automatic proces-
sing would not distinguish the two groups from each other.
Materials and methods
Menft
From 430 outpatients of the Maastricht Memory Clinic of the University Hospital of Maastricht,
the Netherlands, 100 met the DSM III-R criteria for affective disorder, i.e. 61 had major
depression and 39 dysthymia. Only the 25 patients with dysthymia and aged between 40 and
61 years were included in this study. The mean age was 49.1 year (sd 5.2, range 41-61), there
were 19 male and 6 female. The patients had been referred to this department by general
practitioners, psychiatrists and neurologists because of problems concerning cognitive
functioning -most often problems in memory and concentration. The diagnostic procedure has
been described elsewhere in detail [316]. In brief, this involved a standardised psychiatric
interview, a physical and neurological examination, an extensive neuropsychological inves-
tigation and laboratory investigations. Diagnostic classification was made by a neuropsychiatrist
according to the DSM-III-R [7]. Patients were excluded when a physical, neurological or major
psychiatric disorder - including dementia, major depression, double depression or adjustment
disorder- was diagnosed, or when they used medications with known psychoactive effects. A
Hamilton Depression Rating Scale (HDRS)[120] was administered to all patients to obtain an
indication for the degree of the depressive symptoms, but no cut-off was used as a diagnostic
criterion. The mean HDRS-score was 14.1 (sd 4.9, range 5-26) The mean score on the
Mini-Mental State Examination was 28.8 (sd 1.4, 26-30). The cognitive and mood complaints
existed for a mean of 4.6 years (sd 3.6, range 16.4-1.5 years) and the start of the complaints
was gradual. Although the DSM-III-R requires officially a duration of complaints of at least 24
months, in this sample five subjects were included who had complaints between 18 and 24
months.
The control group of 25 volunteers was drawn from a larger population of subjects who were
normal and healthy according to regular criteria used in gerontological research (n=247).
Control subjects were selected by means of matching to the individual patients with respect to
age (± 3 years), gender and level of education (± 1 point). The latter was assessed by a Dutch
scoring system [314], which comprises a scale ranging from 1 (primary education not finished)
to 7 (university degree). The two groups thus consisted of twenty-five matched pairs. The
procedure for recruitment of the controls has been described elsewhere [134]. They
underwent the same procedure of routine physical and neurological examination and neuro-
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psychological investigation as the index group. All subjects were free of significant somatic,
neurological and/or psychiatric disorders. HDRS scores from the controls were not available,
but all dented complaints of lowered mood, nor did they report significant problems of
memory or concentration. The control subjects can be regarded as a representative selection
of the middle aged population [132].
The Z%Y Span (/bwarrf; is a subtask in the Wechsler Adult Intelligence Scale [183] and is
taken as a measure of primary memory for auditory-verbal material.
The ,AM(#tory Verb«/ Zearamg fes/ is a Dutch version of the Rey Auditory Verbal Learning Test
[31,183]. The test consists of one list of 15 monosyllabic and concrete nouns in Dutch, which
are presented in 5 trials by means of a tape recorder. The nouns ("tree, bread, dog, knee,...")
occur very frequently and are acquired earlier in life. Items were presented in the same
• sequence at a rate of one per two seconds. Each trial ends with a free recall of the words (free
immediate recall). After a period of 20 minutes following the fifth trial, the subject is
requested to recall as many words as possible (free delayed recall). Ayes/no recognition test,
consisting of the 15 former words and 15 new but similar words is given after the delayed
recall test. The variables used are: the total number of correct words over the 5 trials as a
measure of learning capability; the number of correct words on delayed free recall as a
measure of retrieval from long-term memory; the number of correct responses on delayed
recognition as a measure of memory consolidation; the total number of errors and double
responses as a measure of the efficiency of the different memory processes and of self
monitoring and evaluation.
The /kwisarf rn»7M*&&g resf (R-TMT; [324]) is an adapted version of the task described
by Reitan [ 183], which is a test of conceptual and visuomotor tracking. The R-TMT consists of
three subtasks. In each subtask, the subject has to connect small circles with digits or letters in
the right order on an A4 sheet of paper. The subject is requested to do this as quickly as
possible. In the first subtask (A), the subject must draw lines to connect consecutively num-
bered circles (1-26). In subtask B, the lettered circles A-Z have to be connected, and subtask C
consists of 26 circles containing 13 digits (1-13) and 13 letters (A-M). The subject is asked to
alternate between the two sequences (1-A-2-B etc.). The layout of the three subtasks is
similar. The variables are: response time in version A and B as a measure of conceptual
tracking. The times needed to complete each subtask are used in the formula: tC-l/2(tA + tB)
as a measure of concept shifting ability for task C (t = time in seconds).
The ttroop Co/owr \ V W /nte?/m?Bce Fes* [183] is a perceptual interference task and
consists of three subtests. The test examines the speed at which colour names are read
(subtask 1) and the speed to name colours (subtask 2). Subtask 3 involves colour names again,
but the printing ink is different from the colour name. The speed at which the printing ink of
the words is named is taken as the test variable. The interference score results from the
subtraction of the time needed for subtask 2 from that of subtask 3.
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The Memory Scawm^g rose (MS7; paper aw/ pena'/ vernow, see [31] for description) is
based upon the Sternberg paradigm [297]. Briefly, a set of 1, 2, 3 and 4 letters has to be
memorised. The subject is asked to search for these letters on a test form consisting of 144
capital letters typed in a 12 x 12 matrix, 4 spaces apart (A4 format). The subject has to mark
the targets with a pencil. A sixth of these letters are items from the memory set, the rest are
distracter letters. There is a practice run with the symbol'%' as memory set before part one
(set size 1). For each of the subtasks, both time and the number of errors of omission and false
positives are noted. The intercept of the time/setsize function is taken as a measure of general
speed of information processing and the slope is a measure of the efficiency of the
memory-scanning stage.
Results
The test performance of both groups was analysed with a multivariate analysis of variance
(MANOVA) with or without repeated measurement for consecutive subtasks. Variables that
deviated markedly from a Gaussian distribution were transformed according to Stevens [298].
P-vatues lower than 0.05 were regarded significant.
Multivariate analysis yielded a significant group-effect (Wilks lambda: 0.39, F=3,75,
p=0.01). Therefore, separate univariate tests per cognitive parameter were carried out. Mean
performances on the various tests are shown in figures 1 a,b,c,d and in table 1. No group
differences were observed in auditory immediate memory (Digit Span). With regard to the
accuracy with which the various tasks were performed, reflected by the number of errors,
corrections, omissions and double responses, significant differences were only found in the
memory scanning test and Stroop-lII.
A repeated measures analysis of variance revealed a significant group-effect for the AVLT :
F(l,48)=31.6l, p<.001. The mean maximum score (usually at the 5th trial) was 22 % lower in
dysthymic subjects than in controls (9,76 vs. 12,6; MANOVA F=28.9, pO .001) . Furthermore,
delayed recall and recognition after 20 minutes were both poorer in dysthymic subjects
(respectively, F(l,48)=34.17, p<0.001 and F(l,48)=15.2, p<0.001). Repeated measures
analysis of variance of the Trail Making Test (R-TMT, fig.lb) revealed a significant group
effects (F(l,45)=5.68, p<0.05), which means that visuomotor tracking is inferior in dysthymic
subjects. There was no significant group by time-interaction. This indicates that dysthymic
subjects did not need more time to shift between the concepts of digit and letter sequences.
Repeated measures analysis of variance of the Stroop test showed a significant group effect
(F(l,48)=13.7, p<.001) and a group by time-interaction (F(2,47)=4.86, p<.01). It appeared
(fig lc) that dysthymic subjects were slower in reading, colour naming, and in the interference
task. Further subgroup analysis showed that this was mainly caused by the fact that the
dysthymic patients, compared to controls, needed much extra time for the interference task.
The results of the paper-and-pencil memory scanning task (fig Id) show that the dysthymic
subjects were generally slower in processing visuomotor information as measured by the letter-
subtask (F(l,44)=ll,72, p<0.01). Moreover, the slope of the total time needed per test
sheet, plotted against the number of items that have to kept in short-term memory, was
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steeper in dysthymic subjects. This suggests that they have slower memory search processes,
especially with increasing memory load.
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Table 1. Psychometric differences between dysthymic patients and controls (N=25): Performance on main test
variables
DïgJ/SjWH
Total in 5 trials
Delayed recall
Delayed recognition
Sroqp Co/or Wbn/rert
Stroop-I (reading)
Stroop-II (color naming)
Stroop-III (interference)
TrialA
TrtdB
Trial C
Memory Scanrang Tes/
"%"
1 letter
2 letter
3 letter
4 letter
intercept
slope
Dysthymics
N
25
25
25
25
25
25
25
25
22
23
24
24
24
23
21
21
21
mean
5.3
37.7
7.0
12.3
65.1
74.2
1337
52.8
54.3
80.8
33.8
39.7
55.2
66.3
78.6
39.9
12.7
sd
1.0
8.3
2.8
2.4
38.0
32.2
56.2
23.6
31.2
52.1
17.1
17.5
17.2
23.1
25.4
18.7
6.2
N
25
25
25
25
25
25
25
25
25
25
25
25
25
25
25
25
25
Controls
mean
5.7
49.0
10.8
14.2
40.2
52.6
89-5
36.1
37.7
60.4
24.7
30.0
42.0
48.9
58.4
31.0
92
sd
1.1
5.7
1.6
0.8
4.7
7.2
12.7
11.5
12.7
24.6
4.0
4.9
6.8
8.7
11.9
5.0
3.3
F
1.1
27.7
27.9
18.7
10.6
10.8
14.7
10.3
6.0
3.3
9.9
5.8
10.3
9.3
12.6
Z=1.65
Z=2.26
P
n.s.
0.001
0.001
0.001
0.01
0.01
0.001
0.01
0.05
n.s.
0.01
0.05
0.01
0.01
0.001
n.s.
0.02
Figures represent means and standard deviation in time (seconds), except for Verbal Learning Test, in which the
number of words recalled are presented. Wilcoxon test for results on intercept and slope of memory scanning test;
repeated measures analysis of variance is applied for i other variables.
Discussion
The major question of the present study was whether middle-aged dysthymic subjects who
seek help from a memory clinic with complaints about memory are characterised by cognitive
deficits, as assessed by their performance in neuropsychological tests. It appeared that the
performance of the dysthymic subjects was significantly inferior to that of age-matched
controls in tests of secondary memory, such as the immediate and delayed recall as well as the
delayed recognition on a verbal learning task. In contrast, primary memory, reflected by the
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score on the Digit Span, did not differentiate between the two groups. Differences were
found in the performance of information processing tasks in which task variables were manipu-
lated in order to change the cognitive complexity of the task: significant differences were
found for those subtasks that had comparatively high cognitive complexity. For instance, the
dysthymic subjects needed significantly more time with increasing memory load to perform
the Memory Scanning Task, as reflected by a significantly increased slope for this task (Fig.ld,
Table 1) than the controls did. In addition, the patients needed more time for the Colour
Word Interference Subtask (Stroop III). In addition to the findings on the complex subtasks,
significant differences were found with those subtasks of Memory Scanning Task, Stroop and
R-TMT that measure the general speed of information processing. Thus, dysthymic subjects
were somewhat slower than the controls in the Memory Scanning Task, in colour naming and
word reading in the Stroop and in visuomotor tracking in the Revised Trail Making Test.
The results can be taken to indicate that the dysthymic subjects, apart from being slower,
had a particular problem with effort-demanding processing. This type of task requires 'con-
trolled processing' as opposed to 'automatic processing', to use the terms proposed by Shiffrin
& Schneider[283]. The results suggest that dysthymic subjects make more use of a controlled
processing strategy, which costs them more time and energy. This is exactly the complaint
that many of these patients have, namely that they are not able to perform simple tasks as auto-
matically as they used to; that everything costs energy and effort; that they feel unable to
perform complex tasks involving several actions parallel to each other and/or in a short time
period. Similar conclusions were reached in studies with depressive subjects (e.g., [330]). The
present findings appear to provide an objective counterpart of the subjective complaints of the
dysthymic subjects investigated. More rearch is needed to investigate in more detail the
performance on tasks which are effort demanding in relation to the subjective complaints,
since cognitive effort may be confounded with limited time for performance in speeded tasks.
Alternative explanations for the differences in test performance between the dysthymic
subjects and controls concern differences in motivation, age and intelligence. However, the
dysthymic subjects were in general highly motivated to perform well because of a subjective
fear of dementia for which they sought help in the memory clinic. Thus, it is not likely that
differences in motivation account for the cognitive group effects. Intelligence Quotient had
not been assessed from the controls and thus, possible differences in intelligence to explain for
the findings of this study can not be completely ruled out. However, this explanation seems
highly unlikely since the groups were matched for level of education. By matching the two
groups for age, we controlled at least for chronological age.
With respect to the relationship between the cognitive impairments and dysthymia, there
are several possibilities. In the first place, it maybe that the cognitive dysfunctions are primary
and result into disturbed adaptation in social and professional life, which in turn leads to a
chronically depressed state and other symptoms of dysthymia. If cognitive impairment is
primary, the question is by what it is caused. One possibility as to aetiology is that an abnormal
aging process is involved. Some of the middle-aged dysthymic subjects could be in a very early
phase of a neurodegenerative disease such as Alzheimer's Disease. Patients with major
depression and cognitive deficits have been shown to have an increased risk to develop
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dementia [78,172,252). Longitudinal research will be carried out with the subjects of this
study to check this notion. It is of interest in this respect that the cognitive deficit profile of
the dysthymics in this study is similar with the profile of cognitive decline commonly reported
for normal aging in persons over 65 years [134]. Another possibility is that other, as yet not
identified, biological factors are responsible for the decreased performance of the middle-aged
subjects. There is some evidence that dysthymics differ from normal subjects and from patients
with major depression with respect to the dexamethasone suppression test, response on
stimulation with Thyrotropin-Releasing Hormone (TRH), respons to antidepressive drugs and
several other biological aspects. [135,136] These differences may reflect an altered brain
functioning, which leads to poor cognitive performance. Interestingly, several conditions have
been identified in which a minor event to the brain (e.g., very mild brain trauma, longstanding
exposure to industrial agents or recovery from infectious diseases) yields a neurasthenic
syndrome -a concept that is covered by the DSM criteria for dysthymia- in which no major
physical or neurological abnormalities can be identified [187]. The findings of the present
study support this possibility, which has also been under consideration in other studies [132,
133]. These indicate that such biological life events could accentuate the effect of normal
biological aging and become manifest in middle-age when the normal biological aging process
becomes evident. The second possibility with regard to the aetiology is that the cognitive
dysfunctions might be an inherent part of the dysthymic disorder, parallel to or even secondary
to mood changes, insomnia, low energy, fatigue etc. that are caused by particular psychosocial
events. A life event as a psychological cause for dysthymia was ruled out by the exclusion of
adjustment disorders, but it is theoretically possible that the patients responded in a neurotic
way to the physiological changes associated with normal biological aging. However, the results
show that the cognitive complaints could be objectified, which precludes a mere neurotic
perception of normal aging as a plausible explanation. Interestingly, the patients in the
present study had functioned well and esteemed life in a positive way both from a social and
professional point of view in the period before the dysthymia had started (1.5 to 6 years before
the start of the present study), which makes an underlying characterologicat disorder unlikely.
A third possible way to conceptualize the relationship between cognitive symptoms and
dysthymia could be that the cognitive complaints as well as some of the dysthymic symptoms,
such as poor appetite and insomnia, are both related to aging itself. This possibility seems
improbable, since the results showed significant differences between the age-matched groups,
all subjects were free from significant somatic problems and since the symptoms above occur
more frequently in the senium, but probably not in subjects aged between 40 and 65.
However, in older patients dysthymia and the process of aging may share some common
characteristics. More longitudinal studies into the course of the different symptoms can
elucidate the relationship between affective and information processing features and will be
carried out in our department.
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Conclusion
The present study shows that middle-aged dysthymic subjects who seek help from a memory
clinic for complaints about memory-related functions are characterized by cognitive deficits
when compared to age-matched controls. The results resemble those found recently for
information processing deficits in depression. The question whether the cognitive dysfunctions
found in the memory clinic population can be generalised to all dysthymic subjects can not be
answered in the present study. We have found that middle-aged patients suffering from
dysthymia -or at least a subgroup of this condition- are characterised by information processing
deficits in addition to the known psychiatric symptoms. The data may provide new insights
into the nature of a disease which, although generally considered as mild, may lead to severe
handicaps in normal daily life. In addition, the data draw attention to the importance of the
factor age in the evaluation of mild cognitive complaints. New models and techniques aimed
at coping styles and cognitive rehabilitation [50, 236,260,337] can be based upon a thorough
knowledge of the cognitive deficits described in the present study.
8A two-year follow-up of non-demented patients
attending a memory clinic*
Introduction
The differentiation of early Alzheimer's disease from normal age-associated memory
impairment is problematic when the clinical symptomatology is below the threshold for
dementia. There is no consensus on the diagnostic criteria of the borderline states between
normal ageing and frank dementia, because there is limited knowledge about which are the
crucial symptoms that accurately predict the development of dementia. A strategy has been
recommended by which a range of variables are followed longitudinally, in the hope that time
will show which symptoms are characteristic for the prodromes of dementia [124].
In this chapter we describe an ongoing longitudinal project at the Memory Clinic of the
University Hospital of Maastricht. The aim of this project is to collect data on a cohort of
middle-aged and older patients who seek help for cognitive complaints in a specialized
memory clinic, in order to establish the clinical characteristics of the prodromes of dementia. A
related goal of this project was to investigate the relationship between cognitive and affective
symptoms by following their course over time. In this chapter, the experiences and difficulties
related to this approach are discussed. The first results of this longitudinal study wilt be
reported.
*VerheyFRJRozendaalN, HouxP, Ponds RWHM.VreelingFW and Jolles J, submitted
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Patients and methods
The cohort of this study consisted of 65 patients who had been examined in the Maastricht
Memory Clinic of the University Hospital of Maastricht (MMC), The Netherlands before May
1990. Patients were included in this study 1) when they had completed the diagnostic
procedure; 2) when they were 40 years or older; 3) when they were not demented, according
to the criteria of the DSM-11I-R [7] or a score on the Mini-Mental State Examination (MMSE)
[97] of 24 or less; and 4) when no organic or somatic causes for the cognitive complaints could
be established after careful assessment as described elsewhere [316]. Because depression or
anxiety may be early signs of Alzheimer's disease [172,252], patients with these disorders
were not excluded in this study. If treatment for a psychiatric disorder was considered
necessary, this was performed after the initial assessment according to regular practice. The
patients were asked to discontinue medications with known psychoactive effects a few days
before the follow-up assessment. The patients had been referred by a general practitioner or a
medical specialist (neurologist or psychiatrist) primarily because of their cognitive complaints,
and not primarily because of a psychiatric condition. There were no self-referrals.
Patients fulfilling the inclusion criteria were contacted 2 years ± 3 months after the initial
investigation in the MMC and were invited to attend follow-up appointments. When patients
declined to participate, they were interviewed by telephone about the reason for their refusal
and about any changes since their visit to the MMC two years ago.
The initial assessment of each patient was carried out by a neuropsychiatrist and a
neuropsychologist and included a detailed history provided the patient and a significant other,
a mental status (including psychiatric) examination, a physical (including neurological)
examination and ancillary examinations such as laboratory tests and a CT scan of the brain.
Psychiatric disorders were diagnosed with DSM-IH-R criteria [7]. The Mini-Mental State
Examination (MMSE [97]) was administered to 55 patients (this test was not part of the
routine MMC procedure in the first months of the clinic, resulting in missing values for the first
10 patients). Hamilton's toting Scale for Depression (HRSD, [120]), the Global Deterioration
Scale (GDS, [255]) and the dementia scale (BDS, [24]) were also administered. The
neuropsychological assessment included psychometric tests, qualitative tests [195] and tests
derived from the information-processing paradigm [297]. The diagnostic procedure of the
MMC has been described in [316].
The follow-up assessment, which lasted 1.5 to 2 hours, was carried out by research assistants
who were trained and supervised by the clinicians working in the MMC with regard to the
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neuropsychiatric and neuropsychological diagnostic procedures. The follow-up assessment
consisted of a clinical and a neuropsychological part.
The clinical measures of the follow-up assessment included a medical history, a
standardized questionnaire, the MMSE and the HRSD. The questionnaire inquired about the
patient's perception of any changes in his or her cognitive functions over the last two years.
Four neuropsychological tests were used to evaluate cognitive changes over the period
between the first and the second assessments: the auditory verbal learning test (AVLT,
[183]), the Revised Trail Making Test (R-TMT; [324]), the Stroop Colour Word Interference
Test [183] and the Memory Scanning Task (MST; paper and pencil version [31]). These tests
are described extensively in chapter 7. The neuropsychological tests were selected on the
basis of the literature on ageing and dementia that suggest that memory decline and cognitive
slowing are among the first aspects of Alzheimer's disease and on previous results from our
group concerning patients with age-associated memory impairment [31, 81, 124, 132, 140,
146,238,299,300,307].
The number of parameters was reduced to three main variables by means of composite scores.
These variables were: memory, sensomotoric speed and cognitive speed. Table 1 lists the
individual test variables that formed the three composite scores. The memory score was
composed of parameters that were thought to represent different aspects of secondary
memory. Sensomotoric speed was composed of those test variables that were thought to
reflect the basic routine cognitive operations, such as visual scanning and reading. Cognitive
speed consisted of variables that were thought to best reflect the speed of mental processing.
In order to form the composite scores, individual test scores were converted to standard z-
scores so that the different tests for each cognitive measure could be combined. For
transformation into z scores, the means and the standard deviations of the normative data of
different age groups published by Houx (1991) were used as reference. For a comprehensive
discussion on the rationale of the composite scores, the reader is referred to Houx (1991).
The composite score of a given variable was regarded as impaired compared to that of the
normative data when its value was below the arbitrary level of -2. In order to obtain a measure
of change within the individual patient, we also examined whether the individual
performances had declined or improved. A decline of a given variable was defined as a
decrease of 2 or more of the composite score of that variable, whereas an improvement was
defined as an increase of 2 or more.
Parametric variables, such as age and time needed to perform a given neuropsychological
test, were compared between groups by using t-tests for independent samples. In order to
make comparisons within groups, t-tests for paired samples were used. Wilcoxon rank sum
tests were used for non-parametric variables. Two-tailed analyses were used to assess the
significance of differences between groups; a level of 5% was considered statistically
significant. One-way analyses were only used in the analysis of the differences between the
patients who developed dementia and those who did not.
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Table 1. Composite cognitive measures and their core variables
Measures Core variable
Memory Auditory Verbal Learning Test
1. maximum number of words recalled
2. total number of words recalled
3. total number of words of the delayed recall
Sensomotoric speed l.basicspeedofmemoryscanmngtest"%"task,time(seconds)
2. basic speed of concept-shifting test (TMT-A): time (seconds)
3. reading speed of Stroop test (Stroop-I): time (seconds)
4. basic speed of memory scanning test, one letter: time (seconds)
Cognitive speed 1. slope of memory scanning test: time in seconds for test with three letters
2. Stroop interference (Stroop-UI): time (seconds)
3. concept-shifting interference (TMT-C): time (seconds)
Results
Of the 65 patients who fulfilled the inclusion criteria of the study, 5 had moved from their
previous address and could not be traced despite intensive effort. Of the remaining 60
patients, 13 subjects dropped out of the study: 1 had died of a heart attack and 12 declined to
participate (3 found the tests too tiring, 3 refused because "they no longer had complaints", 1
was unable to come due to personal circumstances and the other 5 gave no reason). Only 1 of
the patients who found the test too tiring was considered by her daughter to have
deteriorated cognitively, whereas the others were not considered by their relatives to be
developing dementia.
The remaining group of 47 patients consisted of 28 men and 19 women. The mean follow-
up period was 25.0 ± 3.6 months. The mean age was 57.5 ± 11.0 years. Twenty-one patients
(44%) were between 40 and 55 years, 12 (25%) between 55 and 65 years old, 14 (29%) were
65 years or older. Twenty-six patients were classified as stage 2 and 21 as stage 3 of the GDS
[255]. Thirty-four (71%) had an initial MMSE score of 27 or higher, indicating a high global
level of cognitive functioning. The initial Hamilton depression scores of 33 subjects were
below the cut-off score of 13 that has been proposed as a criterion for Age-Associated Memory
Impairment (AAMI [59]), whereas 10 patients had a score between 13 and 18, and 3 had a
depression score higher than 18.
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Table 2. Means and standard deviations for clinical and cognitive measures
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Measure
Clinical measures
HDRS score
MMSE score
Cognitive measures
15 Words learning Test
total recall
delayed recall
delayed recognition
Trail making Test (TMT)
TMT-A
TMT-B
TMT-C
Stroop Color Word Test
Stroop-1 (reading)
Stroop-II (color naming)
Stroop-Ill (interference)
Memory scanning test
baseline ("%")
with 1 letter
with 2 letters
with 3 letters
with 4 letters
Composite scores
Memory
Sensomotoric speed
Cognitive speed
YearO
n mean (sd)
46 9.9 (5.7)
40 28.3 (1.7)
47 39.2(10.8)
47 7.4 (3.4)
47 13.0 (2.5)
46 52.2(17.9)
40 47.5(13.2)
41 77.8(24.0)
47 49.3 (9.2)
47 66.0(13.9)
47125.0(48.5)
45 33.5(10.2)
45 37.4 (7.9)
45 57.9(14.7)
43 72.8(21.8)
30 77.9(25.4)
47 -8.5 (6.8)
45 -7.3 (5.9)
39 -5.9(5.19)
Year 2
n mean (sd)
45 6.5 (5.5)
45 27.5 (1.9)
47 38.1 (11.4)
45 6.7 (4.3)
46 13.3 (2.5)
46 51.1 (27.8)
43 43.9 (15.8)
41 71.6 (25.1)
46 51.9 (11.2)
46 68.8 (14.3)
46122.1 (44.2)
44 33.8 (11.6)
45 37.9 (11.4)
44 56.7 (14.1)
43 68.0 (18.7)
41 79.8 (17.3)
45 -9.5 (7.8)
43 -7.0 (6.2)
40 -4.1 (3.0)
Difference
(%)
-34
-3
-3
-10
3
-2
-7
-8
5
4
-2
1
1
-2
-7
2
-12
4
31
df
43
37
46
44
45
44
38
37
45
45
45
41
42
42
39
29
44
40
35
P
<.001
<.01
ns
ns
ns
ns
ns
ns
ns
ns
ns
ns
ns
ns
ns
ns
ns
ns
<.01
Note: values for the 15-Word Learning Test represent number of items. Values of the o ther cognitive measures
represent seconds. For MMSE and the 15-Word Learning Test, high scores indicate a good performance, whereas for
all other measures high scores indicate a poor performance.
MMSE = Mini-Mental State Examination; HRSD = Hamilton's Rating Scale for Depression. P= level of significance,
t-test for paired samples, two-tailed
Thirty-three patients had received a psychiatric diagnosis according to DSM-IÏI or DSM-III-R at
the initial assessment: 12 had been diagnosed as having major depression and 12 as having
dysthymia. The other psychiatric disorders were: personality disorder (4 patients), anxiety
disorder (2 patients), adjustment disorder (2 patients) and post-traumatic stress disorder.
Fifteen patients had no psychiatric diagnosis according to the DSM-III-R criteria.
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There were no differences in age, level of education and the initial scores on the MMSE
between those patients who were tested in year 2 and those who were not. The only variable
that was different between the two groups was the initial score on the HRSD (9.9±5.7 in the
patients who were retested, versus 13-3±5.5 in those who were not retested: p<0.05,
Wilcoxon rank sum test, two-tailed). Thus, there was some selective attrition in this study: the
patients who could not been retested had a higher level of depressive symptomatology, than
with the entire cohort.
Table 2 shows the numbers of observations, the means and the standard deviations for the
clinical and cognitive measures at the initial assessment and at follow-up for the 47 patients
who attended the follow-up assessment. Some data are missing, because a number of patients
found the tests to too tiring and wanted to stop prematurely, despite encouragement by the
test assistant. As a consequence, the composite score that comprised the variable that was
missing could not be obtained. The mean scores on the HRSD and the MMSE of the tested
group had decreased significantly (two-tailed t-test for paired samples). None of the single
cognitive variables had changed significantly, but the composite score of cognitive speed had
increased significantly at follow-up.
Table 3. Development of the composite scores at follow-up, by initial performance
composite score
Memory (n=45)
Sensomotoric speed (n=4l)
Cognitive speed (n=36)
initial
assessment
impaired:
not impaired:
impaired:
not impaired:
impaired:
not impaired:
N
36
9
36
5
31
5
(X)
(80)
(20)
(88)
(12)
(86)
(14)
follow-up assessment
declined
20
3
11
1
2
1
(56)
(33)
(31)
(20)
(6)
(20)
unchanged
3 (8)
4 (44)
14 (39)
3 (60)
15 (32)
4 (80)
improved
13
2
11
1
14
0
(36)
(22)
(31)
(20)
(61)
( • )
Note: Values represent numbers of patient (%).
Table 3 shows the number of patients with impaired and unimpaired composite scores at the
initial assessment and the development of these scores at follow-up. The memory score was
initially impaired in the majority of the patients who were tested. Memory appeared to have
deteriorated at follow-up in more than 50% of these patients. In contrast, most of the patients
who initially had impaired scores of sensomotoric and cognitive speed did not appear to have
declined further at follow-up.
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At the time of follow-up, 4 patients were found to have become clearly demented by the two
medical specialists, and 1 other patient was diagnosed as questionable dementia (i.e.,
suspected of having dementia, but some data were missing). One patient was diagnosed as
demented by one specialist and as questionable dementia by the other. The other 41 patients
were not found to have become demented at follow-up. Thus, the two raters showed 10096
agreement when the two categories of dementia and questionable dementia were combined.
Téle 4. Clinical measures and composite scores by diagnosis at follcw-up
Dementia p No dementia p p
at follow-up within at follow-up within between groups
(N=6) group (N=41) group
initial folbwup
n meanl,srf mean2,s/ n meanl,»/ mean2 ,s / values values
Clinical measures
Initial age (years) 6 66.0 9.4 41 55.8 /0 .5 <.05
HDRS score 6 9.7 j . j 6.6 46 ns 40 9.9 5 9 6.8 5 9 <.001 ns ns
MMSEscore 5 28.2 i.3 27.2 ƒ.7 ns 35 28.4 /.« 27.5 ƒ.9 <.01 ns ns
Composite scores
Memory 6 -14.86.9 -16.6 5.4 ns 41 -7.5 63 -8.3 7.5 ns <.01 <.01
Sensomotoricspeed5 -5.8 4.6 -13.0 / j i ns 40 -8.2 & / -6.7 6 J ns ns <.05
Cognitive speed 3 -6.5 <>.« -5.6 6.8 ns 37 -5.8 4 7 -4.6 3.4 <.05 ns ns
p= level of significance. T-test for independent samples, one-tailed, for comparisons between groups; t-test for
paired samples,;one-tailed for comparisons within groups.
The 6 patients who were diagnosed as demented (or probably demented) all showed evidence
of gradual deterioration in social functioning at follow-up. None of the patients had had
cerebrovascular symptoms in the follow-up period, nor any other somatic abnormalities.
Therefore, these 6 patients were thought to suffer from probable Alzheimer's disease.
Table 4 shows the characteristics of those patients who became demented in the follow-up
period and those who did not. An analysis of the differences between the two groups showed
that the patients who developed dementia were on average 10 years older and had
significantly worse memory scores, both at the initial and at the follow-up assessment, than the
patients who did not develop dementia. In addition, the sensomotoric speed of the patients
who developed dementia was significantly worse in the dementing group at follow-up. The
two groups did not differ significantly with regard to the initial and the follow-up scores on the
HRSD and the MMSE. Within the group of the patients who developed dementia, none of the
variables had changed significantly. It should be noted, however, that the number of patients
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who developed dementia was small (N=6), and that, additionally, several values were missing.
Within the group of patients who did not develop dementia, the score on the HRSD had
improved significantly, whilst that on the MMSE had decreased. The mean cognitive speed of
the non-dementing group had improved significantly,
/fe/aftons^ijt) betoeen depression and ccgmttcw
Table 5 shows the main characteristics of patients with an initial HRSD score of 13 or more and
patients who had a lower depression score. Besides the ratings on the depression scale, no
significant differences could be found between the two groups.
Table 5-Clinical measures and composite scores by diagnosis at follow-up
Clinical measures
Initial age (yrs)
HDRS-score
MMSE-score
Composite scores
Memory
Sensomotoric speed
Cognitive speed
initial HRSD >13
nmeanl,
13
13
11
12
11
8
59.5
16.5
28.3
-7.8
•5.8
-6.4
(n=13)
a/ mean2,
77.7
5.5 10.3
7.7 26.9
7.2 -8.9
4.6 -8,2
i -5.0
6.7
7.6
6.9
7.4
27
P
within
group
<.02
<.05
ns
ns
ns
n
33
33
29
32
30
28
initial HRSD <13
(n=33)
meanl
56.6
7.1
28.4
-8.4
•7.5
• 5 . 6
7Ö.2
37
7.8
«
67
47
mean2
4.9
27.8
•9.2
•6.8
•3.8
40
7.9
7.5
6J
3/
P
within
group
<.01
<.02
ns
ns
<.01
P
between groups
initial
values
ns
<.oo:
ns
ns
ns
ns
follow-up
values
1 <.001
ns
ns
ns
ns
p= level of significance. T-test for independent samples, one-tailed, for comparisons between groups; t-test for
paired samples, one-tailed for comparisons within groups.
Despite efforts to discontinue psychoactive medication at the initial and the follow-up
assessment, 6 patients used psychoactive drugs at the time of the initial assessment: the scores
for memory and cognitive speed was somewhat lower in these patients (memory: 12.1 in
patients using drugs vs. 9.1 in those without, p<0.05 two-tailed Wilcoxon Rank sum test). At
follow-up, there was no relationship between the use of psychoactive medication (n=6) and
the neuropsychological performance. Within the groups, cognitive speed had improved
significantly in the patioents whose initial HRSD scores were below 13. Twenty-four patients
had received a diagnosis of depression (including dysthyniia) at the initial assessment and 19 of
them also had impaired memory scores. Ten of these 21 patients had deteriorated at follow-
up, but their mean depression score had not changed significantly (HRSD 13.0±6.6 initially,
and I2.1±7.6 at follow-up). However, the memory scores of 8 of these 21 patients had
improved, and so had their depression ratings (initial HRSD score 12,5±3.3 and 7.8±4.6 at
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follow-up). Of the 6 patients who subsequently developed (clear or questionable) dementia, 3
had received a psychiatric diagnosis at the initial assessment: 1 had been diagnosed as having
major depression, 1 as having dysthymia and 1 as having an anxiety disorder. Decliners and non-
decliners with depression had memory scores similar to those of patients without depression.
There was no significant relationship between the direction of change of the memory scores
and that of the depression score.
Discussion
There are several limitations of the present study that should be considered before discussing
the possible implications of its results. First, a substantial number of patients did not come for
follow-up: almost 30% of the original cohort could not be retested. Some patients refused
because they found the tests too tiring, others gave no reason for their refusal. The group that
could not be reassessed had higher ratings on the HRSD, indicating a higher level of
depressive symptomatology. Because a tendency to get stressed and an increased
exhaustibility may occur early in the development of dementia [238], the patients who
dropped out of the study probably represent a group that is at more risk of becoming
demented than those who participated. As a consequence, the results obtained with the
retested group probably underestimate the real level of deficits of the entire cohort. Second,
quite a few patients could not finish all the neuropsychological tests, especially those tests
that demanded relatively more mental effort. For instance, composite scores of cognitive
speed could not be obtained in 23% of the patients who were retested. This is another cause
of selective attrition effects in this study, because the patients who could not finish these tests
are probably those with the worst performance. Third, a control group was not studied in
parallel to the study group. Therefore, the study does not allow for comparisons between the
patient group with the general population, with regard to the clinical course of the symptoms
studied. Because of these methodological problems, the results of these study should be
interpreted with due consideration.
Six out of the 47 patients who were tested (13%) were thought to have become
demented at the two-year follow-up by the two clinicians. Given the fact that the mean age of
the population under study was quite low and that the time of follow-up was short, this
number is much higher than expected on the basis of known incidence figures. If the same
method is applied as has been used by others [227] for estimating the incidence rate in a
given group on the basis of the age distribution, the expected number of patients that would
develop dementia in two years would be less than one (0.47) in our study population. Thus,
the rate observed in this study was much higher than expected. The figures presented here
give only some global indication and should be considered with caution, however, because the
absolute number of patients was small and we did not study a control group. Nevertheless,
these results clearly illustrate the methodological value of services such as the Memory Clinic
for research into the very early manifestations of dementia. Furthermore, a follow-up period
longer than the two years of our study would probably have detected more cases of dementia,
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as there were several patients who showed a decline of cognitive functions but who were not
thought to have become demented .
The present research confirms the findings of other studies that memory decline is among
the first signs of Alzheimer's disease [140, 299, 300], It should be noticed, however, that the
patients were referred to a memory clinic, by which the results may be biased by selection.
We could not confirm the finding of two other studies that Alzheimer's disease begins with
cognitive slowing [238, 307). In our study, patients who developed dementia were not
cognitively slower than those who did not develop dementia, although the first group had low
scores for sensomotoric speed at follow-up. The discrepancy between the results of the two
above-mentioned studies and our investigation may be due to the methodological problems as
discussed in the previous paragraph, but also to the fact that patients with psychopathological
symptomatology had not been excluded from our study. In this respect, our study group was
more heterogeneous than that of the other studies. Cognitive slowing has also been found in
affective disorders [330] and may therefore not be specific for Alzheimer's disease.
There have been few longitudinal studies of the non-cognitive aspects of early dementia.
In fact, patients with psychiatric disorders are usually excluded from most studies. The number
of patients who subsequently developed dementia would have been 50% lower if psychiatric
disorders had been an exclusion criterion in our study. Changes of affectivity and personality
may be among the earliest features of dementia [1,172,238,252, 274]. Therefore, patients
with cognitive complaints who also demonstrate psychopathological symptoms may represent
a population of particular interest with respect to the early detection of dementia.
The results of the present study do not support the view that the level of depressive
symptomatology always parallels the degree of memory impairment. Two patterns of clinical
courses could be distinguished: some patients with depression appeared to have deteriorated
with regard to the memory score, the HRSD score being unchanged, whilst others showed an
improvement of both the depression ratings and the level of cognitive functioning. In the
latter group, it is likely that impaired memory is secondary to the depressive symptomatology.
In the first group, however, the cognitive functions went on to decline irrespective the level
of depression ratings. Therefore, the affective symptoms of this latter group may well be a
psychological consequence of cognitive impairments.
Because of the above-mentioned limitations, the findings of the present study cannot be
considered as conclusive with regard to the early cognitive changes of Alzheimer's disease.
More research still has to be done with larger patient groups and with longer follow-up
periods. The study has also shown that neuropsychological tests that are theoretically of
interest in the assessment of early dementia may be difficult to administer in practice. Many of
the methodological problems that we encountered seem to be inherent to the specific aims of
the study, i.e., looking for the first manifestations of dementia. Patients who are the most
anxious and uncertain about their cognitive abilities may be the first to refuse to participate.
Patients who experience relatively little stress as been a burden, a feature which is probably
one of the first characteristics of dementia, may be particularly likely to stop the assessment
procedure prematurely. These findings may explain why only a few longitudinal studies into
early dementia have been performed so far. They underscore the need for a more
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individualized approach to the diagnosis of early dementia. It may be worthwhile to develop a
more qualitative type of assessment as well, in which the reason for failing to finish a given test
is also taken into account. The present study wil! be extended by reassessing the patients after
another two years, parallel to a control group of normal subjects, in order to enable
comparisons between the patients' course and that of normal subjects.

9A comparison between six current sets of criteria
for the diagnosis of vascular dementia*
Introduction
Dementia can be caused by a variety of disorders [333], but by far the most frequent causes
are Alzheimer's Disease (AD) and vascular dementia (VD) [156]. Therefore, the differentiation
between AD and VD is of major importance, not only from a clinical viewpoint [116,178], but
also for epidemiological research [286]. Several instruments have been developed for this
purpose. In 1975, Hachinski and coworkers designed the Ischaemic Score (H-IS) to rate the
probability of a vascular pathogenesis in patients with dementia [ 117]. The H-IS consists of 13
items related to the course, risk factors, signs and symptoms. Although Hachinski's IS has been
criticized for several reasons [70,189,190], it appears to differentiate between VD and AD
reasonably well, but not between VD and mixed dementia (i.e., AD coexisting with cerebral
ischaemic lesions) [79,214,269,327]. The H-IS has had considerable impact and still serves as
the gold standard in clinical research.
Since the publication of Hachinski's IS, at least five other sets of criteria have been
proposed to improve the accuracy of the diagnosis of VD (see also the appendix of this
chapter). Rosen's modification of Hachinski's IS (R-IS) was formulated on the basis of
pathological data from 14 patients. In this version, five of the original H-IS items were omitted
that did not contribute to the clinical differentiation between AD and VD [269]. Loeb and
Gandolfo validated the H-IS by using CT scan data from 101 patients with dementia and
proposed another version of the IS (L-IS) on the basis of their findings. The U S includes only
"Verhey FRJ, LodderJ, Rozendaal N, JollesJ. Submitted for publication
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four of the original H-IS items, and is expanded to include single- or multiple low density areas
on CT scan [192,193]. The criteria for Vascular Dementia from the DSM-III-R, similar to those
from the DSM-III [7], comprise, besides the presence of dementia, presence of a stepwise
deteriorating course with a patchy distribution of deficits; focal neurological signs and focal
neurological symptoms; and evidence from history, physical examination or laboratory tests of
significant cerebrovascular disease judged to be etiologically related to the disturbance. The
DSM criteria are not quite unambiguous. The "patchy pattern of deficits" is difficult to
operationalize, and it is not clear whether the second criterion should be taken literally as
signs and symptoms, or, more liberally, as signs and/or symptoms, as has been interpreted by
others [93] • Erkinjuntti et al. defined VD, multi-infarct type, as dementia evolving in
connection with acute neurological symptoms or signs and/or findings on CT indicating
multiple cortical and/or deep vascular lesions of the brain [80,83]. Finally, a recent proposal
for the diagnosis of VD was presented in a report by the State of California Alzheimer's Disease
Diagnostic and Treatment Centers (ADDTC) [46]. In this proposal, no reference is made to
any course characteristic; neuroimaging evidence of an infarct (by CT or MR1) is necessary; and
at least two ischaemic strokes are required, or, in case of one stroke, the evidence of a
temporal relationship to the onset of dementia. Both Erkinjuntii's criteria and those from the
ADDTC allow for a diagnosis of possible VD, when there is a single stroke without a temporal
relationship to demenria. Moreover, the ADDTC criteria classify Binsranger's syndrome also as
possible VD.
Thus far, none of the above sets of criteria for VD has clearly been proven to be superior
and all are currently used for clinical and research goals. In this study we applied the six sets to
a sample of demented patients visiting an university hospital, in order to compare the
prevalence rates of VD and AD as detected by each criterion and to obtain insight into the
similarities and differences between the different criteria. The aim of this study was to
examine whether or not the different criteria can be regarded as interchangeable, which
would have implications for the comparison of studies into VD or AD carried out with different
criteria.
Patients
The data of the patients consecutively referred to the Maastricht Memory Clinic (MMC) were
used for this study. Included were patients with completed diagnostic work-up, and with
dementia according to the DSM-III-R criteria [7] whithout any somatic, neurological or
psychiatric disorders other than of primary degenerative and/or vascular origin. The diagnostic
procedure has been described elsewhere [316] and includes a semi-structured history
provided by the patient and his or her caregiver, a standardised psychiatric interview, an
internal, neurological examination and neuropsychological investigation, laboratory tests and a
CT-scan of the brain (in most cases: Philips Tomoscan 310). A neurologist experienced in
cerebrovascular pathology (JL) examined all CT scans for the presence of ischaemic (lacunar or
cortical) infarctions and leukoaraiosis, according to regular criteria[80] and without knowledge
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of the clinical diagnosis. Only CT scans made during the assessment of dementia, and not those
eventually made in the acute stage of a stroke, were used for this study.
Methods
Soon after the diagnostic work-up, all relevant clinical data of each patient had been entered
in the database of the MMC. These included, among others, all items from the Hachinski's
Ischaemic scale, number, type and localization of the strokes, relevant CT scan data, existence
of a temporal relationship with the onset of dementia and clinical features of binswager's
syndrome as defined in the ADDTC report. [46] Thus, although most of the patients had been
assessed before the ADDTC criteria were published (March 1992), the different sets of criteria
could be applied in retrospect for all selected patients. The only data that were not available
pertained to the DSM-III-R criterion for VD of a "patchy distribution of deficits". This aspect
was ignored, because it was felt that it could not be operationalized easily. Furthermore, the
second criterion of the DSM-III-R was interpreted as signs and/or symptoms. Cut-off scores for
VD and AD were used as described in the original publications. For uniformity of terms, the
concepts Multi-Infarct Dementia as used by the different authors[7, 83, 117, 192, 269] and
probable IVD [46] are all referred to as "Vascular Dementia". Likewise, the term "mixed
dementia" denominates patients with IS scores between the cut-off values, probable and
haemodynamic type VD[80,83] and possible Ischaemic VD [46]. A fourth category is formed by
the patients who could neither be classified as AD nor as VD or mixed dementia. Frequencies
of the diagnosis of VD obtained for a specific set of criteria were compared pairswise with
those for AD (or mixed dementia) obtained for the corresponding set of criteria to exclude a
vascular etiology (see also table 2)
The agreement between the different sets of criteria was assessed by calculating the kappa
statistics. Kappa is the rate of observed agreement between a single pair of sets adjusted for
the proportion of the agreement that can be exspected to occur by chance.
Results
One hundred and nine patients were included in this study. The mean age of the patients (52
male, 57 female) was 70.1 ± 8.8 years. The patients were mildly or moderately demented, as
reflected by a mean score on the Mini-Mental State Examination [97] of 17.9 ± 5.8. The main
clinical and CT-scan characteristics are summarized in Table 1.
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Table 1. Patient characteristics (N= 109)
Feature
Acute onset
Stepwise deterioration
Fluctuating course
Nocturnal confusion
Preserved personality
Depression
Somatic complaints
Emotional lability
(History of) hypertension
History of TIA's or stroke(s)
Signs of associated atherosclerosis
Focal neurological symptoms
Focal neurological signs
Multiple low dense areas on CT
Single low density area on CT
Evidence of multiple strokes
with temporal relation to dementia
without temporal relation to dementia
Evidence of a single stroke
with temporal relation to dementia
without temporal relation to dementia
Binswanger's syndrome
N
24
25
26
20
54
41
30
27
29
31
24
19
36
11
13
13
13
24
10
14
3
(X)
(19%)
(20%)
(21%)
(16%)
(44%)
(33%)
(24%)
(22%)
(23%)
(28%)
(19%)
(15%)
(29%)
(9%)
(10%)
(10%)
(10%)
(22%)
(9%)
(13%)
(2%)
Table 2 shows the numbers of patients diagnosed according to each criterion. Thirty-nine had
vascular dementia according to at least one set of criteria, whereas only 8 patients were
diagnosed as VD by all sets of criteria. Seventy-five patients had AD diagnosed by at least one
set of criteria, whereas 51 patients were diagnosed as such by all sets. The R-IS and the H-IS
resulted in the highest number of patients with VD (about 30%), whereas only 13% of the
subjects were diagnosed as having VD when the ADDTC, the DSM or Erkinjuntti's criteria
were used. The proportion of patients diagnosed as AD varied from 64% (using the L-IS) to
54% (using the DSM criteria). Between 8 and 3296 of the patients were diagnosed as suffering
from mixed dementia. The proportion of patients who could not be classified as either VD,
mixed dementia or AD, ranged from 32% (using the DSM criteria) to 2% (using the H-IS).
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Téle 2. Frequencies of vascular dementia and Alzheimer's disease according to six different sets of criteria
Criterion
Hachinski's Ischaemic Scale
VD: H-IS score >7
mixed: H-IS score >4 and <7
AD: NINCDS/ADRDA criteria, and H-IS score <4
unclassified
Rosen's Ischaemic scale
VD: R-IS score >4
mixed: R-IS score of 3
AD: NINCDS/ADRDA criteria, and R-IS score <2
unclassified
Loeb's ischaemic Scale
VD: L-IS score >5
mixed: L-IS score of 3 or 4
AD: NINCDS/ADRDA criteria, and L-IS score <2
unclassified
DSM-III(-R)
VD: 'Multi-infarct dementia'
mixed: f«o( covererf iy DSM cn'(en'a)
AD: 'Primary Degenerative Dementia'
unclassified
Erkinjuntti's criteria
VD: Multi-infarct dementia (MID)
mixed: 'PVD'and'Haemodynamic type dementia'
AD: NINCDS-ADRDA criteria, with exclusion of MID
unclassified
ADDTC criteria
VD: 'Probable IVD'
mixed: 'Possible IVD'
AD: NINCDS-ADRDA criteria, with exclusion ofprobable or possible IVD
unclassified
N
32
10
65
2
36
6
64
3
23
12
70
4
15
.
59
35
14
26
61
8
15
9
66
19
(*)
(29)
(9)
(60)
(2)
(33)
(6)
(59)
(3)
(21)
(11)
(64)
(14)
(54)
(32)
(13)
(24)
(56)
(7)
(13)
(8)
(61)
(17)
Note: VD = Vascular Dementia; AD = Alzheimer's Disease; H-IS = Hachinsk i ' s I schaemic Score [119]; R-IS =
Rosen's Ischaemic Score [269]; US = Loeb's Ischaemic Score [192]; MID = Multi-infarct D e m e n t i a ; PVD =
Probable Vascular dementia [83]; IVD = Ischaemic Vascular Dementia [46]; unclassified = not dassifyable as e i ther
VD, AD or mixed dementia
In Tables 3a and 3b, the kappa values between all possible combinations of criteria are shown
for VD and AD (using the different criteria to exclude vascular dementia), respectively. On the
average, the agreement for AD was somewhat higher than for VD (kappa: 0.75 versus 0.70),
whereas only fair agreement existed for mixed dementia (kappa: 0.32). Concerning the
diagnosis of VD, almost perfect agreement existed between the ADDTC criteria and those of
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Erkinjuntti and the DSM, and between the H-IS on the one hand and the R-IS and the L-IS on
the other. Moderate agreement existed between the H-IS and R-IS on the one hand and the
ADDTC and Erkinjuntti's criteria on the other. With respect to the diagnosis of AD, the H-IS,
the R-IS and the L-IS showed considerable agreement, and so did the ADDTC with the
DSM-III-R and Loeb's criteria.
Table 3a. Agreement (kappa-values) between the different sets of criteria for the diagnosis of vascular dementia.
Criteria fladimsh' toen Zoe6 QSM-ffl £rfe'n/un«i'
0.894
0.808
0.648
0.559
0.588
0.777
0.622
0.536
0.564
0.722
0.744
0.772
£r*m;an8j  .  .  0.687
0.867 0.937
Table 3b. Agreement (kappa-values) between the different sets of criteria to exc/wfe vascular dementia for the
diagnosis of Alzheimer's Disease.
Criteria HflG&msW Rosen to* O M /
/fasen
loeè
ZXSW-WZ
£nb'n;untfi
0.905
0.825
0.664
0.775
0.675
0.807
0.684
0.794
0.657
0.681
0.829
0.805
0.555
0.869 0.680
Note: Kappa statistics, interpretation of the level of agreement: 0.0 to 0.2, slight; 0.2 to 0.4, fair; 0.4 to 0.6, moderate;
0.6 to 0.8, substantial; and 0.8 to 1.0, almost perfect [177].
The highest disagreement occurred between the H-IS and the R-IS on the one hand and the
ADDTC and Erkinjuntti's criteria on the other: 32 patients had a H-IS score indicative of VD,
but no more than 20 of them would not have been diagnosed as such according to the ADDTC
criteria (21 according to Erkinjuntti's criteria). Five of these patients had an insidious onset of
dementia and no clinical history of stroke or hypodense areas on the CT scan, and would have
been diagnosed as AD by the NINCDS/ADRDA criteria when the ADDTC criteria were used for
the exclusion of VD; however, four of them demonstrated slight unexplained focal signs and /
or symptoms (e.g., one-sided palmomental reflex), whereas the fifth patient demonstrated a
fluctuating course and scored on all one-point items of the H-IS, leading to the high H-IS
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score. Nine other patients with VD according to the H-IS were classified as mixed dementia by
the ADDTC: three patients with Binswanger's syndrome (as defined in the ADDTC report) and
six with evidence of only one stroke without a clear temporal connection with dementia. Six
patients identified with the H-IS as VD could not be classified appropriately by the ADDTC
criteria: 3 patients were said to have become demented acutely instead of insidiously (thus not
fulfilling criteria for AD), neither was there evidence of stroke in the history, physical
examination or on CT scan (thus not fulfilling the criteria for possible or probable VD).
Moreover, three other patients became demented as a result of a single stroke without there
being demonstrable hypodense areas on the CT scan. The ADDTC criteria do not cover these
two situations, but Erkinjuntti's criteria would have classified them as mixed dementia.
Of the 24 patients who had a history of one single stroke, in 14 there was no temporal
relationship between the stroke and the onset of dementia. Most of these patients had had a
minor stroke many years before the first manifestations of cognitive impairment. With the R-IS,
all these 14 patients would have been diagnosed as VD, whereas with the H-IS and the L-IS 11
and 10 patients would have had this diagnosis respectively. In contrast, only 3 of the 14
patients, namely those who showed evidence of more than one infarct on the CT scan, had
been diagnosed as VD by the ADDTC or Erkinjuntti's criteria, whereas the other 11 were
merely diagnosed as mixed dementia.
Discussion
The present study shows that application of the six sets of criteria for the diagnosis (or the
exclusion) of vascular dementia led to differences in the frequency of AD and VD that cannot
be neglected. For example, the IS of Rosen resulted in more than twice as many patients with
VD than the DSM-II1-R criteria. The ADDTC and Erkinjuntti's criteria showed almost perfect
agreement with each other, and so did the ischaemic scales of Hachinski and of Rosen.
Otherwise, the sets of criteria cannot be regarded as interchangeable. The choice of a
particular set of criteria appears more critical in demonstrating a vascular etiology for the
diagnosis of VD than in making such an etiology unlikely for the diagnosis AD. In the
'clear-cut' patients, e.g., in those who demonstrated clear evidence of multiple strokes in
their history, clinical examination, and CT scan, different criteria led to similar diagnoses. The
criteria diverged when information from one category did not confirm the other, e.g.,
evidence of stroke from CT scan without focal neurological symptoms or vice versa.
In the absence of neuropathological data, no definite conclusion can be drawn as to which
of the criteria is superior. However, pathological data are of relative value for the confirmation
of the clinical diagnosis of VD, since the existence of ischaemic infarctions at autopsy does not
prove that they actually produce dementia. Only the ADDTC and Erkinjuntti's criteria provide
the opportunity to assess explicitly the issue of causality between strokes and dementia by
making use of the criterion of a temporal relationship with dementia. This is also true for the
DSM criteria ("evidence of cerebrovascular disease judged to be related to dementia"),
although rather implicitly. The present study shows that if the aspect of a temporal connection
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is taken into account, it influences the diagnostic outcome considerably. The same is true
when the neuroimaging data are taken into consideration (the L-IS, the ADDTC and
Erkinjuntti's criteria). E.g., evidence of ischaemic infarcts on CT scan was found in our study in
45 to 100% of the patients diagnosed as VD, and in 0 to 13% of the patients with AD,
depending on which criterion was used. Ischaemic infarcts have been described in other
studies in 20 to 90% of the patients with VD and in 0 to 37% of the patients with AD[80,250,
263, 291]. These great variations are likely to be explained by differences in the criteria'used
for the diagnosis of VD, as has been suggested by others [286].
In summary, this investigation shows that the results of studies which use different criteria
for the diagnosis or the exclusion of VD must be compared with caution. Given the impact of
the issues of temporal connection and of neuroradiological data, the ADDTC and Erkinjuntii's
criteria can presently be regarded as the criteria of choice, although they still await further
validation by pathological studies. The controversy on whether VD is overdiagnosed [33] or
underdiagnosed [228] may be related to differences in the criteria used, which is possibly an
overlooked source of interstudy outcome variance.
10
Depression, insight and personality changes
in Alzheimer's disease and vascular dementia*
Introduction
Alzheimer's disease (AD) and vascular dementia (VD) are the two most common causes of
dementia [156], Differentiation between these two disorders in an early phase is important as
remedial therapeutic interventions for vascular dementia are probably then more successful
[116], Furthermore, homogeneous diagnostic groups are a prerequisite for epidemiological
and pharmacological research. In the past, many attempts have been made to diagnose VD on
clinical grounds. Mayer-Gross et al.[199) described, in the Handbook of Clinical Psychiatry
(1969), its typical clinical presentation as follows:
"The patient with VD is in the first stages of the disease restlessness, very emotional, and
inclined to wander at night. (...) Memory and intellectual impairment may be preceded by a
caricature of one or more personality traits.(...) Drive and initiative diminished (...) yet
judgement and the basic personality may be well preserved and the patient can retain
remarkably good insight ...leading to despondency and pessimism.(...) Depression is
noticeable at some stage in almost a third of cases".
This description provided Hachinski and coworkers with the basis for the ischemic scale (IS) as
a tool to assess the cerebrovascular etiology of dementia [119]. Hachinski's IS is still widely
used and contains, among others, the items 'depression' and 'relatively retained personality'.
In view of the widespread popularity of Hachinski's IS, it is apparently assumed that
depression and preserved personality occur more frequently in VD than in AD. Additionally, a
* Verhey FR], Ponds RHWM, Rozendaal N and Jolles J,submitted for publication
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relatively intact insight into ones' deficit is also generally regarded as being more
characteristic for patients with VD than for patients with AD [7,199], However, there is little
empirical evidence that AD and VD can be discerned reliably on the basis of these features.
Hardly any study has determined whether an intact insight and a preserved personality can be
used to differentiate between AD and VD. The few studies that there are on the relationship
between depression and the type of dementia have yielded conflicting results. For instance,
depression has been found to occur more often in VD than in AD [64j, less often in VD than in'
AD [252], or in similar frequencies [94]. It is relevant to note that these studies for the most
part included inpatients and that the results are thus difficult to generalize to less severely
demented outpatients. Thus, reliable data on the prevalence of clinical characteristics that
differentiate between AD and VD in relatively mild stages of dementia are virtually non
existent. Additionally, variations in the frequencies of occurence of a given feature seem most
related to differences in the diagnostic criteria. For instance, some have used Hachinski's IS to
distinguish between AD and VD [64,65]. When depression and personality are studied, the use
of this scale leads to circularity since it includes these two features. Another source of variation
may stem from differences in the study samples. For example, some have reported that
depressive symptoms occur more often in the early stages of AD [35] and in female subjects
[35,182]. Moreover, the age of onset of dementia may be a possible important characteristic
that influences the results of comparisons of different groups [78], Thus, the severity of
dementia, sex distribution, and age of onset are potentially confounding factors that should be
taken into account when comparing the prevalence of depression in different groups of
demented patients.
The present study addresses the question whether patients with VD and patients with AD
differ in the prevalence of depression, lack of insight, and personality changes. In order to rule
out differences attributable to differences in related sample characteristics, we compared
patients with AD to patients with VD who were carefully matched for age, sex, and extent of
dementia. The aim of this study was to examine whether or not these clinical features would
help to differentiate between AD and VD in a relatively early phase of the disease.
Patients and methods
We selected demented outpatients with AD and VD who had been consecutively referred to
the Maastricht Memory Clinic of the University Hospital of Maastricht, The Netherlands [316].
Dementia was diagnosed according to DSM-III-R criteria. [7] AD was diagnosed using the
NINCDS/ADRDA criteria for possible and probable Alzheimer's Disease [207]. The diagnosis of
VD was based on the DSM-III-R criteria for dementia and a score of 4 or more on Rosen's
modified ischemic score [269]. In contrast to Hachinski's original IS, the modified IS does not
include the items depression and retained personality. The severity of dementia was assessed
by the Global Deterioration Scale (GDS) [255]. The degree of functional impairment was
measured by the dementia scale of Blessed-Tomlinson-Roth (BDS) [24],
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The original group consisted of 93 patients with AD and 48 patients with VD. Compared to
the patients with VD, the patients with AD were significantly younger (74.0 vs. 70.7 years,
p<.05) and less severely demented, as measured with the GDS (mean GDS score 4.8 and 4.3
respectively; Wilcoxon test, df=l, p<0.02). Therefore, we selected 48 patients from the AD
group who were matched pairswise with regard to the GDS score, age, and sex to the 48
patients with VD. Matching was preferred rather than controlling and correcting for an effect
of the GDS score and age by means of an ANCOVA procedure, in order to avoid the problems
of using an ordinal variable as a covariate [285]. Matching was carried out by a research
assistant who was blind to patient data other than these three characteristics. Forty-four out of
the 48 patients were matched within the same GDS score. Patients were matched for age
within ± 3 years, all patients were matched for sex.
A distinction was made between depression, as a syndrome, and depressive symptoms.
Depression was diagnosed according to the DSM-III-R criteria for a major depressive episode,
ignoring the organic exclusion [7]. Depressive symptoms were assessed using Hamiltons'
rating scale for depression, which also served as a global measure for the extent of the
depressive symptomatology [120], The HRSD has been proven to be reliable in demented
patients [113].
For the purpose of this study, impaired awareness or lack of insight was defined, according
to Schachter (1990), as the absence of knowledge or recognition of cognitive deficits. In
analogy to others, the extent of awareness was assessed by comparing the patients' and the
caregivers' history [205,278]. Awareness of deficits was rated on a four-point rating scale,
ranging from 4 ('intact') to 1 ('absent'), using the following guidelines (see also appendix of
chapter 11). At the initial interview, the patient was asked to say why he or she had been
referred. The caregiver had been asked not to make any comments before being requested to
do so. Awareness was judged to be mfócf (awareness score, AS=4) when the cognitive
problems were mentioned spontaneously by the patient in reply to the opening question: of
why he or she had been referred, and when the history of the caregiver corresponded with
that of the patient. Awareness was scored as m»W(y /mpa/rerf (AS=3) when the patient
commented spontaneously about his or her memory in reply to the opening question, but
when there were apparent discrepancies between the patient's and the caregiver's anamnesis.
Awareness was scored sei/ere/jam/werf (AS=2) when there the patient made no comment to
the first question, when he acknowledged memory impairments only on explicit questioning,
and when there were clear discrepancies between the patient's and the caregiver's anamnesis.
Awareness was scored as a t e / (AS=1) when the patient denied any problems related to
dementia, even when asked explicitly. Awareness was scored by the neuropsychiatrist, who
saw the patient first. In order to assess inter-observer reliability, awareness was scored
independently by two clinicians (a neuropsychiatrist and a neuropsychologist) in a subgroup of
20 consecutive patients. The kappa value was 0.70, indicating substantial interobserver
agreement [177]. Details about the assessment of awareness have been described elsewhere
[321].
As an indication of the extent of the change in personality, the sum of the scores for the
BDS subitems concerning changes in personality was calculated (BDS personality subscale,
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items 12-19). These eight subitems were: increased rigidity, increased egocentricity,
impairment of regard for feelings of others, corsening of affect, impaired emotional control,'
e.g. irritability; hilarity in inappropriate situations, diminished emotional responsiveness, and'
sexual misdemeanour, appearing de novo in old age. Each subitem could be scored as l' (the
specific change in personality was present for more than 6 months, or as 0 (no change, or the
change was present for less than 6 months). Scoring was carried out by an experienced
neuropsychiatrist on the basis of the information provided by the caregiver
A t-test was used to compare both groups on the variable age. Because of the ordinal level of
most of the data (GDS, HDRS, BDS, and the awareness score) nonparametric tests were used;
Wilcoxon two-sample tests, analysis of variance (ANOVA) with rank sums, and Spearman's rank-
order correlation coefficients (Rs) [285]. Probability (P) values lower than 0.05 were regarded
as being significant.
Results
The main patient characteristics of both groups are shown in Table 1. Seventy-nine percent of
the patients had (very) mild or moderate dementia, as measured by the GDS score (very mild,
GDS 3: 4 AD, 5 VD; mild, GDS 4: 12 patient in each group; moderate, GDS 5:22 AD, 23 VD;
severe, GDS 6:10 AD, 8 VD; very severe, GDS 7: no patients). Only nine patients, three with'
AD and six with VD, fulfilled DSM-III-R criteria for major depression. These numbers were too
small to carry out a meaningfull statistical analysis.
Table 1. Patient characteristics of matched groups
Alzheimer"s disease vascular dementia P
n=48 n=48
Age (mean,&ƒ} 72.9 ±7.6
Sex (M/F) 31/17
GDS (mean, sd) 4.8 ± ftp
BDS (mean, srf) 7.9 ±4.2
Duration in years (mean, so) 3.28 ± 2 4
Education (1-7) 3.6 ± j j
Note: GDS = Global Deterioration Scale, BDS = Blessed Dementia Scale. Level of education according to [3141:1:
primary school - 7: University grade.
73.9
31/17
4.7
8.0
3.31
3.7
±7.7
±0.9
±45
±2/
±/.5
ns
ns
ns
ns
ns
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AD
VD
mild moderate severe
Figure 1. Mean Hamilton's depression scores in patients with Alzheimer's
disease and vascular dementia, by severity of dementia
mild moderate severe
Figure 2. Mean awareness score in patients with Alzheimer's disease and vascular
dementia, by severity of dementia
mild moderal
Figure 3- Mean BDS personality-subscore in patients with Alzheimer's disease
and vascular dementia, by severity of dementia
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The mean scores on the HRSD did not differ significantly between the patients with AD and
those with VD (9.4 ± 9.4 for patients with AD, and 9.1 ± 4.5 for patients with VD; Z=-0,l6,
Wiicoxon test, n.s.). An analysis of the separate items of the HRSD did not reveal differences in
any of the subitems between the groups. A correlation between the severity of dementia
(GDS score) and the score on the HRSD was virtually nonexistent in both groups (Rs: 0.04 and
0.01 for AD and VD, respectively, n.s.), i.e., mildly demented patients of both etiologies had
similar depression scores compared to the more advanced stages.
Table 2. Distribution of awareness scores among patients with Alzheimer's disease and vascular dementia
Awareness
Intact Mildly Moderately Severely Total
disturbed disturbed disturbed
Alzheimer's disease 3 (6%) 17 (35%) 19 (39%) 9 (19%) -,„ ^ „ „ ,
Vascular dementia 6 (13%) 13 (27%) 20 (4296) 9 (19%) 48 (100%)
Total 18 (9%) 30 (31%) 39 (40%) 18 (19%) 141(100%)
The distribution of awareness scores is shown in table 2. The awareness scores were more or
less equally distributed among patients with AD and patients with VD (Wiicoxon test, n.s,). The
mean score on the personality subscale was 1.9 ± 1.2 for patients with AD and 1.3 ± 0.8 for
patients with VD. The scores were not statistically significantly different (Wiicoxon test).
The number of patients with depression, the Hamilton depression scores, the awareness scores
and the personality scores did not differ significantly between patients with AD or VD when
the items were analysed separately with a rank-sum ANOVA for mild (GDS 3 and 4), moderate
(GDS 5), and severe dementia (GDS 6) (see figures).
Discussion
The main conclusion that emerged from this study is that level of depression, lack of insight,
and personality changes occurin AD and in VD with comparable frequencies.
Differences between AD and VD with regard to depressive symptoms have been examined
in four other studies [64, 65, 94, 252]. The patients from our study were all ambulatory, in
contrast to the patients from these previous studies, which included hospitalized patients from
specialized wards. Therefore, the results of our study are difficult to compare with those of the
other reports. The two studies that used the IS of Hachinski [64,65] yielded higher
depression scores in the VD patients than in the AD patients. However, this might be related
to the fact that patients with depression have an increased change of being diagnosed as
having VD when the IS of Hachinski is used. The severity of dementia of the different groups
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was mentioned only in two studies, and in both reports the patients with AD appeared on
average significantly more severely demented than the patients with VD. In one of these two
studies [94], the patients with AD had higher depression scores than the patient with VD,
whereas the other study reported the opposite [64]. The study sample showing higher
depression scores in patients with VD consisted of chronic inpatients who were, on average,
nine years older than the patients of the other study. These differences probably influence the
study outcome.
There are hardly any other studies that explicitly addressed differences in the level of
awareness between these two types of dementia. We know of only one study, in which
awareness was reported to be significantly less impaired in VD than in AD [65]. However, this
study cannot be regarded as conclusive because there were no dear diagnostic criteria and
because of the vague operationalization of the terms.
Depression and preserved personality have been examined implicitly in several studies that
investigated the validity of Hachinski's IS [79, 83, 93, 192, 214, 269]. Without exception,
neither depression nor preserved personality appeared to discriminate between AD or VD.
Thus, there is no basis for the view that depression, preserved awareness, and/or personality
favor a vascular etiology rather than Alzheimer's disease. Therefore, these features should not
be included in the diagnostic criteria for vascular dementia.
Both the awareness scores and the BDS-personality subscores were associated with the
degree of the dementia, irrespective its etiology (Rs: 0.56, with p<.0001 and Rs: 0.23 with
p<0.05, respectively). In addition, age correlated significantly with the GDS score (Rs=0.49,
with pO.0001). When we would have compared the original group of (younger and less
disturbed) patients with AD to the patients with VD, the level of awareness and the personality
changes would have been significantly different between AD and VD. However, this finding
should be regarded as spurious, as the two groups would not have been comparable with
regard to age and severity of the dementia. This underscores the necessity to control for these
factors when different types of dementia are compared.
A limitation of our study may be that no pathological data were available to confirm the
clinical diagnosis. However, it should be emphasized that pathological data are of relatively
little value for the confirmation of the clinical diagnosis of VD, since the existence of ischemic
infarctions at autopsy does not prove that they actually caused the dementia. In this study, the
diagnosis of VD was based in this study on Rosen's IS. More elaborated diagnostic criteria have
been published very recently, but these were not available at the time of this study. Although
patients in the vaguest category of 'mixed' dementia (i.e., with a score on Rosen's IS of 3)
were not included in this study to avoid diagnostic uncertainties, the results may be still
somewhat different if the new and probably more accurate criteria would have been applied.
Conclusion
We conclude that depression or depressive symptoms, a lack of insight into ones ' deficits
and/or a preserved personality are not of relevance for the differential diagnosis between AD
and VD in outpatients with relatively mild stages of dementia.

11
Dementia, awareness and depression*
Introduction
It is well established that symptoms of depression occur more frequently in patients with
Alzheimer's disease (AD) and other dementing disorders than in the normal elderly population
[94, 182, 202, 340], Insight into the relationship between depression and dementia
contributes to the understanding of the pathogenesis of the disorder and has important
implications for the choice of therapeutic strategies. An overlap in the neuropathological and
neurochemical substrate of depression and AD, cerebrovascular disease and Parkinson's disease
has been suggested as a biological explanation for the higher prevalence rate of depression in
dementia (e.g., [62,295,342,343]). In contrast, psychological mechanisms underlying the
depressive symptoms of demented patients have received much less attention.
In this respect, the phenomenon of awareness in dementia may be relevant. The terms
unawareness of deficits, lack of insight and anosognosia (which are used interchangeably in this
article, in accordance with the literature) refer to a lack of knowledge or recognition of one's
deficits (e.g.,[205]). The few publications that exist on anosognosia in dementia report a
general pattern of decreasing insight with increasing severity of the dementing process [87,
205,258]. Depressive symptoms have been reported to occur also more frequently in mild
dementia than in the more severe stages [64, 94], Thus, depressed feelings in demented
patients may be seen as an understandable reaction, as a patient becomes aware of his or her
loss of intellectual capacity and impending deterioration; as insight deteriorates with the
progression of dementia, the patient may be less liable to suffer from depression (e.g. f 118
323,333]).
*Verhey FRJ, Rozendaal N, Ponds RWHMJollesJ. International Journal of Geriatric Psychiatry 1993; 8: in press
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The aim of this study was to ascertain whether or not depressive symptoms are indeed
more likely to occur in demented patients who have some degree of awareness of their
deficits than in those who lack this insight. We expected the outcome to show that patients
who are relatively aware of their deficits are more likely to develop depression or, at least,
depressive symptoms and that anosognosia may 'protect' against depressive symptoms in
dementia.
Patients and methods
The subjects were 170 outpatients with dementia who had been consecutively referred to the
Maastricht Memory Clinic of the University Hospital of Maastricht [316]. Dementia was
diagnosed according to the DSM-III-R criteria [7]. Patients were diagnosed as possible or
probable Alzheimer's Disease (AD) based on the NINCDS criteria [207], The diagnosis of
vascular dementia (VD) was based on a score of 4 or more on Rosen's modified Ischaemic Score
[269]. It should be noted that, in contrast to Hachinski's original IS, the modified IS does not
include the items depression and retained personality. Other etiologies were diagnosed
according to regular criteria. The severity of dementia was assessed by the Global
Deterioration Scale (GDS) [255]. In the assessment of depression in dementia, a distinction
was made between the syndrome of depression and symptoms of depression. A diagnosis of a
depressive syndrome was made according to the DSM-III-R criteria for Major Depressive
Episode without applying the organic exclusion [7]. The Hamilton Depression Rating Scale of
Depression (HRSD, 17 item version [120]) was administered to obtain a measure of the
severity of depression and as a checklist for depressive symptoms. The reliability of this
clinician-rated scale has been demonstrated in demented patients [113,235].
Assessmen/ <?ƒ awareness
No generally accepted standardized assessment procedure to measure anosognosia or
impaired awareness is available to date. For the purpose of this study, impaired awareness was
defined, according to Schachter (1990), as the absence of knowledge or recognition of
cognitive deficits. In analogy to others, the degree of awareness was assessed by comparing
the patients' and the caregivers' history (see [205, 278]). Awareness of deficits was rated on a
four-point scale, ranging from 4 ('intact') to 1 ('absent'), using the guidelines as are shown in
the appendix of this chapter. It was scored by the neuropsychiatrist who carried out the initial
interview with the patient and his or her caregiver.
Because of the ordinal level of most of the data, non-parametric tests were used for the
analysis of the dependent variables of awareness score, GDS score and depression score: rank-
order correlation coefficient (Spearman) for correlations between variables, Wilcoxon's test
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(rank sums) for group differences, and Kruskal-Wallis rank ANOVA with covariates, which
approximates a chi-square distribution [285). T-tests were used to examine differences in age
between the groups. Probabilities greater than 0.05 were considered as non-significant. In the
analysis of the HRSD-subitems, a level of P less than 0.002 was adopted according to a
Bonferroni-type adjustment, to protect against spurious significance arising from multiple
comparisons.
Results
The study group consisted of 170 patients, 103 with AD and 43 with VD and 24 with other
causes (seven Parkinson's disease, four frontal lobe dementia, two normal pressure
hydrocephalus, two alcohol related dementia, two Huntington's disease and seven
miscellaneous causes). Their mean age was 71.2 ± 8.6 years, sex ratio 77 males/ 94 females.
The mean duration of cognitive symptoms was 38.3 ± 28.2 months. Most patients were mildly
or moderately demented, as measured by the GDS score (very mildly demented, GDS 3: 17
patients, mildly demented, GDS 4: 77 patients; moderately demented, GDS 5: 55 patients;
severely demented, GDS 6: 21 patients). The mean score on the Mini-mental State
Examination [97] was 18.1 ± 6.1 (2-29). The three groups (AD, VD and others) differed with
regard to age (70.7, 74.0 and 68.0 years respectively, p<.05) and the degree of dementia
(average GDS scores 4.4,4.7 and 4.1 respectively, Wilcoxon chi-square: 11.3, DF=2, p<0.05).
Table 1. Distribution of awareness scores by severity of cognitive decline (GDS score) among 170 patients with
dementia.
GDS stage
3
4
5
b
Very mild dementia
Mild dementia
Moderate dementia
Severe dementia
Awareness-score
4
Intact
5
5
2
(29%)
(7%)
(4%)
(0%)
3
Mildly
disturbed
11 (65%)
45 (58%)
16 (29%)
1 (5%)
2
Moderately
disturbed
1
17
30
7
(6%)
(22%)
(55%)
(33%)
1
Severely
disturbed
- (0%)
10 (13%)
7 (13%)
13 (62%)
Total
17
93
48
41
(100%)
(100%)
(100%)
(100%)
In order to assess inter-observer reliability, awareness was scored independently by two
clinicians (a neuropsychiatrist and a neuropsychologist) in a subgroup of 20 consecutive
patients. The kappa value was 0.70, indicating substantial interobserver agreement [177].
Lack of insight was a common phenomenon in this population. Of the 170 patients, only
twelve (7%) were able to give their history spontaneously without there being clear
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discrepancies between their histories and that given by the caregiver. On the other hand, only
30 patients (18%) showed a complete lack of insight. Patients with AD tended to'have
somewhat higher awareness scores than patients with VD, but this difference was not
statistically significant (Kruskal-Wallis, chisq=2.62, df=2).
Table 2. Correlation coefficients (Spearman rank order, Rs) between awareness-scores and score on the Hamilton
Rating Scale of Depression (HRSD) in demented patients (n = 169).
mean Rs
M S D , foto/ score.- 9,14 0.03
1 Depressive mood
2 Suiddal ideation
3 Feeling of guilt
4 Insomnia, early
5 Insomnia, middle
6 Insomnia, late
7 Work and activities
8 Retardation
9 Agitation
10 Anxiety, psychic
11 Anxiety, somatic
12 Gastrointestinal complaints
13 Somatic complaints, general
14 Genital symptoms
15 Hypochondriasis
16 Loss of weight
17 Psychological insight
1.17
0.05
0.26
0.09
0.13
0.16
1.99
1.03
0.71
1.08
0.57
0.20
0.65
0.10
0.05
0.26
0.53
0.14
0.04
0.12
0.07
•0.05
0.01
•0.19
•0.09
•0.04
0.27*
0.11
0,02
0.06
0.10
0.01
•0.04
•0.05
Spearman-rank order correlation, * p < 0.0001
The awareness scores correlated significantly with age (Spearman rank order correlations -Rs-:
0.33 with p<0.0001). The distribution of the awareness scores by the severity of dementia
(measured by the GDS) is shown in Table 1. There was a significant negative correlation
between the GDS score and the awareness score (Rs:-0.51, with p<0.0001). In contrast to
what has been found in other studies [64, 94], we did not find a clear correlation between the
HRSD score and the GDS scores (Rs: 0.11, n.s.), i.e., patients who were mildly demented had
similar depression-scores to those with severe dementia. Only 16 out of 169 patients (9%), 9
with AD, 4 with VD, and 3 with other causes, fulfilled the DSM-IH-R criteria for major
depression (missing data:n=l). The distribution of the awareness scores was not unequal
between the patients with depression and those without (Kruskal-Wallis, chisq,=.05, df=l,
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ns). Actually, the majority of the patients with depression (9 out of 16) displayed little or no
insight into their cognitive deterioration. Using rank ANOVA with age and GDS scores as
covariate, no significant relation could be found between the awareness score and the
depression score (F=0.42, df=3, ns). Spearman rank order correlation coefficients between
the awareness scores and the scores on the HRSD (total and subitems) are shown in table 2.
The mean score on the HDRS was 9.1 ± 4.9 (0-25). No significant correlation could be found
between the total HRSD score and the awareness score (Rs=-0.03, n.s.). As is shown in this
table, only the score on the item 'psychic anxiety' showed a weak but significant correlation
with the awareness scores, i.e., patients showing a greater degree of insight had higher scores
on this subitem (R=0.28 with P<0.0001).
Discussion
This study showed that impaired awareness was very common in this sample of demented
patients. In only 7 percent of the patients were there no obvious discrepancies between the
history provided by the patient and that of the caregiver. However, it was also noted that
about half of the patients spontaneously reported problems with their memory at the opening
question, indicating at least some partial knowledge of their impairments. Thus, it seem
oversimplified to state that "it is not possible for patients with memory disorders to remember
that one has forgotten" [95].
A statistically significant correlation was found between the awareness scores and severity of
the dementia syndrome as measured by the GDS score, a finding which is consistent with
other reports [87,258]. No significant relationship could be demonstrated between the level
of awareness and the presence of major depression or the total score on the HRSD. The
relationship between awareness and depression in dementia has only been studied previously
in one study [87], in which also no significant correlation could be found between denial
scores and Hamilton depression scores. An additional finding in our study was that the
depression scores did not correlate with the severity of the dementia. Therefore, this study
cannot provide any support for the view that depression lessens as awareness deteriorates with
the increasing severity of dementia. A relatively intact awareness was not clearly associated
with the development of depressive symptoms in dementia and anosognosia did not protect
against depression. A modest but significant correlation could be found between awareness
scores and the HRSD- subscores on the item 'psychic anxiety' even after a Bonferroni type of
adjustment. Although this finding should be considered with caution untill further research has
been done, it may suggest that feelings of anxiety may be secondary to insight into cognitive
decline. This supports the notion that symptoms reflecting an internal psychic state are related
to psychological mechanisms [182], In contrast, major depression in dementia, apparently
unrelated to the degree of insight, may be predominantly based on neuropathological or
neurochemical abnormalities. The possible implications for the treatment of these complaints,
namely a more psychological approach to symptoms of anxiety, and an emphasis on biological
interventions for the treatment of major depression, should be looked at in further studies.
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It could be argued that the absence of a relationship between awareness and depression is
due to the fact that impaired awareness pertains to both cognition and depression. In this
view, a low score on HRSD items might simply reflect anosognosia for depressive feelings,
rather than the absence of these symptoms. However, this does not seem very likely, since
one may expect that severity of dementia would have correlated then with the depression
scores, which is not the case. Additionally, the applicability of the HRSD as an objective clinical
rating'scale, in contrast to self-report measures, has been demonstrated even in advanced
dementia [113, 235].
Some limitations in this study have to be considered. It is likely that patients who
experience cognitive decline will consent more readily to further evaluation in the Memory
Clinic than those without any complaints, and thus some degree of selection bias may have
been occurred. Furthermore, a four-point rating scale may be too global for the assessment of
such a complex phenomenon as awareness of deficits. Systematic investigation of anosognosia
has begun only recently, and to date, there is no assessment tool available that provides
reliable and valid information with certainty. Finally, the assessment of awareness in this study
was based on discrepancies between the patients' and the caregivers' reports and thus
depends largely on the reliability of the caregiver. However, caregivers of patients with AD
were recently found to be reliable informants of their relatives' memory deficits [168] and
thus, this does not seem an important source of error.
Conclusions
Our findings suggest that a relatively intact level of awareness in demented patients is not
accompanied by an increase in the prevalence of depression. However, it may lead to some
specific depressive symptoms, notably psychic anxiety. More research is needed to confirm
theresults of this study.
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Summary and concluding remarks
This thesis deals with clinical aspects of the early diagnosis and the differential diagnosis of
dementia, particularly in relation to depression and normal forgetfulness. The thesis opens
with a general introduction on the rationale of an early diagnosis of dementia (Öwpfór / ) .
The patients of the studies described have been examined in the Memory Clinic of the
Academic Hospital of Maastricht, between May 1986 and October 1992. The aims, methods
and organisation of the Maastricht Memory Clinic is presented. The MMC addresses especially
patients with cognitive impairments which are not severe enough to merit the diagnosis of
dementia or for patients who are suffering from mild stages of dementia. This specific aim of
the MMC is reflected by the characteristics of the patients: they were on average younger and
less cognitively impaired than in traditional psychogeriatric departments. Therefore, the
results of the studies of this thesis cannot be generalized to populations of older, more
severely disturbed patient groups without due consideration.
An introductory review of the literature on mild dementia is presented in CAajDfór 2 . The
aim of this review is to present the state-of-the art knowledge and to identify critical issues in
the research of mild stages of dementia. Dementia is generally regarded as a syndrome, not as
a disease, but important differences exist in the interpretation of this notion. Therefore, the
various meanings of the term are discussed first. Next, the most frequently used criteria for the
clinical diagnosis of dementia (the DSM-III-R criteria) and of Alzheimer's disease (those of the
NINCDS/ADRDA workgroup) are amply discussed. The accuracy of the diagnosis of dementia
has largely been improved by these diagnostic criteria. An attempt is made to depict the
clinical features of Alzheimer's disease before it has developed to frank dementia, on the base
of empirical data from longitudinal studies. The earliest manifestations of Alzheimer's disease
are qualitative rather than quantitative: patients may perform on traditional
128 CHAPTER 12
neuropsychological tests within normal limits, but they need more time and get tired easily.
Non-cognitive features are prominent in early stages: feelings of anxiety and psychological
vulnerability, passivity, an increased dependency on the environment and decreased
spontaneity are likely characteristcs of very early Alzheimer's disease. Unfortunately, non-
cognitive aspects have received much less attention than cognitive aspects. Among the earliest
neuropsychological deficits are impaired delayed recall, fluency and general speed of
information processing. It is concluded that the diagnosis of early Alzheimer's disease is based
on clinical judgement and repeated cognitive measures over time. It is not known, however,
which features can best be followed, and how long the intervals between the tests should be!
In recent decades, many different proposals have been made for the classification of the state
of mild memory impairment. These are discussed in view of their reliability and predictive
validity. Important clinical issues in the assessment of mild dementia are the differentiation
from normal aging, age-associated memory impairments and depression, clinical variations
related to subtypes of dementia, and the influence of comorbidity and age upon the diagnosis
of dementia.
The issues of studies of this thesis can be divided into three main themes: the influence of
the discipline that make the diagnosis, clinical features of non-demented subjects with
cognitive complaints and clinical characteristics of patients with dementia.
The influence of the discipline that make the diagnosis
In view of the fact that the diagnosis of dementia still depends to a large extent on clinical
judgement, it is quite remarkable that the influence of different specialists upon this diagnosis
has so far been neglected. Therefore, an experimental study of interdisciplinary differences in
the diagnosis of dementia was carried out, described in Giw/rfer j . An inquiry was held among
the participants of the Dutch consensus meeting on dementia. Eighty-five clinicians diagnosed
the case descriptions of ten patients with various forms of cognitive dysfunctions. There was no
difference between the disciplines with regard to syndrome diagnoses. However, with regard
to aetiology, significant differences existed between the specialties: neurologists were more
often in agreement with a "golden standard" diagnosis than the psychiatrists. Furthermore, the
level of consensus increased with the severity of the cognitive disturbances of the patients.
The diagnosis was more often erroneous when depressive symptoms existed. The nature of
the diagnoses appeared to depend on the discipline of the diagnostician. Finally, the number
of the various terms that were used by the responding clinicians was inversely related to the
severity of the cognitive deterioration.
In Chapter 4, the discrepancies in diagnostic outcome were examined between the
multidisciplinary, criteria-based approach in patients referred to the Memory Clinic and the
monodisciplinary approach of the referrers. Of the 278 patients not fulfilling the criteria
dementia, 19 had been previously diagnosed as being demented (specificity 0.93). In 60 of
152 demented patients, dementia had not been diagnosed before (sensitivity 0.61).
Underreporting was frequent in mildly demented patients and in patients with coexisting
SUMMARY 129
depressive symptoms. In patients referred by psychiatrists, sensitivity rates for dementia and
Alzheimer's disease were low; in patients referred by neurologists, depression often went
unreported.
In order to investigate whether the use of the MMC diagnosis as the 'gold standard' in the
above-mentioned study was correct, a study was carried out on the predictive validity of the
diagnoses of dementia from the MMC. Available clinical data were collected on the course of
the cognitive and behavioral symptoms of 114 patients, 81 with Alzheimer's disease and 33
with vascular dementia. Most patients were only mildly or moderately demented at the initial
assessment. After a mean period of 41 months (16.7-71.2), 95% of the patients were described
as having deteriorated since the initial assessment. This figure indicates that the diagnosis of
dementia, even in relatively mild stages, can be made reliably. This finding supports the
validity of the diagnostic model of dementia, as used in the MMC.
Mild dementia is not a diagnosis that can be made by rudimentary bedside screening
instruments, but neither do we believe that the diagnosis can only be made by esoteric
experts that use highly sophisticated technology. The main difference between our approach
and the usual monodisciplinary approach is the combined and integrated use of common
assessment methods that are used in daily clinical practice, and the consequent application of
generally accepted diagnostic criteria.Many sorts of data have to be taken into account. For
instance, it was found that referrers quite often failed to investigate the functional significance
of the cognitive impairments, as is required by criterion C of the DSM-HI-R.
The studies further confirm the stereotype ideas about several disciplines: psychiatrists and
psychologists are good at recognizing depression, neurologists look especially at brain
diseases, whereas physicians from nursing-homes and geriatricians pay particular attention to
potentially treatable causes such as polypharmacy. These are all important aspects, but
unfortunately a price has to be paid for specialization: psychiatrists did not always complete
the somatic diagnostic work-up, and neurologists and other somaticaily orientated clinicians
did not recognize psychiatric disorders. Thus, all of the specialties had specific advantages, but
also certain flaws. This is not say that each discipline should be blamed for not being an expert
in their colleague's area of interest, but rather to plead for more modesty when working
separately, as no one specialism knows everything. Neurologists, psychiatrists and
neuropsychologists complement each other in the early stages of dementia, whereas internists
or geriatricians may be of value in the older patient who has several other severe medical
disorders and significant comorbidity.
Thus, a more systematic use of multidisciplinary services for patients with cognitive
disorders is to be encouraged. However, such a multidisciplinary approach should be more
than the mere sum of the different elements. Special emphasis must be laid upon the
integrative abilities of each one: the different disciplines should be familiar with each other's
terminology and paradigms. Trainees in one relevant area need to be better educated in the
integration of their specific findings with those of others.
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Clinical aspects of non-demented patients with cognitive complaints
It is generally known that memory and other cognitive complaints are seen in a variety of
organic disorders, one of which is Alzheimer's disease. However, it is often not sufficiently
recognized that cognitive impairments are also a common feature of many functional
psychiatric disorders: in clinical practice major depression is often seen as the single functional
cause. The study described in Cfoz/Sfór <J was carried out in order to determine whether
psychiatric conditions other than depression are relevant in elderly patients with memory
disturbances. Therefore, 430 consecutive outpatients (242 males, 188 females; mean age 61.7
years) who visited the Maastricht memory clinic were examined by using a standardized
diagnostic procedure which included somatic, neurological, psychiatric and neuropsychological
examinations. Psychiatric disorders were diagnosed according to DSM-III(-R) criteria. Of 152
patients with dementia, 34 had a secondary depressive syndrome and 19 another secondary
psychiatric disorder. Of the 37 patients with an organic mental disorder other than dementia,
16 had an organic mood disorder. Of the other 241 patients, 152 had 159 primary psychiatric
diagnoses: there were 100 diagnoses of mood disorders (depression and dysthymia) and 59
diagnoses of other psychiatric disorders, especially adjustment disorders, anxiety disorders and
personality disorders. Together, no fewer than 40% of all primary or secondary psychiatric
diagnoses concerned other disorders than mood disorders. Therefore, the differential
diagnosis of memory deficits should encompass more than just looking at whether depression
is present or not. Moreover, the relationship between psychiatric disorders and cognitive
functioning is complex and requires a careful psychiatric assessment. The studies of this thesis
illustrate the idea that a too linear view on causality between the two, i.e., depression causing
cognitive impairments, does not do justice to the complex interplay between cognition,
substrate, emotionality and subjective meaning.
From a scientific point of view, studying the combination of psychiatric symptoms and
cognitive deficits in the elderly is of importance, because they may be the very first features of
dementing disorders. Longitudinal studies have indicated that these symptoms are often too
mild to merit the diagnosis of major depression. This condition may be covered more-or-less
by other DSM diagnoses, notably dysthymia. Q>#p/er 7 reports a study in which the nature of
cognitive functioning was examined in a group of 25 middle-aged dysthymic subjects, who
sought help for memory complaints in the Maastricht Memory Clinic. There were no differen-
ces in the performance of primary memory. However, their performance for secondary
memory was significantly inferior to that of controls matched for age, sex-distribution and
educational level. In addition, the performance on a memory scanning task (with subtasks with
increasing memory load) and the Stroop Colour-Word Interference Task was also impaired in
dysthymic subjects. The results suggest that dysthymic patients are characterised by a problem
with effort demanding processes; the patients appear to make more use of a controlled
processing strategy, which takes them more time and energy and which results in subjective
complaints.
Recent neuropsychological concepts have made it possible to unravel the process of
retaining information into different psychological operations, each one of which can be
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analysed separately, e.g., attention, speed of processing, susceptibility for interfering stimuli,
encoding strategies and rehearsal strategies, and au tomat ic versus cont ro l led process ing of
information. Tasks derived from this paradigm may provide m o r e insight into t h e psychological
processes of early Alzheimer's disease than the tasks that a re usually a d h e r e d to in medical
practice, in which old-fashioned terms such as sho r t - t e rm and long- te rm m e m o r y still
dominate. The findings of the study described in chap te r 7 illustrate this po in t clearly: all
dysthymic patients studied had scores within the normal range on Folstein's Mini-Mental State
Examination, a widely used, but static and not very demand ing test for n o n - d e m e n t e d subjects.
In contrast, when there was increasing memory load, t h e pe r fo rmances of t h e pa t ien t s
diverged significantly from those of the controls. The ques t ions w h e t h e r t h e cognitive dysfunc-
tions found in the memory clinic population can b e genera l ised to all dysthymic subjects ,
cannot be answered in the present study. Interestingly, the profiles of t h e dysthymic pat ients
had much in common with those seen in ageing. It is u n k n o w n yet t o wha t ex ten t t h e
neuropsychological deficits of the patients of this s tudy may b e caused by a p r imary
degenerative brain disease: we must wauit for the results of a longitudinal s tudy tha t is
presently carried out in our department. As our studies have been carried o u t in a m e m o r y
clinic, the relatively high proportion of patients that had cognitive complaints t oge the r with
functional disorders may be due to our method of pat ient selection. Therefore, the s tudy in to
the cognitive aspects of dysthymia should be reproduced in a general psychiatric practice, in
order to find out whether these findings can be genera l ized to less well-selected pa t ien t
samples.
Longitudinal studies can shed light upon the development of t h e psychiatric and cognitive
symptoms and their mutual relationship, and, hopefully, provide impor tan t clues abou t the
prodromes of dementia. In Giwpter 8, a two-year follow-up study of 65 n o n - d e m e n t e d patients
complaining of their memory is described. Forty seven pat ients could b e reexamined after a
mean follow-up period of 25.0±4 months. Patients w h o could be re tes ted had lower initial
depression scores than those who were not retested, indicating s o m e selective attrit ion. Six
out of 47 patients were found to be demented at follow-up. This figure is a manyfold of the
one that was to be expected. Patients with subsequent demen t i a were o lder and per formed
worse with regard to memory aspects, but were comparable to those w h o were n o t d e m e n t e d
at follow-up with regard to the depression score, and rat ings of cognitive and s e n s o m o t o r
speed. The level of depressive symptomatology did no t always parallel the d e g r e e of cognitive
impairments. Some patients appeared to be improved on b o t h measu re s of cogni t ion and
depression, but others deteriorated with regard to cognitive functions while t h e depress ion
score remained unchanged. These results indicate that affective disorders may cause cognitive
dysfunctions in some patients, and, inversely, be the (psychological) c o n s e q u e n c e in o the r s .
The conclusions of the study described are limited b e c a u s e of t h e many me thodo log ica l
problems that were involved. For instance, selective attrition s e e m inhe ren t to this type of
study, as those subjects who are the most uncertain and anxious abou t b e c o m i n g d e m e n t e d
are the most likely to refrain from participating in the study. Larger samples with longer follow-
up periods are necessary. Despite the limitations of this s tudy, it can b e c o n c l u d e d tha t
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departments such as the memory clinic are suitable for clinical research into the earliest
features of Alzheimer's disease.
Apan from a possible relationship between the cognitive aspects of psychiatric disorders
and dementia, there are other reasons why cognitive functioning deserves more attention
than they receive at present. Cognitive aspects of functional disorders are too often viewed as
mere epiphenomena, only of diagnostic significance because they are included in some of the
DSM-III-(R) criteria. It is important to note that the patients that were examined in our
memory clinic sought help primarily for their cognitive problems and not for their psychiatric
condition. Cognitive impairments may compromise the individual's capacity to function in
demanding activities. Besides, patients may perceive their limited cognitive capacity as the
first signs of dementia and become severely distressed. Therefore, the development of
therapeutic psychological interventions aimed at coping strategies for the cognitive
impairment is another negelcted area of research. Memory clinics can also be useful in this
respect.
Clinical aspects of patients with dementia
The differentiation between Alzheimer's disease and vascular dementia was, untill recently,
mainly clinical: Ischaemic scores, in which several clinical features are collected, have long'
been used as a diagnostic tool for the diagnosis of vascular dementia. However, more
elaborate diagnostic criteria have been published recently. The new criteria differ from the
old criteria in that brain-imaging data are taken into consideration and in that attention is paid
to the temporal relationship between stroke and dementia. Introduction of new criteria for
vascular dementia also has an impact on the diagnosis of Alzheimer's disease, as the frequency
of this latter diagnosis is directly to the exclusion of other disorders: vascular dementia is the
most frequent disorder to be ruled out. Cïwp/er 9 describes a comparison between six
currently used sets of clinical criteria for the diagnosis of vascular dementia in a sample of 109
demented patients. These are: the ischaemic scales of Hachinski, Rosen and Loeb, the criteria
from the DSM-III, those outlined by Erkinjuntii and coworkers, and those from the State of
California Alzheimer's Disease Diagnostic and Treatment Centres (ADDTC). Depending on
which criteria were used, the frequency of vascular dementia ranged from 13% to 33%, and
the frequency of Alzheimer's disease from 54% to 64%. The Ischaemic Scales of Hachinski and
Rosen resulted in the highest frequencies of vascular dementia, whereas the criteria of
Erkinjuntti et al., the DSM-HI criteria and the ADDTC yielded the lowest. The number of
patients with vascular dementia was reduced substantially when neuroradiological data and the
temporal relationship between stroke and dementia were taken into consideration. The
ADDTC criteria and those of Erkinjuntti seem to be the most advisable. The NINCDS-ADRDA
criteria for Alzheimer's disease should be adopted on this point, once the validity for the
criteria of vascular dementia has been established. Differences, in the criteria for vascular
dementia and Alzheimer's disease may be an overlooked source of interstudy variance.
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The study described in chapter 10 investigated the popular notion that depression, intact
awareness or preserved personality favour a diagnosis of vascular dementia rather than
Alzheimer's disease. Most of the studies on this subject have been carried out with severely
demented inpatients, and confounding factors such as age, sex and severity of dementia have
not been taken into account. We compared 48 patients with relatively mild vascular dementia
with 48 patients with Alzheimer's disease who were matched for age, sex and severity of
dementia. The two groups did not differ with regard to the prevalence of major depression,
the mean depression score, the awareness score or the sum of scores on the items of the
Blessed dementia Scale concerning personality changes. We concluded that depression, lack of
insight and personality changes do not favour an aetiology of vascular dementia rather than
Alzheimer's disease.
Chapter 11 reports a study into the relationship between insight into ones' own deficits
and depression in demented patients. It is commonly thought that demented patients may
become depressed when they become aware of their cognitive limitations, although the
empirical evidence for this notion is little. We examined 170 outpatients, 103 with
Alzheimer's disease, 43 with vascular dementia and 24 with various other causes, in order to
investigate whether or not depressive symptoms were more likely to occur in dementia
patients who had some degree of awareness of their cognitive deterioration. Awareness was
rated on a four point scale that assessed discrepancies between the patient's and the
caregiver's history. The level of awareness was significantly related to the severity of
dementia, but not to depression or to the score on Hamilton's depression scale. However, the
score on the item 'psychic anxiety' showed a significant correlation with the level of insight.
The occurence of anxiety and other non-affective psychiatric symptoms in dementia have
received much less attention than depression. It would be worthwhile investigating symptoms
of anxiety in demented patients more extensively, as the relationship to insight into one's
condition may suggest a more psychological origin. Related to this, symptoms of anxiety may
respond better to psychological treatments, such as psycho-education.
The studies in chapter 10 and 11 illustrate an important methodological point as well,
namely the necessity of considering age and degree of dementia when the characteristics of
the different types of dementia are to be compared. Our patients with Alzheimer's disease
differed from those with vascular dementia with regard to the degree of awareness and of
personality changes, but these differences disappeared after correction for age and severity of
the dementia. This point has not had enough coverage in the literature so far.
In general, cognitive aspects of dementia have received much more attention than the non-
cognitive aspects, although it is these aspects that cause the caregivers more problems for
than those related to cognition. That non-cognitive aspects of dementia are so often
neglected may be related to the fact that they are more difficult to measure. Therefore, more
refined instruments should be developed in order to establish these non-cognitive aspects
more precisely, both qualitatively and quantitatively. Psychopathological symptoms in organic
brain disorders are the subject of an ongoing research project in our department. Until better
measures for behavioural and emotional symptoms become available, we must rely on the
subtleties of clinical evaluation.

Samenvatting
Dit proefschrift gaat over de klinische aspecten van de vroege - en differentiële diagnose van
dementie. Het proefschrift begint met een algemene beschouwing over het nut van een
vroege diagnose bij dementie (foo/ifrta/fe f). De patiënten die voor dit proefschrift werden
onderzocht, werden tussen mei 1986 en oktober 1992 gezien in de polikliniek voor
geheugenstoornissen van het Academisch Ziekenhuis Maastricht. De doelstellingen, werkwijze
en organisatie van deze Maastrichtse geheugen-polikliniek worden in dit hoofdstuk
beschreven. Deze polikliniek richt zich vooral op patiënten met lichte dementie, of met
dermate lichte cognitieve stoornissen dat ze niet voldoen aan de diagnose dementie. Dit
weerspiegelt zich in de kenmerken van de patiënten: deze zijn in het algemeen jonger en
minder ernstig cognitief gestoord dan in traditionele psychogeriatrische afdelingen. Het
generaliseren van de bevindingen van dit proefschrift naar de situatie bij oudere patiënten
met ernstiger cognitieve stoornissen dient daarom met enige terughoudendheid piaats te
vinden.
Ter inleiding wordt in foojitafe^ een overzicht van de literatuur over het stellen van de
diagnose dementie, vooral in een licht stadium, gegeven. Het doel van dit overzicht is de
huidige stand van zaken te beschrijven, en belangrijke aspecten voor het onderzoek te
bespreken. In het algemeen wordt dementie beschouwd als een klinisch syndroom, maar deze
opvatting blijkt in de dagelijkse praktijk verschillend te worden geïnterpreteerd. Daarom
wordt eerst stilgestaan bij de verschillende betekenissen van het begrip dementie. In het
hoofdstuk wordt vervolgens ingegaan op de meest gehanteerde diagnostische criteria voor
dementie (de DSM-III-R-criteria) en de ziekte van Alzheimer (de NINCDS/ADRDA-criteria).
Door deze criteria is de betrouwbaarheid van de klinische diagnose dementie de laatste jaren
aanmerkelijk verbeterd. Daarna wordt er een poging gedaan om de allereerste verschijnselen
van de ziekte van Alzheimer te beschrijven aan de hand van empirische gegevens uit
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longitudinaal onderzoek. De allereerste verschijnselen van de ziekte van Alzheimer zijn vooral
kwalitatief: patiënten presteren op kwantitatieve psychometrische tests vaak nog binnen de
normale grenzen, maar hebben meer tijd nodig en zijn sneller moe. Niet-cognitieve
verschijnselen staan in de vroegste stadia van de ziekte van Alzheimer vaak op de voorgrond:
de patiënten zijn psychisch kwetsbaar, angstig, passief, afhankelijk van de omgeving,
teruggetrokken en minder spontaan. Deze niet-cognitieve aspecten zijn echter veel minder
onderzocht dan de cognitieve verschijnselen. De eerste neuropsychologische stoornissen
betreffen de uitgestelde herinnering, de vloeiendheid van de taal (fluency) en de snelheid
waarmee informatie wordt verwerkt. Een conclusie uit het literatuuroverzicht is dat de
diagnose 'beginnende ziekte van Alzheimer' vooral gebaseerd is op een kwalitatief klinisch
oordeel en op verschillende metingen van het cognitief functioneren in de tijd. Het is
evenwel nog onduidelijk welke symptomen zich het beste lenen om in de tijd vervolgd te
worden, en hoe lang de periodes tussen de tests zouden moeten zijn. In de laatste decennia
zijn er verschillende voorstellen gedaan om tot een classificatie te komen van patiënten met
lichte cognitieve stoornissen. Deze worden eveneens in dit hoofdstuk besproken, waarbij met
name gelet wordt op de betrouwbaarheid en de voorspellende waarde (predictieve validiteit)
van de verschillende concepten. Belangrijke problemen bij het diagnostiseren van lichte
dementie zijn verder het onderscheid met normale veroudering, veroudering-gerelateerde
geheugenstoornissen en depressie, de variatie in de verschijningsvormen en de invloed van
bijkomende ziektes en de leeftijd op de diagnostiek.
De onderwerpen van de onderzoeken uit dit proefschrift betreffen drie hoofdthema's,
namelijk de invloed van de discipline die de diagnose stelt, klinische kenmerken van
patiënten met cognitieve stoornissen bij wie geen sprake is van dementie, en klinische
kenmerken van patiënten met dementie.
De invloed van de discipline die de diagnose dementie stelt
Gezien het feit dat de diagnose dementie in belangrijke mate is gebaseerd op het klinisch
oordeel, is het opmerkelijk dat nauwelijks onderzocht is in hoeverre de discipline van de
diagnostics hierop van invloed is. Een experimenteel onderzoek naar de verschillen tussen de
disciplines in het diagnostiseren van cognitieve syndromen wordt beschreven in foq/M j .
Hiertoe werd er onder de deelnemers aan de Nederlandse consensus-vergadering over
dementie een enquête gehouden. Vijfentachtig clinici, afkomstig uit verschillende disciplines,
diagnostiseerden tien 'papieren' casus van tien verschillende patiënten met cognitieve'
stoornissen. Ten aanzien van de syndromale diagnose (dementie of geen dementie) werden er
geen verschillen tussen de disciplines gevonden. Ten aanzien van de etiologische diagnose
bleken er echter wèl significante verschillen te bestaan: neurologen bleken daarbij de
'gouden standaard' diagnosen meer te benaderen dan psychiaters. In geval van lichte
dementie liepen de meningen sterker uiteen dan in ernstiger gevallen. Men was het vaker
onderling oneens wanneer er ook sprake was van depressieve symptomen. De diagnostische
uitspraak bleek mede bepaald te zijn door de discipline die men vertegenwoordigde. Ten
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slotte bleek dat het aantal verschillende termen die door de respondenten werden gebezigd
in omgekeerde zin samenhing met de ernst van de cognitieve stoornissen.
in toq/fe/«& 4 wordt een onderzoek beschreven bij 430 patiënten naar de verschillen
tussen de diagnosen van de (multidisciplinair werkende) Maastrichtse polikliniek voor
geheugenstoornissen en die van (in het algemeen monodiscipliniar werkende) verwijzers,
vooral neurologen, psychiaters en huisartsen. Zestig van de 152 patiënten met dement ie
waren door de verwijzer niet eerder als zodanig gediagnostiseerd (sensitiviteit: 0.61). Dit
betrof vooral patiënten met lichte dementie en pat iënten die tevens depressieve
verschijnselen hadden. Van de 278 patiënten die niet voldeden aan de criteria voor dementie,
bleken er 19 eerder wel als dement te zijn gediagnostiseerd (specificiteit: 0.93). Bij de
patiënten die door psychiaters werden verwezen werden vaak de diagnosen 'dementie ' en
'ziekte van Alzheimer' gemist; bij de patiënten die door neurologen waren verwezen werd de
diagnose 'depressie' vaak niet gesteld.
In het hierboven beschreven onderzoek golden de diagnosen van de geheugenpolikliniek
als de gouden standaard waarmee de verwijzers werden vergeleken. Om na te gaan of een
dergelijke handelswijze geoorloofd was, werd er een onderzoek uitgevoerd naar de
voorspellende waarde van de diagnose dementie, zoals die was gesteld door de polikliniek
voor geheugenstoornissen (to/ata/fe 5). Hiertoe werden diverse beschikbare gegevens
verzameld over het beloop van het cognitief en algemeen functioneren van 114 demente
patiënten, 81 met de ziekte van Alzheimer en 33 met vasculaire dementie . De meeste
patiënten waren ten tijde van het eerste o n d e r z o e k o p de polikliniek voor
geheugenstoornissen slechts licht of matig dement. Na een gemiddelde periode van 41
maanden (16.7-71.2), bleken 109 van de 114 patiënten (95%) in cognitief en/of sociaal
opzicht slechter te functioneren dan bij het eerste onderzoek. De geldigheid van de diagnose
dementie, zoals die door de geheugenpolikliniek werd gesteld, wordt hiermee ondersteund.
De hier beschreven onderzoeken bevestigen de bekende ideeën over de diverse
disciplines: psychiaters en psychologen letten vooral op het voorkomen van depressie,
neurologen kijken vooral naar hersenpathologie en verpleeghuisartsen en geriaters letten
vooral op potentieel behandelbare medische aandoeningen, zoals polypharmacie. Dit zijn
ieder voor zich natuurlijk belangrijke aspecten, maar hier staat tegenover dat ieder specialist
ook zijn (haar) eigen blinde vlekken had: de psychiaters verrichtten onvolledig lichamelijk
onderzoek, de neurologen en de andere somatisch georiënteerde clinici mistten juist vaak
psychiatrische stoornissen. Kennelijk heeft ieder specialisme zijn sterke en zijn zwakke kanten
in de benadering van de patiënt met cognitieve stoornissen. Uiteraard kan men niet van de
verschillende disciplines verwachten dat ze expert zijn op het gebied van hun collega's. Wèl
nopen de resultaten van dit onderzoek tot meer bescheidenheid, want kennelijk is er geen
specialisme dat alle wijsheid in dezen in pacht heeft. Neurologen, psychiaters en
neuropsychologen vullen elkaar vooral bij lichte dementie goed aan. Internisten en geriaters
kunnen een waardevolle bijdrage leveren bij de oudere patiënt met meer bijkomende
lichamelijke aandoeningen.
Het is niet verwachten dat de diagnose 'lichte dementie" betrouwbaar gesteld kan worden
met behulp van een eenvoudige screeningstest, maar evenmin is de diagnose slechts
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weggelegd voor een handjevol superspecialisten die de beschikking hebben over zeer
gespecialiseerde onderzoeksmethoden. In feite was het belangrijkste verschil tussen de
diagnostische benadering van de geheugen-polikliniek en die van de verwijzers de
geïntegreerde multidisciplinaire aanpak en de consequente toepassing van algemeen
geaccepteerde diagnostische criteria. Voor de diagnose moeten vele gegevens van
uiteenlopende aard in beschouwing worden genomen. Zo bleek bijvoorbeeld dat verwijzers te
weinig letten op de functionele betekenis van de cognitieve stoornissen, zoals dat door het C-
criterium van de DSM-III-R bijvoorbeeld wordt vereist.
De bevindingen van deze onderzoeken pleiten voor een meer systematisch gebruik van
een multidisciplinaire benadering bij patiënten met cognitieve stoornissen. Een dergelijke
multidisciplinaire aanpak hoort evenwel meer te zijn dan alleen maar de som van de
afzonderlijke delen. Er dient meer nadruk gelegd te worden op de integratie van de
verschillende disciplines onderling: specialisten zouden meer van eikaars werkwijzen,
referentiekaders en terminologie op de hoogte moeten zijn. Studenten en assistenten zouden
bij het onderwijs in de verschillende specialismes meer dan thans het geval is geoefend
moeten worden in de integratie van de bevindingen van het eigen vak met die van hun
collegae.
Klinische aspecten van niet- demente patiënten met cognitieve verschijnselen.
Het is algemeen bekend dat klachten over het geheugen en andere cognitieve functies in het
kader van veel verschillende organische stoornissen voor kunnen komen. Het is echter veel
minder bekend dat cognitieve stoornissen ook een veel voorkomend verschijnsel zijn bij
diverse functionele psychiatrische stoornissen. In de dagelijkse praktijk wordt er bij het
onderzoek naar psychiatrische oorzaken voor geheugenklachten vrijwel uitsluitend aandacht
gegeven aan depressie. Het onderzoek dat in foq/fewK wordt beschreven, werd uitgevoerd
om na te gaan in hoeverre ook andere psychiatrische stoornissen dan depressie voorkomen bij
patiënten met geheugenklachten. Vierhonderddertig patiënten van de Maastrichtse
polikliniek voor geheugenstoornissen (242 mannen en 188 vrouwen, gemiddelde leeftijd 61,7
jaar) werden onderzocht volgens een gestandaardiseerd diagnostisch protocol, dat onder meer
een lichamelijk, een neurologisch, een psychiatrisch en een neuropsychologisch onderzoek
inhield. Psychiatrische stoornissen werden gediagnostiseerd volgens de criteria van de DSM-
III(-R). Van de 152 patiënten met dementie hadden er 34 tevens een depressief syndroom en
19 een andere bijkomende psychiatrische stoornis. Van de 37 patiënten met andere
psycho-organische stoornissen hadden er 16 een organische stemmingsstoornis, 21 andere
psychopathologie. Bij de overige 241 patiënten werden er bij 152 in het totaal 159
functionele psychiatrische diagnosen gesteld: in 100 gevallen betrof dat een stemmings-
stoornis, in 59 andere stoornissen, vooral angst-, aanpassings- en persoonlijkheidsstoornissen.
In het totaal betroffen maar liefst 40% van alle psychiatrische aandoeningen een andere
stoornis dan depressie of dysthymie. Hoewel stemmingsstoornissen dus de meest
voorkomende psychiatrische stoornissen waren in deze populatie, waren er diverse andere
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psychiatrische aandoeningen in het kader waarvan geheugenprob lemen ook konden
voorkomen. Het psychiatrisch onderzoek bij patiënten met geheugenklachten dient derhalve
niet uitsluitend gericht te zijn op het al dan niet vaststellen van depressieve verschijnselen.
Bovendien kunnen psychopathologie, cognitieve symptomen en onderliggend substraat op
verschillende wijzen met elkaar samenhangen. Aan de hand van een aantal casus wordt
duidelijk gemaakt dat een te lineair causale visie hierop (depressie als oorzaak van cognitieve
stoornissen) geen recht doet aan de ingewikkelde relatie die er kan bestaan tussen cognitie,
emoties en substraat. Het belang van een goed uitgevoerd psychiatrisch onderzoek bij de
patiënt met geheugenstoornissen wordt hiermee onderstreept.
Ook uit wetenschappelijk oogpunt is het van belang om onderzoek te doen bij patiënten
met de combinatie van psychiatrische verschijnselen en cognitieve stoornissen, omdat er
aanwijzingen zijn dat het bij hen relatief vaak zou kunnen gaan om de al lereerste
manifestaties van de ziekte van Alzheimer. Uit longitudinaal onderzoek is gebleken dat de
emotionele veranderingen die in het kader van beginnende ziekte van Alzheimer worden
gezien vaak niet zo ernstig zijn als bij een depressie in engere zin. Deze toestand voldoet
betrekkelijk vaak aan de criteria van dysthymie volgens de DSM-1II-R. In Aoq/i/sta& 7 wordt
een onderzoek beschreven naar het cognitief functioneren van 25 dysthyme patiënten van
middelbare leeftijd die in verband met geheugenklachten werden verwezen naar de
polikliniek voor geheugenstoornissen. Ten aanzien van het primaire geheugen werden geen
duidelijke verschillen tussen de patiënten en de controle-groep gevonden. Wat het
secondaire geheugen betreft presteerden deze patiënten echter gemiddeld slechter dan 25
normale proefpersonen met dezelfde leeftijd, geslachtsverdeling en opleidingsniveau. Verder
bleek dat de dysthyme patiënten sprake was van een vertraagd geheugen-zoekproces en van
een verhoogde afleidbaarheid voor taak-irrelevante stimuli. Deze bevindingen suggereren dat
althans deze groep van dysthyme patiënten wordt gekenmerkt door problemen bij inspanning
vereisende cognitieve processen. Dit gaat dan ten koste van tijd en (mentale) energie, en
leidt dan tot de subjectieve klachten van dysthymie.
Recente neuropsychologische concepten hebben het mogelijk gemaakt om geheugen-
processen te ontrafelen in verschillende psychologische operaties, die ieder afzonderlijk
kunnen worden onderzocht, zoals aandacht, snelheid van informatieverwerking, gevoeligheid
voor storende stimuli in de omgeving, het gebruik van strategieën bij het inprenten en
opdiepen van informatie, en het automatisch versus gecontroleerd verwerken van informatie.
Hiermee wordt een beter inzicht verkregen in de dynamiek van de psychische veranderingen
bij het begin van de ziekte van Alzheimer dan met de tests die traditioneel worden gebruikt
in de dagelijkse praktijk, waar nog altijd vrijwel uitsluitend begrippen als korte- en lange-
termijn geheugen worden gehanteerd. De bevindingen van het onderzoek in hoofdstuk 7
illustreren dit: alle onderzochte patiënten scoorden binnen de normale grenzen op de Mini-
Mental State Examination, een veel gebruikte maar statische en weinig belastende test voor
mensen die niet dement zijn. Bij de geheugenvergelijkingstaak bleek dat, naarmate het
geheugen meer werd belast, de prestaties van de dysthyme pat iënten s teeds meer
achterbleven bij die van de normale proefpersonen. Het profiel van de cognitieve stoornissen
bij de patiënten uit dit onderzoek vertoont overeenkomsten met dat wat o p oudere leeftijd
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verwacht kan worden. Het is derhalve mogelijk dat het hier gaat om een versterkt
leeftijdseffect wat het cognitief functioneren betreft. Dit onderzoek kan geen uitsluitsel
geven over de vraag in hoeverre de patiënten inderdaad lijden aan een beginnende primair
neurodegeneratieve aandoening zoals de ziekte van Alzheimer. Hiervoor moeten de
resultaten afgewacht worden van een longitudinaal onderzoek, dat thans in de polikliniek
voor geheugenstoornissen wordt uitgevoerd. Of de bevindingen gegeneraliseerd kunnen
worden naar andere dysthyme patiënten kan met dit onderzoek evenmin worden beantwoord
omdat er waarschijnlijk sprake is van een selectie van patiënten: allen werden immers naar
een geheugenpolikliniek verwezen in verband met cognitieve klachten.
Om meer te weten te komen over de voorstadia van dementie en over de samenhang
tussen cognitieve en psychische veranderingen werd een follow-up-onderzoek uitgevoerd bij
65 patiënten mèt geheugenklachten, maar zonder dementie. Dit onderzoek wordt in
Aoo/rfrfwè 8 beschreven. Na een periode van gemiddeld 25.0±4 maanden konden 47
patiënten weer opnieuw worden onderzocht. Patiënten bij wie follow-up onderzoek plaats
kon vinden hadden lage uitgangs-scores op de depressie-schaal van Hamilton dan de patiënten
die niet vervolgd konden worden. Er was dus sprake van enige selectieve uitval uit het
onderzoek. Zes van de 47 patiënten die werden vervolgd werden als dement
gediagnostiseerd bij follow-up. Dit aantal was een veelvoud van hetgeen mocht worden
verwacht op grond van bekende incidentiegegevens. Patiënten die dement waren geworden
waren gemiddeld ouder en hadden slechtere prestaties op de geheugenmaten dan degenen
die niet dement waren geworden, maar er werd verder geen verschil gevonden in score op de
depressieschaal of op de maten voor de cognitieve en de sensomotorische snelheid. Het bleek
dat de mate van stemmingsstoornissen niet altijd parallel liep met de mate waarin cognitieve
stoornissen aanwezig waren: sommige patiënten bleken na twee jaar te zijn verbeterd, zowel
in cognitief opzicht als wat hun stemming betreft; anderen waren juist in cognitief opzicht
verslechterd, met gelijke scores op de depressieschaal. Deze resultaten suggereren dat
stemmingsstoornissen bij sommige patiënten de oorzaak zijn voor de cognitieve stoornissen,
maar bij anderen juist het gevolg.
Een aantal methodologische problemen doen zich voor bij dit onderzoek. Zoals gezegd was
de uitval het onderzoek selectief. Dit probleem lijkt inherent te zijn aan het type onderzoek,
waarbij juist de personen bij wie de sterkste verdenking op beginnende dementie bestaat, het
meest onzeker zijn bij het onderzoek, en dus eerder van verdere deelname zullen afzien.
Bovendien ontbrak een controlegroep en konden bij een aantal patiënten niet alle gegevens
worden verkregen, omdat men bijvoorbeeld de taken te moeilijk vond en deze voortijdig
moest beëindigen. Hierdoor is het niet goed mogelijk 'harde' conclusies te trekken uit de
bevindingen van dit onderzoek. Een grotere groep van patiënten wordt thans een langere
periode vervolgd. Wel kan op basis van onze ervaringen met dit onderzoek worden gesteld
dat de geheugenpolikliniek een geschikte voorziening is om dit soort onderzoek uit te
voeren.
Afgezien van de mogelijke relatie tussen de cognitieve stoornissen en eventuele dementie,
is er nog een andere reden waarom het cognitief functioneren bij psychiatrische stoornissen
meer aandacht verdient dan tot dusver het geval is. Cognitieve stoornissen bij functionele
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aandoeningen worden te vaak nog beschouwd als een soort epifenomeen, hooguit relevant
omdat ze nu eenmaal in de DSM-III criteria staan. Het is van belang erop te wijzen dat alle
patiënten die in onze polikliniek voor geheugenstoornissen werden onderzocht in eerste
instantie hulp zochten voor hun cognitieve problemen en niet voor hun psychiatrische
toestand. Cognitieve stoornissen kunnen het functioneren van de patiënt aanzienlijk
beinvloeden. Bovendien zien veel patiënten hun geheugenklachten als een eerste teken van
dementie, hetgeen een extra bron van ongerustheid vormt. Het ontwikkelen van
therapeutische interventies die zich richten op het omgaan met deze cognitieve stoornissen is
een tot dusver verwaarloosd gebied. Geheugenpoliklinieken kunnen ook in dit opzicht van
waarde zijn.
Klinische aspecten van patiënten met d e m e n t i e
Het onderscheid tussen de ziekte van Alzheimer en vasculaire dementie werd tot voor kort
vooral gemaakt op basis van de kliniek. Vasculaire dementie werd vooral gediagnostiseerd met
behulp van één van de diverse ischemische scores, waarin een aantal klinische criteria
verzameld zijn. Niet lang geleden zijn er echter andere, meer omvattende, criteria voor
vasculaire dementie voorgesteld. Het verschil tussen deze nieuwe en de oude criteria is, dat
in de nieuwe voorstellen rekening wordt gehouden met gegevens van neuroradiologische
technieken zoals CT en MRI, en dat aandacht wordt gegeven aan de relatie in de tijd tussen
de dementie en eventuele beroertes. Het introduceren van nieuwe criteria voor vasculaire
dementie heeft rechtstreeks gevolgen voor de diagnose 'ziekte van Alzheimer', omdat deze
diagnose vooral gesteld wordt door andere aandoeningen uit te sluiten. Vasculaire dementie is
de meest voorkomende vorm van dementie die moet worden uitgesloten: de bekende
NINCDS/ADRDA criteria voor de ziekte van Alzheimer adviseren de ischemische score van
Hachinski hiervoor te gebruiken.
tfoq/Jtafe 9 beschrijft een onderzoek waarin zes verschillende maar veel gebruikte criteria
voor vasculaire dementie werden toegepast bij 109 patiënten met dementie. Deze criteria
waren: de ischemische scores van respectievelijk Hachinski, Rosen en Loeb, de criteria van de
DSM-III-R, de criteria van Erkinjuntii et al, en die van de State of California Alzheimer's
Disease Diagnostic and Treatment Centres (ADDTC). Afhankelijk van welke criteria werden
toegepast, varieerde de mate waarin vasculaire dementie in deze groep voorkwam van 13 tot
33%, en de ziekte van Alzheimer van 54 tot 64%. De ischemische scores van Hachinski en
Rosen leidden tot het hoogste aantal diagnosen vasculaire dementie. Het aantal patiënten met
vasculaire dementie nam duidelijk af wanneer de neuroradiologische gegevens en de
tijdsrelatie bij de diagnostiek werden betrokken. Deze aspecten zijn belangrijk en op grond
hiervan lijken de criteria van Erkinjuntii en die van de ADDTC de voorkeur te genieten. Dit
onderzoek laat evenwel geen uitspraken toe over de validiteit van de verschillende criteria.
Zodra de validiteit van de nieuwe criteria bevestigd is, dienen de NINCDS/ADRDA-criteria
voor de diagnose ziekte van Alzheimer op dit punt te worden aangepast.
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Het onderzoek beschreven in £oo/afsta& /O richtte zich op de wijdverbreide opvatting dat
depressie, aanwezig ziektebesef en een behouden persoonlijkheid differentiaal-diagnostisch
meer pleiten voor vasculaire dementie dan voor de ziekte van Alzheimer. De meeste
onderzoeken hiernaar werden uitgevoerd bij opgenomen patiënten met ernstige dementie,
en in het algemeen werd daarbij onvoldoende rekening gehouden met factoren als leeftijd,
geslacht en ernst van de dementie. Ten aanzien van deze aspecten werden 48 patiënten met
vasculaire dementie en 48 patiënten met de ziekte van Alzheimer, met dezelfde gemiddelde
leeftijd, geslachtsverdeling en ernst van de dementie, onderling vergeleken. De meeste
patiënten waren licht dement. De twee groepen verschilden onderling niet in de mate waarin
depressie voorkwam en hadden vergelijkbare scores op schalen waarmee de mate van
depressieve symptomen, de mate van ziektebesef en de mate van persoonlijkheids-
veranderingen werden gemeten. Op grond hiervan concludeerden wij dat deze aspecten geen
bijzondere waarde hebben bij de differentiële diagnostiek tussen vasculaire dementie en de
ziekte van Alzheimer.
//oo/ïfcfw£ / i beschrijft een onderzoek naar de relatie tussen ziektebesef en depressie bij
demente patiënten. Het wordt vaak aangenomen dat demente patiënten depressief worden
wanneer zij besef hebben van hun aftakelingsproces, maar empirisch onderzoek hierover is er
nauwelijks. Om na te gaan of depressieve verschijnselen inderdaad meer voorkomen bij
patiënten die blijk geven van enig besef van hun deterioratie, onderzochten wij 170 demente
patiënten, 103 met de ziekte van Alzheimer, 43 met vasculaire dementie en 24 met
verschillende andere oorzaken. De mate van ziektebesef werd vastgelegd op een vier-
puntsschaal, waarmee discrepanties tussen de anamnese van de patiënt en die van de
begeleider (gebruikt als referentie) werden nagegaan. Het bleek dat de mate waarin
ziektebesef aanwezig was omgekeerd samenhing met de ernst van de dementie, maar niet
met de het voorkomen van depressie of de score op de depressie schaal van Hamilton. Het
item 'psychische angst' van deze Hamilton-schaal hing daarentegen wèl significant samen met
het ziektebesef. Angstverschijnselen en andere niet-affectieve psychische symptomen zijn veel
minder dan depressie onderzocht bij demente patiënten. Het is van belang uitgebreider
onderzoek te doen naar het voorkomen van angstsymptomen bij dementie, omdat het
verband met een intact ziektebesef suggereert dat deze symptomen vooral psychologisch
bepaald zouden kunnen zijn. Depressie bij dementie zou daarentegen meer biologisch
bepaald kunnen zijn. Als dit waar is, heeft dit gevolgen voor de wijze waarop deze
verschijnselen therapeutisch moeten worden benaderd.
De onderzoeken beschreven in de hoofdstukken 10 en 11 laten nog een belangrijk
methodologisch punt zien, namelijk het belang rekening te houden met leeftijd en ernst van
dementie bij het vergelijken van klinische kenmerken van verschillende types dementie.
Aanvankelijk verschilden de patiënten met de ziekte van Alzheimer uit ons onderzoek wèl van
die met vasculaire dementie, maar dit verschil verdween nadat voor bovengenoemde
variabelen was gecontroleerd. In de betreffende literatuur is tot dusver onvoldoende rekening
gehouden met dit gegeven.
Hoewel cognitieve aspecten bij dementie veel meer aandacht genieten dan de niet-
cognitieve, zijn het vooral deze laatste symptomen die voor de verzorgers sterk belastend
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zijn. Dat er niettemin nauwelijks onderzoek gedaan is naar deze niet-cognitieve symptomen,
heeft wellicht te maken met het feit dat deze veel moeilijker te meten zijn. Daarom is het
noodzakelijk dat er verfijndere instrumenten worden ontwikkeld waarmee de niet-cognitieve
symptomen zowel kwantitatief als kwalitatief nauwkeuriger vast te stellen zijn. Zolang deze
instrumenten er nog niet zijn, moeten wij varen op de nuances van het klinisch onderzoek.
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Diagnostic criteria for forgetfulness and mild dementia:
Age-associated memory impairment (AAMI), Crook et a l . , 1986 [59]
1 Age above 50 years.
2 Complaints of memory loss reflected in everyday problems.
3 Onset of memory loss gradual, without sudden worsening in recent months.
4 Memory test performance at least 1 standard deviation below the mean established
for young adults in a test of secondary memory with normative data.
5 Evidence of adequate intellectual function as determined on the Vocabulary subtest
of the Wechsler Adult Intelligence Scale.
6 Absence of dementia as determined by a score of 24 or higher on die Mini-Mental
State Exaination.
7 Evidence of delirium, confusion, or other disturbances of consciousness.
8 Any neurologic disorder that could produce cognitive deterioration.
9 History of infective or inflammatory brain disease.
10 Evidence of cerebral vascular pathology as determined by the Hachinski Ischaemia
Score or by neuroradiologic examination,
11 History of repeated minor head injury or one major head injury.
12 Current psychiatric diagnosis (according to DSM-III criteria) of depression, mania or
major psychiatric disorder.
13 Current diagnosis or history of alcoholism or drug dependence.
14 Evidence of depression as determined by the Hamilton Depression Rating Scale score
of 13 or more.
15 Any medical disorder that could produce cognitive deterioration.
16 Use of any psychotropic substance or any other drug that may significantly affect cognitive
function.
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Global deterioration scale (GDS) , Reisberg et al., 1982 [255]
Very WH'W ccgra'tive dec/me (GDS 2- /o?ge#w/Kfósj5te):
Subjective complaints of memory deficits, most frequently in the following areas:
1 forgetting where one has placed familiar objects;
2 forgetting names one formerly knew well.
3 No objective evidence of memory deficits on clinical interview.
4 No objective deficits in employment or social situations. Appropriate concern with respect
to symptomatology
Afiitf cognitive afec/me f<S!DS3-'
Earliest clear-cut deficits.
Manifestations in more than one of the following areas:
1 patient may have got lost when travelling to an unfamiliar location
2 co-workers become aware of patient's relatively poor performance
3 word and name finding deficit become evident to intimates
4 patient may read a passage or a book and retain relatively little material
5 patient may demonstrate decreased facility in remembering names upon introduction to
new people
6 patient may have lost or misplaced an object of value
7 concentration deficit maybe evident on clinical testing
8 Objective evidence of memory deficits obtained only with an intensive interview
9 Decreased performance in demanding employment and social settings
10 Denial begins to become manifest in patient. Mild to moderate anxiety accompanies
symptoms.
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Clinical dementia rating (CDR) Hughes et a l . 1982 [139]
Qwesto/wè/e rfemenftö (COR 0,5J:
1 Mild consistent forgetfulness; partial recollection of events; "benign forgetfulness"
j t ó no more to too o/tóe/o//oiww#
2 Some difficulty with time relationships; oriented for place and person at examination but
may have geographic disorientation
3 Moderate difficulty in handling complex problems; social judgement usually maintained
4 Unable to function independently at community affairs though may still be engaged in
some; may still appear normal in casual inspection
5 Mild but definite impairment of function at home; more difficult chores abandoned; more
complicated hobbies and interests abandoned
6 Needs occasional prompting in personal care
Or:
1 No memory loss or slight inconstant forgetfulness
and too of the above mentioned criteria 2 - 6
1 Moderate memory loss, more marked for recent events; defects interferes with everyday
activities
A ta tóree o/ tóe /o tomg;
2 Some difficulties with time relationships; oriented for place and person at examination but
may have geographic disorientation
3 Moderate difficulty in handling complex problems; social judgement usually maintained
4 Unable to function independently in community affairs though still be engaged in some;
may still appear normal to casual inspection
5 Mild but definite impairment of function at home; more difficult chores abandoned; more
complicated hobbies and interests abandoned
6 Needs occasional prompting in personal care
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CAMDEX Roth et aL, 1986 [271, 272]
1 Limited and variable impairment in acquisition of new information and in recalling recent
events
2 An increased tendency to misplace and lose possessions
3 Minor and variable errors in orientation
4 Some blunting in the capacity to follow or pursue a reasoned argument and to solve
problems
5 Occasional errors (but of slowly advanced frequency) in occupational tasks and/or
housework, Errors of judgement on occasion in professional or highly skilled tasks or
socially responsible roles requiring difficult decisions or choices
6 Self-care unimpaired
7 Emotional life and responses well preserved
8 Clinical examination usually yields negative results except for manifest anxiety when asked
to carry out demanding tasks
ear
1 Difficulty in acquiring new information and recalling recent events. Belongings are
therefore lost or misplaced and information imparted intermittently forgotten or totally
lost
2 Orientation as regards the date, day or week, time and place is impaired to a limited
extent or in a patchy and inconsistent manner
3 Impairment is evident in activities demanding problemsolving or reasoning
4 speech shows mild defects in respect of clarity of meaning
5 Defects of knowledge of names of prominent figures, important events, simple
geographical information
6 Impairment of skills in daily living, errors and confusion of tasks in everyday work,
mistakes in housework, cooking (inappropriate ingredients or other errors). More
conspicuous errors of judgement and inappropriate conduct in professional, highly skilled
or socially responsible activities
7 Self care mildly impaired or not at all. There may be occasional errors in dress and a
limited decline from usual standards of tidiness and cleanliness
8 Emotional responsiveness may be well retained or mildly impaired according to the type
of dementia. There may be blunting or lability of emotion or both
9 Clinical examination at this stage shows the social facade well preserved, but systematic
enquiry reveals indoubitable cognitive deficits and emotional or personality changes
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Items of six different sets of criteria for the diagnosis of ischaemic vascular
dementia
abrupt onset
stepwise deterioration
fluctuation
nocturnal confusion
preserved personality
depression
somatic complaints
emotional lability
hypertension
history of strokes
signs of ath.sclerosis
focal neural, symptoms
focal neurol. signs
low density area on ct
multiple strokes
temporal relation
Hachinski
[117]
2
1
2
1
1
1
1
1
1
2
1
2
2
-
•
Rosen
[269]
2
1
-
-
-
-
1
1
1
2
•
2
2
-
-
Loeb
[192]
2
-
-
-
-
-
-
-
-
1
-
2
2
2/3a
-
DSM-III Erkinjuntti ADDTC
[7] [83] [46]
+
+
-
+
-
-
-
-
+ - +
-
+ + +
+ + +
±± + +
±± + +c
+b +d
note: + = obligatory; ±±= ambiguous
a either isolated (2 points) or multiple (3 points) hypodense areas on ct scan
b in absence of a temporal relation: probable vd
c at least one infarct outside the cerebellum
din case of a single stroke
166 APPENDIX OF CHAPTER 11
Guidelines for the rating of awareness of cognitive deficits
General instructions:
After the clinician has introduced himself, he concentrates on the patient, and the caregiver is
requested to refrain from any comment. The following questions are asked:
/Yftzse te/Z me aèotó tóe/voWemsj'Oü «reèere/or. \% «War.... seratyou to /te c/;ratf
When the patient has other complaints not directly related to dementia:
Do jow £a t>e awy ctóer comp&w'rate?
When the patient has no spontaneous complaints about his cognitive functions:
Wow «jour memory yunc/iontflg ? Lto jyou fMz£ jou tew a poor memory ?
When the patient denies deficits of memory or other cognitive functions:
So, tóere are no memory /woè/ewis af a//? 7s e^ eryfMzggomg a// ngfe/or you?
After these opening questions, the complaints are discussed more extensively in an open
interview, in which the clinician tries to get an impression of the degree and the nature of the
cognitive symptoms and the patient is asked to provide examples.
Then, the clinician puts the same questions to the caregiver adapted to find out about the
patients' cognitive functions (e.g., U%aY«Vr.... r^ erra/_yoar/a/i!)er/motóer/... toftec/mfc.?).
Scoring of awareness is made directly after the interview. Allowance should be madein scoring for
cognitive impairments such as paraphasias or concretisms (eg, "72m is a We m my èrcwz").
Scoring
Patient has adequate knowledge of his cognitive deficits.
Spontaneous complaints about memory or other cognitive
disfunctions. Gives examples. History of the patient is congruent
with the history of the informant.
3 MW/y flïy/wrèeo' Patient has some knowledge of his cognitive deficits, but with some
gaps. Spontaneous complaints about memory. History of the patient
shows some discrepancies with the history of the informant.
Patient has only vague and passive knowledge of cognitive deficits.
No spontaneous complaints, admits to memory deficits only when
questioned about them. Obvious discrepancies with the history of
the informant.
Denies any deficits. No complaints about memory whatsoever, even
after explicit questioning.
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